shaona
william
pornpun
ferdinand
amber
peter
glen
christoph
present
author
chrispow
ualbertaca
medicin
univers
alberta
medic
microbiolog
immunolog
univers
alberta
psychiatri
univers
alberta
background
neuropsychiatr
disord
hivaid
common
although
contribut
infect
brain
particular
individu
gene
occurr
brain
disord
unknown
herein
vivo
transgen
model
gener
nef
gene
express
myeloid
cell
ensu
neurobehavior
phenotyp
associ
molecular
chang
investig
method
transgen
tg
mice
gener
express
full
length
nef
control
cfm
promot
neurobehavior
perform
assess
locomotori
forc
swim
fst
elev
plu
maze
epm
tmaze
test
host
gene
transgen
express
assess
brain
myeloid
cell
sqrtpcr
immunoblot
enzymat
activ
immunohistochemistri
biogen
amin
measur
hplc
result
tg
anim
exhibit
nef
express
brain
microglia
cultur
macrophag
tg
anim
display
hyperact
behavior
includ
augment
locomotor
activ
decreas
immobl
forc
swim
test
increas
openarm
epm
explor
compar
wildtyp
wt
litterm
p
total
dopamin
level
mao
activ
dopamin
transport
dat
express
reduc
striatum
tg
anim
p
tg
anim
display
increas
express
concurr
ifnalpha
suppress
striatum
compar
wildtyp
litterm
p
conclus
nef
express
microglia
disrupt
striatal
dopaminerg
pathway
conjunct
increas
express
result
manialik
behavior
phenotyp
shruti
nagagop
present
author
sagnihot
bidmcharvardedu
gener
hospit
harvard
medic
school
boston
current
affili
beth
israel
deaco
medic
center
boston
gener
hospit
harvard
medic
school
boston
background
varicella
zoster
viru
vzv
reactiv
well
known
caus
herp
zoster
howev
also
associ
variou
neurolog
complic
occur
without
rash
describ
case
seen
institut
present
diagnost
challeng
case
year
old
healthi
male
present
hemineglect
due
pariet
hemorrhag
next
sever
month
develop
multiterritori
ischem
infarct
seizur
vascular
imag
cerebrospin
fluid
csf
examin
normal
eight
month
sinc
initi
present
develop
meningoenceph
herp
zoster
csf
posit
vzv
pcr
case
year
old
male
aid
recent
chemotherapi
burkitt
lymphoma
present
progress
monoparesi
follow
paraparesi
urinari
retent
mri
show
patchi
hyperintens
gadolinium
enhanc
lesion
lower
spinal
cord
conu
zoster
rash
emerg
day
ill
csf
pcr
vzv
posit
case
year
old
hiv
posit
male
treatment
develop
fever
dysphagia
somnol
mri
demonstr
hydrocephalu
confluent
hyperintens
along
basal
cistern
slyvian
fissur
along
diffus
leptomening
enhanc
initi
lp
show
wbc
increas
three
day
later
later
develop
zoster
rash
seizur
csf
vzv
pcr
posit
case
year
old
femal
aid
develop
hemiparesi
difficulti
speech
mri
brain
identifi
multipl
acut
infarct
cta
show
irregular
multipl
larg
medium
size
vessel
csf
show
wbc
normal
protein
posit
vzv
pcr
conclus
vzv
reactiv
complic
vasculopathi
meningoenceph
cranial
nerv
palsi
myelopathi
myeloradicul
also
occur
seemingli
immunocompet
patient
preced
even
absenc
rash
csf
may
may
show
pleocytosi
melissa
dionna
w
joan
w
cecilia
lishomwa
c
bruce
present
author
bshirami
hawaiiedu
center
aid
john
burn
school
medicin
univers
hawaii
honolulu
hi
einstein
colleg
medicin
new
york
ny
background
monocyt
mo
increasingli
recogn
reservoir
hiv
implic
pathogenesi
hivassoci
neurocognit
disord
hand
despit
effect
combin
antiretrovir
therapi
cart
transmigr
characterist
monocyt
traffic
central
nervou
system
mo
subset
hiv
dna
content
may
import
understand
mechan
lead
hand
sought
adapt
establish
invitro
bloodbrainbarri
bbb
model
use
translat
approach
use
blood
patient
drawn
real
time
set
pbmc
cocultur
establish
mo
subset
transmigr
bbb
model
quantit
hiv
dna
subset
materi
fresh
peripher
blood
mononuclear
cell
pbmc
obtain
cartsuppress
hivseroposit
patient
four
distinct
mo
subset
base
variat
express
isol
pmbc
cell
sort
integr
hiv
dna
quantifi
mo
subset
pcr
prebbb
anoth
aliquot
pbmc
place
transwel
cultur
invitro
bbb
model
establish
human
vascular
endotheli
cell
astrocyt
target
migrat
use
chemokin
hour
transmigr
cell
rephenotyp
assess
mo
subset
represent
cell
sort
reanalyz
hiv
dna
copi
number
postbbb
result
mo
subset
pbmc
transmigr
across
bbb
character
flow
cytometri
approxim
log
higher
copi
number
hiv
dna
postbbb
transmigr
mo
cell
conclus
translat
use
invitro
bbb
model
may
help
clinic
research
examin
role
mo
hand
incorpor
combin
invitro
bbb
transmigr
studi
quantifi
hiv
dna
character
mo
subset
intervent
studi
may
contribut
understand
pathogenesi
hand
cs
ln
bs
jwb
dww
merck
graduat
scienc
dissert
fellowship
dww
benjama
michael
wen
tatyana
vanessa
brian
matthew
shendra
brandon
nirzari
julio
jeffrey
brian
william
brian
present
author
drexelmededu
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
infecti
diseas
hiv
medicin
depart
medicin
drexel
univers
colleg
medicin
consult
ltd
human
immunodefici
viru
type
infect
result
product
extens
number
genet
variant
base
infidel
viral
revers
transcriptas
select
pressur
encount
cours
diseas
viral
adapt
involv
genet
alter
across
genom
genet
signatur
preferenti
associ
viral
phenotyp
categor
base
coreceptor
usag
dual
tropic
virus
sequenc
current
major
coreceptor
usag
determin
predict
differ
silico
methodolog
util
positionspecif
score
matrix
pssm
algorithm
sequenc
deriv
lo
alamo
nation
laboratori
lanl
databas
drexelm
hivaid
genet
analysi
cohort
classifi
genotyp
associ
specif
colinear
long
termin
repeat
ltr
tat
vpr
genotyp
pattern
differenti
amino
acid
daa
signatur
tat
vpr
well
differenti
nucleotid
dn
signatur
ltr
identifi
viru
util
maximum
likelihood
tree
build
strategi
genet
related
readili
character
wherea
tat
vpr
ltr
hand
genet
divers
genesregion
interest
determin
mean
genet
distanc
mgd
evalu
group
indic
differenti
evolut
viral
genet
theoriz
differenti
signatur
also
use
defin
differ
genotyp
phenotyp
virus
accur
order
develop
next
gener
diagnost
prognost
tool
examin
diseas
develop
new
therapeut
vaccin
prevent
treat
hivaid
associ
neurolog
complic
work
support
nihnind
nida
nimh
nimh
david
alvarez
biswajit
da
jonathan
karn
present
author
caseedu
case
western
reserv
univers
wherea
incid
hivassoci
dementia
declin
due
success
antiretrovir
treatment
preval
milder
form
includ
asymptomat
neurocognit
impair
ani
minor
neurocognit
disord
mnd
increas
ani
mnd
part
known
hivassoci
neurocognit
disord
hand
howev
molecular
mechan
explain
regul
hiv
activ
brain
remain
illdefin
transrepress
pathway
recent
describ
regul
glial
cell
respons
brain
inflamm
limit
overreactiv
nfkappabdepend
proinflammatori
gene
report
unlik
latentlyinfect
tcell
latentlyinfect
microgli
cell
hiv
induc
pharmacolog
inhibitor
corest
complex
chromatinmodifi
enzym
inhibitor
also
sensit
cell
lpsmediat
hiv
reactiv
shrnamedi
knockdown
corest
yield
similar
result
chromatin
immunoprecipit
analysi
follow
high
throughput
next
gener
sequenc
reveal
upon
microglia
treatment
tnfalpha
nuclear
receptor
corepressor
strongli
interact
facilit
transrepress
present
hiv
promot
activ
recruit
earliest
time
point
presenc
fluctuat
time
likewis
corest
recruit
hiv
promot
chang
epigenet
signatur
lower
repressor
role
protein
regul
hiv
emerg
latenc
confirm
unbias
shrna
screen
factor
involv
maintain
hiv
silenc
latentlyinfect
microgli
cell
data
indic
axi
play
role
prevent
hiv
overreactiv
microgli
cell
studi
mechan
detail
may
provid
therapeut
target
treatment
hand
david
alvarez
yoelvi
garciamesa
biswajit
da
stephani
miln
roja
roxana
jonathan
karn
present
author
caseedu
case
western
reserv
univers
tolllik
receptor
tlr
recogn
molecul
deriv
microb
play
key
role
mediat
innat
immun
respons
multipl
tlr
typic
express
cell
monocyt
lineag
includ
microglia
microgli
cell
constitut
major
reservoir
hiv
infect
brain
inflammatori
condit
central
nervou
system
cn
believ
induc
hivassoci
neurocognit
disord
hand
use
hivlat
infect
microgli
cell
line
investig
whether
tlr
stimul
induc
hiv
transcript
treatment
panel
tlr
ligand
includ
mycobacterium
tuberculosi
mtb
deriv
molecul
found
unlik
monocyt
cell
reactiv
hiv
tlr
ligand
significantli
restrict
microglia
flagellin
agonist
lesser
extent
lipopolysaccharid
lp
agonist
abl
reactiv
hiv
htertimmort
glial
hthmicrogliahiv
human
fetal
microgli
cell
contrast
agonist
potent
reactiv
hiv
cell
lesser
extent
schiv
monocyt
cell
nfkappabdepend
manner
mtbderiv
molecul
lprg
potent
agonist
reactiv
hiv
schiv
cell
unlik
show
signific
express
conclud
tlr
signal
probabl
play
minor
role
activ
hiv
replic
cn
potenti
drive
replic
peripher
monocyt
cell
surendra
alexand
colleen
stephani
patricia
lorrain
benjamin
denni
present
author
asuren
mailmedupennedu
neurolog
perelman
school
medicin
univers
pennsylvania
patholog
univers
texa
medic
branch
primari
human
monocytederiv
macrophag
mdm
infect
hiv
express
induc
antioxid
respons
protein
heme
specif
strongli
reduc
late
infect
time
correl
increas
neurotoxin
releas
infect
mdm
examin
rna
deriv
frontal
cortex
autopsi
individu
texa
neuroaid
research
center
brain
bank
cohort
hiv
hiv
hiv
case
confirm
hand
enceph
confirm
enceph
hive
rna
level
measur
qpcr
abi
taqman
primer
target
gene
normal
gapdh
valu
report
deltact
contrast
protein
reduct
signific
specif
increas
mrna
hiv
patient
group
separ
differ
signific
hive
patient
nonencephalit
brain
addit
hand
patient
without
enceph
also
show
increas
mrna
level
observ
posit
correl
mrna
interferon
induc
chang
proteasom
apparatu
may
lead
increas
degrad
despit
increas
rna
small
signific
decreas
rna
inn
hiv
infect
mdm
similar
decreas
rna
thu
account
strong
specif
reduct
protein
infer
sourc
increas
rna
hiv
brain
infect
mdm
posit
astrocyt
highli
induc
major
sourc
rna
conclud
rna
express
induc
potenti
antiinflammatori
respons
brain
hiv
infect
lead
specif
protein
loss
possibl
enhanc
proteasom
degrad
restor
loss
could
feasibl
therapeut
target
neuroprotect
hand
carlo
amorin
daep
eliseo
eugenin
present
author
carlodaep
rutgersedu
rutger
univers
public
health
research
institut
dengu
viru
denv
annual
affect
million
individu
worldwid
approxim
case
develop
dengu
hemorrhag
fever
known
treatment
avail
vaccin
current
market
increas
global
dispers
denv
mosquito
vector
emerg
pathogen
demand
attent
patient
suffer
sever
denv
infect
often
exhibit
encephalopathi
enceph
suggest
viru
success
infiltr
bloodbrain
barrier
bbb
infect
local
cell
popul
thu
neg
impact
normal
central
nervou
system
cn
function
howev
exact
mechan
denv
neuropathogenesi
unknown
current
data
show
denv
infect
human
primari
pbmc
lead
increas
hr
pi
absolut
monocyt
popul
compar
uninfect
control
also
detect
signific
elev
sever
adhes
molecul
ie
jama
surfac
monocyt
requir
monocyt
transmigr
across
bbb
determin
qrtpcr
western
blot
confoc
microscopi
furthermor
result
show
despit
infect
human
primari
astrocyt
increas
observ
cultur
supernat
collect
denvinfect
human
primari
astrocyt
similarli
laboratori
previous
show
elev
hiv
infect
essenti
enhanc
monocyt
transmigr
cn
togeth
data
suggest
denv
infect
increas
monocyt
popul
akin
hiv
increas
adhes
molecul
express
chemokin
product
among
bbb
cell
astrocyt
propos
elev
astrocyt
increas
express
surfac
adhes
molecul
key
compon
denv
neuropathogenesi
carolin
gloria
von
tori
ned
justin
avindra
present
author
nihgov
infect
nervou
system
nation
institut
neurolog
disord
stroke
nation
institut
health
hopkin
univers
depart
neurolog
background
clear
neurocognit
dysfunct
may
occur
despit
adequ
antiretrovir
therapi
unknown
may
ongo
neuron
injuri
neurocognit
normal
individu
method
immunostain
autopsi
brain
tissu
seven
hivinfect
virolog
wellcontrol
individu
five
hivneg
age
gender
match
control
antibodi
neurofila
heavi
chain
nfh
develop
elisa
measur
nfh
sensit
pgml
csf
cohort
hiv
infect
patient
analyz
compar
patient
remit
relaps
multipl
sclerosi
ms
noninflammatori
neurolog
diseas
ond
valu
present
meansem
result
immunostain
pariet
lobe
show
nfh
found
cytoplasm
neuron
hivinfect
individu
frequent
hiv
neg
control
csf
analysi
baselin
show
hiv
patient
significantli
p
elev
nfh
rang
pgml
vs
ms
pgml
ond
pgml
individu
normal
neurocognit
function
pgml
significantli
differ
asymptomat
pgml
mild
neurocognit
dysfunct
pgml
dementia
patient
undetect
csf
plasma
viral
load
group
patient
yr
age
higher
nfh
level
versu
p
correl
nadir
cell
count
cn
penetr
efficaci
score
art
note
month
follow
older
patient
greater
increas
nfh
level
conclus
clear
evid
ongo
neuron
injuri
neurocognit
normal
individu
hiv
infect
degre
injuri
compar
neurocognit
impair
individu
influenc
age
moniqu
yoshimi
raya
nyater
yuetsu
unsong
steven
present
author
mailnihgov
branch
nind
nih
uva
branch
nind
nih
immunolog
graduat
school
medicin
univers
ryuku
neurolog
virginia
commonwealth
univers
human
retroviru
associ
adult
tcell
leukemia
lymphoma
atll
well
neuroinflammatori
disord
associ
myelopathi
tropic
spastic
paraparesi
hamtsp
patient
primarili
found
cell
subset
regulatori
cell
treg
cell
respons
peripher
immun
toler
known
dysfunct
hamtsp
howev
due
inher
inflammatori
compon
hamtsp
marker
normal
use
character
reg
problemat
differenti
treg
recent
evid
shown
express
function
determin
epigenet
specif
dna
methyl
tregspecif
methyl
region
tsdr
precis
character
treg
cell
analyz
methyl
statu
specif
cpg
tsdr
pbmc
cell
cell
normal
healthi
donor
nd
hamtsp
patient
demonstr
decreas
demethyl
pbmc
cell
hamtsp
patient
compar
nd
despit
increas
frequenc
hamtsp
decreas
tsdr
demethyl
correl
decreas
function
suppress
treg
cell
hamtsp
patient
addit
increas
tax
express
pbmc
cultur
correl
decreas
tsdr
demethyl
overal
suggest
infect
decreas
treg
function
suppress
capac
hamtsp
epigenet
modif
within
locu
dysregul
treg
function
may
contribut
hamtsp
diseas
pathogenesi
gregori
michael
vanessa
william
benjama
jean
sonia
shendra
brandon
wen
brian
rui
jeffrey
brian
present
author
gregorychristopherantel
drexeledu
biomed
engin
scienc
health
system
drexel
univers
depart
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univ
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
consult
ltd
biostatist
epidemiolog
center
clinic
epidemiolog
biostatist
univers
pennsylvania
school
medicin
infecti
diseas
hiv
medicin
depart
medicin
drexel
univers
colleg
medicin
identif
long
termin
repeat
ltr
singl
nucleotid
polymorph
snp
peripher
blood
pb
deriv
integr
provir
dna
correl
clinic
paramet
diseas
sever
use
inform
role
viral
genet
pathogenesi
ltr
sequenc
subtyp
b
patient
enrol
drexelm
hivaid
genet
analysi
cohort
philadelphia
analyz
respect
tcell
count
viral
load
multipl
visit
ltr
serv
viral
promot
respons
regul
transcript
activ
integr
proviru
current
studi
focu
identif
ltr
signatur
deriv
pb
viru
use
molecular
marker
increas
risk
develop
sever
hiv
diseas
neurolog
complic
date
eight
snp
identifi
associ
tcell
count
viral
load
complement
compar
data
collect
integr
proviru
cell
pb
compart
brain
sampl
obtain
nation
neuroaid
tissu
consortium
nntc
also
analyz
ltr
sequenc
deriv
proviru
extract
multipl
brain
region
demonstr
presenc
eight
snp
independ
associ
neurocognit
statu
time
death
result
suggest
evolut
genom
swarm
throughout
diseas
may
result
viral
phenotyp
indic
predict
sever
hiv
diseas
given
snp
also
present
cn
end
stage
diseas
polymorph
may
also
associ
hivassoci
neurocognit
disord
hand
work
support
nihnind
nida
nimh
nimh
claudia
avalo
suzann
queen
brandon
bullock
ming
li
erin
shirk
lucio
gama
janic
clement
present
author
jhmiedu
molecular
compar
pathobiolog
john
hopkin
school
medicin
main
barrier
hiv
erad
continu
presenc
viral
reservoir
infect
patient
despit
treatment
antiretrovir
drug
furthermor
patient
live
longer
treatment
preval
hivassoci
neurocognit
disord
hand
increas
postmortem
analys
cn
tissu
suggest
hand
depend
migrat
monocyt
brain
monocyt
shown
traffic
blood
brain
barrier
popul
perivascular
site
differenti
macrophag
contribut
viral
persist
latenc
addit
infect
monocyt
found
blood
hiv
infect
patient
treat
haart
laboratori
develop
character
acceler
consist
siv
infect
pigtail
macaqu
model
hiv
aid
neurolog
diseas
use
siv
infect
pigtail
macaqu
character
flow
cytometri
activ
state
monocyt
microglia
infect
addit
recent
develop
assay
quantit
number
infect
blood
monocyt
tissu
macrophag
similar
quantit
outgrowth
assay
use
hiv
siv
cell
assay
allow
us
investig
number
siv
infect
cell
peripher
blood
tissu
siv
infect
pigtail
macaqu
could
potenti
contribut
siv
persist
brain
alessia
bachi
lee
campbel
allyssia
boelk
italo
mocchetti
present
author
bachisa
georgetownedu
depart
neurosci
georgetown
univers
medic
school
opioid
shown
potenti
glia
respons
hiv
viral
protein
tat
exacerb
tat
toxic
howev
morphin
protect
cortic
cultur
toxic
effect
mtropic
bal
use
rat
primari
neuron
observ
repeat
exposur
morphin
day
attenu
iiibmedi
neurotox
thu
research
requir
determin
whether
opioid
exhibit
neuroprotect
neurotox
activ
presenc
hiv
hiv
viral
protein
hiv
envelop
protein
shown
reduc
level
trophic
factor
bdnf
alter
enzymat
process
precursor
probdnf
interestingli
chronic
morphin
shown
increas
level
tissu
plasminogen
activ
tpa
activ
plasmin
convert
probdnf
bdnf
thu
opioid
may
reduc
neurotox
effect
augment
downstream
enzymat
process
probdnf
use
rat
cortic
neuron
observ
morphin
increas
level
releas
bdnf
time
decreas
probdnf
interestingli
similar
imbal
ratio
probdnfmatur
bdnf
confirm
rat
chronic
day
inject
morphin
effect
morphin
probdnf
due
increas
level
activ
tpa
data
suggest
morphin
abil
alter
probdnf
process
might
crucial
neuroprotect
effect
studi
identifi
new
mechan
interact
morphin
hiv
protein
aditya
santhi
prasanta
edward
jaclyn
larisa
howard
michael
yutong
present
author
yutongliu
unmcedu
pharmacolog
experiment
neurosci
univers
nebraska
medic
center
pharmacolog
experiment
neurosci
depart
radiolog
univers
nebraska
medic
center
despit
widespread
use
antiretrovir
therapi
art
infect
patient
suffer
form
cognit
impair
term
associ
neurocognit
disord
hand
hand
howev
remain
diagnosi
exclus
rang
opportunist
infect
cancer
thu
test
distinguish
hand
disord
sore
need
monitor
diseas
progress
therapeut
intervent
end
develop
manganes
enhanc
magnet
reson
imag
memri
differenti
specif
consequ
infect
brain
mous
model
human
neuroaid
memri
signal
intens
hippocampu
amygdala
virusinfect
anim
show
profound
chang
accumul
regionspecif
affect
highlight
neuron
aberr
link
cognit
function
infect
anim
posit
memri
could
use
imag
biosignatur
investig
neuropatholog
aberr
associ
advanc
viral
infect
mihyun
veera
venkata
ratnam
myounghwa
avindra
xuesong
jonathan
myriam
mark
p
norman
present
author
gmailcom
john
hopkin
univers
school
medicin
depart
neurolog
divis
neuroimmunolog
neurolog
infect
baltimor
md
infect
nervou
system
nind
nih
bethesda
md
pharmacolog
physiolog
therapeut
univers
north
dakota
school
medicin
health
scienc
grand
fork
nd
genet
nia
nih
baltimor
md
neurosci
nia
nih
baltimor
md
widespread
use
cart
develop
countri
dramat
increas
expect
lifespan
hivinfect
patient
extend
lifespan
frequent
accompani
prematur
brain
age
acceler
deposit
amyloid
beta
abeta
peptid
primarili
locat
lysosom
autophag
compart
molecular
mechan
regul
intraneuron
deposit
pattern
abeta
understood
studi
identifi
seri
cellular
event
evok
neurotox
promot
format
intraneuron
deposit
abeta
tripl
transgen
mice
contain
plaqu
deposit
younger
age
intraneuron
deposit
pattern
abeta
deposit
accompani
increas
level
sphingomyelin
ceramid
ultrastructur
analysi
brain
tissu
show
enlarg
lysosom
numer
electron
dens
lipid
inclus
mice
neuron
cultur
acceler
format
perturb
clearanc
abeta
mechan
involv
atyp
activ
chemokin
receptor
signal
protein
kinas
cjun
ntermin
kinas
jnk
mitogen
activ
protein
kinas
pathway
diverg
level
jnk
increas
transcript
express
betasecretas
inhibit
peroxisom
proliferatoractiv
receptor
gamma
increas
amyloid
precursor
protein
app
express
posttranscript
mechan
involv
enhanc
bind
heterogen
nuclear
ribonucleoprotein
c
hnrnpc
app
mrna
app
cosequest
membran
microdomain
activ
enhanc
abeta
product
increas
increas
abeta
effect
clear
accumul
lysosom
conjunct
sphingomyelin
calcium
stimul
calcium
efflux
lysosom
agonist
channel
facilit
clearanc
sphingomyelin
abeta
data
suggest
strategi
preserv
restor
lysosom
function
neurodegen
set
may
provid
neuron
protect
increas
cellular
clearanc
sphingolipid
abeta
peptid
nichola
jacquelin
charl
randal
present
author
nicholasbaird
ucdenveredu
neurolog
univers
colorado
school
medicin
pediatr
children
hospit
univers
iowa
iowa
citi
iowa
neurolog
microbiolog
univers
colorado
school
medicin
varicella
zoster
viru
vzv
exclus
human
neurotrop
alphaherpesviru
caus
varicella
chickenpox
primari
infect
vzv
becom
latent
ganglion
neuron
along
entir
neuraxi
vzv
reactiv
usual
result
zoster
shingl
often
complic
postherpet
neuralgia
less
frequent
vzv
mening
vasculopathi
myelopathi
ocular
diseas
attempt
studi
vzv
infect
neuron
vitro
difficult
primarili
contamin
nonneuron
cell
becom
lytic
infect
lead
destruct
cultur
lytic
vzv
infect
vzv
dna
replic
viral
gene
transcrib
translat
high
titer
infecti
particl
produc
lead
cell
death
week
less
herein
show
vzvinfect
differenti
neuron
beta
iiitubulin
posit
develop
cytopath
effect
lack
marker
activ
apoptot
pathway
cleav
neuron
cultur
steadi
state
level
vzv
dna
maintain
viru
gene
transcript
delay
day
reduc
compar
lytic
infect
fibroblast
vzv
glycoprotein
c
import
structur
protein
involv
virion
assembl
reduc
electron
microscop
analysi
reveal
high
number
aberr
viral
particl
frequent
lack
dna
core
suggest
nonlyt
infect
neuron
vitro
result
defect
viru
assembl
part
due
reduc
glycoprotein
c
product
success
develop
model
nonlyt
vzv
infect
neuron
allow
studi
elucid
molecular
mechan
involv
viru
reactiv
veera
venkata
ratnam
michel
justin
c
igor
scott
norman
j
present
author
jhmiedu
neurolog
john
hopkin
univers
school
medicin
north
wolf
street
baltimor
md
epidemiolog
neurolog
mayo
clinic
rochest
mn
neurolog
patholog
medicin
epidemiolog
john
hopkin
univers
school
medicin
north
wolf
street
baltimor
md
neurobehavior
research
program
depart
psychiatri
school
medicin
univers
california
san
diego
la
jolla
ca
despit
effect
viral
control
combin
antiretrovir
therapi
approxim
half
hivinfect
patient
develop
form
cognit
impair
fulli
understand
individu
infect
hiv
develop
cognit
impair
other
persist
lowlevel
inflamm
thought
contribut
cognit
declin
eicosanoid
famili
signal
molecul
produc
oxid
fatti
acid
regul
inflamm
immun
although
eicosanoid
compris
larg
number
product
deriv
fatti
acid
docosahexaeno
acid
dha
eicosapentaeno
acid
epa
tend
protect
obtain
fatti
acid
arachidon
acid
aa
linol
acid
la
often
proinflammatori
present
studi
measur
eicosanoid
plasma
hiv
patient
healthi
control
subject
found
eicosanoid
metabolit
undetect
control
subject
elev
hiv
patient
includ
mixtur
epa
deriv
metabolit
epet
dha
deriv
metabolit
aa
metabolit
dihetr
dihet
baselin
cognit
impair
hiv
patient
better
cognit
perform
follow
visit
higher
level
eicosanoid
metabolit
compar
hiv
patient
either
cognit
normal
cognit
impair
visit
cognit
normal
control
subject
includ
epa
metabolit
dha
dha
metabolit
la
la
metabolit
aa
aa
metabolit
number
metabolit
associ
vascular
cardiac
dysfunct
alter
platelet
aggreg
hiv
patient
cognit
statu
improv
level
metabolit
decreas
preliminari
result
suggest
alter
eicosanoid
product
hivinfect
patient
may
contribut
cognit
impair
mechan
involv
alter
vascular
platelet
function
support
award
jhunimh
center
bandaru
srimoy
banerje
lindsey
gerngross
traci
fischersmith
present
author
srimoyebanerje
templeedu
templ
univers
school
medicin
hiv
enceph
hive
neuropatholog
correl
sever
form
hivassoci
neurocognit
disord
hand
affect
hiv
infect
individu
previous
report
expans
monocyt
subset
hiv
infect
individu
detect
plasma
viremia
phenotyp
similar
macrophag
accumul
central
nervou
system
cn
hive
hypothes
macrophag
coloni
stimul
factor
mcsf
elev
cerebr
spinal
fluid
hive
drive
expans
monocyt
subset
peripher
blood
mononuclear
cell
pbmc
mcsf
increas
frequenc
monocyt
henc
examin
cn
tissu
siv
infect
rhesu
macaqu
patient
hiv
possibl
alter
express
independ
presenc
absenc
infect
neuron
express
observ
cn
tissu
examin
increas
sivhiv
even
greater
express
siveh
relationship
express
neuron
injuri
impli
correspond
decreas
posit
increas
ligand
fl
reveal
similar
pattern
increas
neuron
express
sive
contrast
neuron
fl
macrophagemicrogli
express
observ
sivhiv
infect
greater
express
seen
enceph
vitro
studi
demonstr
alter
express
differenti
sknsh
cell
respons
variou
concentr
fl
mcsf
differ
time
interv
suggest
multipl
factor
may
contribut
alter
express
cn
function
role
express
sivhiv
unclear
howev
interact
ligand
associ
neuron
surviv
develop
cn
fl
express
cn
diseas
may
neuroprotect
promot
neuron
surviv
express
macrophagemicroglia
howev
may
contribut
cn
pathogenesi
hivsiv
promot
surviv
activ
infect
noninfect
macrophagesmicroglia
victoria
michel
robert
barbara
dian
present
author
jhmiedu
molecular
microbiolog
immunolog
john
hopkin
bloomberg
school
public
health
baltimor
md
scienc
institut
depart
neurolog
john
hopkin
univers
school
medicin
baltimor
md
recent
outbreak
encephalomyel
caus
arthropodborn
alphavirus
reveal
import
emerg
caus
human
diseas
disabl
patient
recov
acut
diseas
especi
infant
children
often
left
lifelong
debilit
neurolog
defect
cognit
deficit
impair
motor
control
emot
behavior
disturb
sindbi
viru
sinv
prototyp
alphaviru
produc
rash
arthriti
human
neurotrop
mice
provid
excel
model
studi
alphavirusinduc
encephalomyel
previou
studi
shown
infecti
viru
clear
within
day
viral
rna
clear
slowli
persist
low
level
life
anim
neuron
damag
seen
alphaviru
infect
thought
due
immun
respons
glutam
excitotox
fiveweekold
mice
intranas
inocul
sinv
pb
batteri
behavior
test
use
assess
motor
neurocognit
function
differ
phase
infect
follow
behavior
test
brain
spinal
cord
collect
infecti
viru
titer
sinv
rna
level
viral
antigen
presenc
assess
height
activ
viru
infect
character
peak
infecti
viru
titer
detect
viral
antigen
brain
sinvinfect
mice
demonstr
increas
activ
open
fieldtest
markedli
impair
hippocampaldepend
memori
contextu
cu
fear
condit
follow
recoveri
clinic
diseas
sinvinfect
mice
continu
show
memori
deficit
contextu
fear
condit
viral
rna
present
brain
treatment
glutamin
inhibitor
affect
inflamm
glutam
excitotox
partial
inhibit
clinic
diseas
neurolog
deficit
measur
contextu
fear
condit
find
show
sinv
induc
longterm
neurolog
sequela
mice
persist
beyond
activ
viru
infect
inhibit
inflamm
glutam
excitotox
partial
mitig
develop
deficit
frank
laur
emma
naresha
jiri
elizabeth
cori
present
author
drexeledu
univers
colleg
medicin
vermont
molecular
genet
academi
scienc
czech
republ
multipl
sclerosi
ms
debilit
chronic
inflammatori
diseas
nervou
system
affect
approxim
one
million
individu
worldwid
higher
occurr
femal
consom
mous
line
also
known
chromosom
chr
substitut
strain
uniqu
allow
acceler
detect
compar
tradit
backcross
intercross
map
binaryquantit
trait
loci
direct
genomewid
physic
map
genet
distinct
parent
strain
employ
myelin
oligodendrocyt
glycoproteininduc
experiment
allerg
encephalomyel
mogea
mous
model
ms
evalu
sex
differ
consom
pwdphj
mice
mu
musculu
domesticu
util
panel
pwdphj
consom
subconsom
strain
mice
cover
autosom
wild
deriv
pwd
strain
mu
musculu
musculu
posit
gene
control
mogea
strain
combin
fifteen
exhibit
evid
loci
twenti
linkag
found
seven
malespecif
four
femalespecif
nine
nonsex
specif
suggest
greater
genet
load
male
femal
identifi
common
evolutionarili
conserv
pathway
underli
sexual
dimorph
eae
multipl
sclerosi
ms
suscept
find
greater
overlap
pathway
common
ms
male
eae
compar
femal
eae
vs
basi
sexual
dimorph
importantli
result
provid
scheme
consom
mous
strain
provid
better
understand
polygen
human
diseas
sarah
beck
suzann
queen
joseph
mankowski
present
author
jhmiedu
john
hopkin
univers
school
medicin
immun
pressur
exert
mhc
class
imedi
cytotox
tlymphocyt
ctl
drive
hiv
escap
mutat
nonetheless
relationship
viral
escap
hiv
cn
diseas
remain
poorli
understood
mhci
allel
confer
resist
sivinduc
cn
diseas
pigtail
macaqu
prototyp
escap
develop
immunodomin
siv
gag
epitop
hypothes
escap
viru
reduc
fit
vivo
vitro
ctlmediat
immun
pressur
switch
immunodomin
gag
epitop
subdomin
epitop
anim
inocul
siv
use
sitedirect
mutagenesi
insert
gag
escap
mutat
backbon
neurovirul
molecular
clone
produc
clone
replic
versu
compar
cell
primari
macaqu
microglia
macrophag
lymphocyt
although
replic
compet
cell
type
viral
replic
reduc
compar
extend
vitro
find
express
macaqu
inocul
three
three
wildtyp
parent
differ
plasma
viral
load
slightli
lower
csf
viral
load
anim
inocul
versu
inocul
wildtyp
absenc
immunodomin
epitop
gag
ctlmediat
immun
pressur
redirect
subdomin
manea
siv
tat
epitop
viral
escap
evid
surprisingli
anim
inocul
escap
mutat
genotyp
stabl
plasma
rapidli
revert
wt
gag
csf
microglia
data
clearli
demonstr
viral
fit
cn
differ
peripheri
therapeut
vaccin
strategi
enhanc
ctl
respons
hiv
gag
could
promot
hiv
escap
vital
understand
consequ
viral
escap
cn
diseas
jame
jeremi
j
sudhir
lawrenc
samantha
steven
sandra
aaron
andrew
eileen
eric
cynthia
ann
ned
present
author
beckerjt
upmcedu
psychiatri
neurolog
psycholog
univers
pittsburgh
infecti
diseas
microbiolog
univers
pittsburgh
infecti
diseas
depart
medicin
northwestern
univers
epidemiolog
john
hopkin
bloomberg
school
public
health
neurolog
cedarssinai
medic
center
neurolog
univers
california
lo
angel
psychiatri
rush
univers
school
medicin
psychiatri
univers
california
lo
angel
psychiatri
john
hopkin
univers
school
medicin
radiolog
northwestern
univers
neurolog
john
hopkin
univers
school
medicin
gene
apo
map
chromosom
e
allel
found
approxim
popul
sever
recent
studi
examin
apo
among
individu
hiv
diseas
date
data
suggest
link
weak
best
describ
relationship
among
apo
genotyp
subject
characterist
incid
neuropsycholog
impair
time
death
among
men
enrol
multicent
aid
cohort
studi
mac
genom
dna
isol
lysat
either
buffycoat
bcell
immort
cell
line
men
median
age
rang
mac
genom
dna
concentr
qualiti
assess
use
uv
andor
fluorometr
quantit
endpoint
genotyp
apo
variant
ct
ct
perform
use
taqman
openarray
technolog
men
hivinfect
uninfect
men
identifi
white
least
one
copi
e
allel
wherea
race
least
one
e
allel
odd
ratio
separ
model
race
whiteminor
found
signific
associ
presenc
e
allel
age
hiv
statu
death
neuropsycholog
outcom
use
cox
proport
hazard
model
investig
time
death
found
signific
associ
hiv
infect
time
death
caus
well
older
age
race
educ
apo
statu
significantli
associ
time
death
signific
associ
time
neuropsycholog
impair
age
educ
hiv
serostatu
associ
apo
interact
apo
hiv
infect
age
outcom
interest
result
confirm
extend
previou
find
apo
allel
associ
death
neuropsycholog
impair
among
men
age
group
jame
lawrenc
samantha
sandra
aaron
andrew
eileen
eric
cynthia
ann
ned
ola
present
author
pittedu
psychiatri
neurolog
psycholog
univers
pittsburgh
epidemiolog
univers
pittsburgh
epidemiolog
john
hopkin
bloomberg
school
public
health
neurolog
cedarssinai
medic
center
neurolog
univers
california
lo
angel
psychiatri
rush
univers
psychiatri
univers
california
lo
angel
psychiatri
john
hopkin
univers
school
medicin
radiolog
northwestern
univers
neurolog
john
hopkin
univers
school
medicin
multicent
aid
cohort
studi
follow
natur
treat
histori
hiv
key
compon
biannual
assess
cognit
function
describ
analysi
cohort
survivorship
factor
men
mac
cohort
complet
least
one
neuropsycholog
test
batteri
enrol
cohort
cohort
cohort
predominantli
white
wherea
predominantli
africanamerican
also
educ
educ
men
older
men
endors
depress
symptom
estim
iq
differ
function
cohort
ie
measur
psychomotor
speed
verbal
nonverb
memori
fine
motor
coordin
decemb
men
classifi
activ
inact
dead
still
activ
compar
men
among
uninfect
men
differ
rate
cognit
abnorm
combin
wherea
infect
men
rate
abnorm
significantli
lower
seroneg
men
remain
aliv
activ
studi
show
small
consist
increas
rate
abnorm
cognit
first
last
visit
vs
sever
cognit
abnorm
rose
among
inact
men
among
individu
die
followup
differ
volunt
recruit
reflect
cohort
characterist
baselin
visit
tend
persist
among
activ
particip
loss
data
due
death
dropout
may
affect
estim
preval
neuropsycholog
abnorm
among
studi
particip
anna
elena
donatella
maria
sara
manuela
simona
silvia
lucia
ada
anna
teresa
valeria
present
author
bellizzianna
yahoocom
public
health
infecti
diseas
sapienza
univers
rome
medicosurg
scienc
biotechnolog
section
neurolog
sapienza
univers
rome
neurolog
psychiatri
sapienza
univers
rome
biomed
surgeri
dental
scienc
univers
milan
public
health
infecti
diseas
institut
pasteur
cencibolognetti
foundat
sapienza
univers
rome
raffael
pisana
scientif
institut
research
hospit
health
care
rome
institut
cancer
research
molecular
medicin
center
biotechnolog
colleg
scienc
technolog
templ
univers
philadelphia
pennsylvania
usa
progress
multifoc
leukoencephalopathi
pml
onset
caus
polyomaviru
jc
jcpyv
patient
affect
multipl
sclerosi
ms
natalizumab
treatment
rais
concern
safeti
profil
agent
therefor
aim
studi
jcpyv
reactiv
monitor
noncod
control
region
nccr
viral
protein
analysi
patient
affect
ms
treat
natalizumab
perform
jcpyvspecif
quantit
pcr
biolog
sampl
collect
moment
recruit
everi
month
year
subsequ
analysi
nccr
rearrang
carri
moreov
viruslik
particlebas
enzymelink
immunosorb
assay
perform
detect
specif
antijc
viru
antibodi
serum
enrol
subject
data
analyz
use
chisquar
test
result
show
signific
associ
jc
viruria
jcpyv
antibodi
year
natalizumab
moreov
sequenc
isol
peripher
blood
mononuclear
cell
pbmc
patient
jcpyv
antibodi
show
nccr
type
iir
duplic
unit
insert
result
boxb
delet
g
transvers
spib
bind
site
patient
preval
genotyp
predomin
jcpyv
genotyp
europ
observ
conclus
could
import
understand
whether
specif
inflammatori
scenario
multipl
sclerosi
could
affect
jcpyv
reactiv
latenc
particular
kidney
moreov
accur
pml
risk
stratif
test
jc
viruria
seem
use
identifi
patient
harbor
jcpyv
undetect
jcpyvspecif
humor
immun
respons
patient
may
also
import
studi
jcpyv
nccr
rearrang
particular
spib
express
pbmc
could
play
crucial
role
jcpyv
replic
nccr
rearrang
sarah
j
bertrand
charl
f
mactutu
steven
b
harrod
amanda
j
morgan
rosemari
booz
present
author
bertran
emailscedu
psycholog
depart
univers
south
carolina
hand
patient
exhibit
chang
key
brain
region
respons
motiv
drive
mesocorticolimb
system
transgen
rat
chronic
expos
low
level
protein
brain
may
occur
human
cart
present
studi
use
adult
femal
ovariectom
transgen
rat
initi
five
bottl
prefer
test
use
wv
sucros
solut
follow
h
water
restrict
use
evalu
respons
novelti
well
potenti
sensori
differ
control
rat
although
differ
overal
volum
consum
initi
test
day
rat
consum
significantli
sucros
solut
suggest
heighten
novelti
respons
across
follow
day
test
control
rat
significantli
differ
pattern
consumpt
sucros
suggest
overal
tast
prefer
sucros
alter
subsequ
rat
learn
respond
sucros
wv
reinforc
oper
condit
chamber
anim
briefli
water
restrict
autoshap
anim
eventu
progress
onto
nonrestrict
train
accord
increas
fixedratio
requir
signific
retard
rate
rat
progress
higher
fr
schedul
compar
control
suggest
chang
basal
intern
motiv
state
critic
present
result
suggest
alter
intern
motiv
state
anim
display
inabl
meet
criterion
progress
fix
ratio
schedul
readili
attribut
alter
novelti
tast
prefer
result
suggest
transgen
rat
may
underli
intern
motiv
deficit
obtain
natur
reward
sucros
unlik
alter
respond
drug
abus
grant
number
ajay
scott
davey
mariana
anya
tricia
kenneth
william
walter
present
author
abharti
ucsdedu
neurobehavior
research
program
univers
california
san
diego
biolog
boston
colleg
medicin
univers
maryland
neurolog
univers
maryland
object
endem
area
malaria
hiv
frequent
infect
host
combin
effect
brain
poorli
understood
hypothes
combin
malaria
hiv
would
amplifi
monocytemacrophag
activ
contribut
worsen
neurolog
hiv
diseas
method
subject
hiv
hiv
evalu
use
comprehens
neuropsycholog
test
batteri
global
domainspecif
deficit
score
gd
dd
gener
use
determin
impair
subject
lack
symptom
acut
malaria
diagnos
base
peripher
smear
find
hemoglobin
hematocrit
tcell
count
hiv
rna
level
solubl
solubl
measur
result
statist
significantli
common
hiv
hiv
subject
vs
odd
ratio
p
overal
associ
nci
p
among
subject
hiv
like
motor
impair
hiv
vs
trend
toward
associ
execut
function
impair
account
hiv
statu
p
interact
count
present
associ
nci
among
peopl
count
vs
opposit
true
subject
higher
count
vs
level
significantli
higher
mh
group
compar
mh
group
higher
level
associ
higher
odd
impair
interact
malaria
signific
conclus
common
among
hiv
individu
nigeria
malaria
may
lead
wors
nc
function
specif
motor
execut
function
individu
greater
immunosuppress
like
experi
impair
coinfect
malaria
malaria
also
result
higher
level
biomark
monocytemacrophag
activ
jennif
p
mark
olga
wuyuan
suzann
alfredo
present
author
jbharucha
ihvumarylandedu
human
virolog
univers
maryland
school
medicin
human
virolog
univers
maryland
school
medicin
human
virolog
depart
microbiolog
immunolog
univers
maryland
school
medicin
human
virolog
depart
biochemistri
univers
maryland
school
medicin
human
virolog
depart
medicin
univers
maryland
school
medicin
human
betadefensin
hbd
broadspectrum
antimicrobi
peptid
secret
epitheli
cell
astrocyt
other
shown
inhibit
primari
cell
cell
intracellular
inhibitori
activ
mediat
receptor
bind
chemokin
hbd
although
loss
cell
contribut
mucos
immun
dysfunct
macrophag
virtu
role
innat
adapt
immun
major
sourc
persist
spread
hiv
develop
complic
especi
brain
interestingli
hbd
express
cn
littl
known
role
brain
hypothes
besid
cell
hbd
protect
microgli
cell
perivascular
macrophag
product
hiv
infect
data
primari
monocytederiv
macrophag
mdm
use
vitro
model
microgli
cell
show
inhibit
hiv
replic
dosedepend
manner
investig
mechan
involv
determin
neither
alter
surfac
express
hiv
receptor
induc
express
antihiv
cytokin
betachemokin
mdm
studi
use
gprotein
signal
antagonist
singlecycl
report
viru
system
show
suppress
hiv
earli
postentri
stage
via
gpcrmediat
signal
data
also
illustr
block
hiv
enhanc
express
mdm
express
share
chemokinehbd
receptor
albeit
variabl
level
among
donor
howev
neither
receptor
necessari
hiv
inhibit
suggest
signal
via
addit
receptor
preliminari
data
also
show
intern
earli
endosom
mdm
find
suggest
inhibit
hiv
mdm
via
one
mechan
may
aid
develop
new
approach
treat
hiv
infect
system
cn
bridgett
jeann
emili
giovanna
iren
sarah
john
chigo
kareem
steve
william
h
present
author
bridgettebillioux
nihgov
branch
nation
institut
neurolog
disord
stroke
nation
institut
health
epilepsi
section
nation
institut
neurolog
disord
stroke
nation
institut
health
laboratori
nation
institut
neurolog
disord
stroke
nation
institut
health
neurolog
branch
nation
institut
neurolog
disord
stroke
nation
institut
health
background
previou
studi
suggest
possibl
role
mesial
tempor
lobe
epilepsi
mtle
etiolog
agent
roseola
associ
central
nervou
system
cn
disord
may
neurotrop
method
use
digit
droplet
pcr
ddpcr
examin
viral
dna
studi
new
cohort
mtle
patient
six
focal
cortic
dysplasia
fcd
ddpcr
highli
sensit
precis
novel
pcr
technolog
enabl
absolut
quantif
target
dna
molecul
result
viral
dna
detect
mtle
patient
posit
frequenc
consist
previou
find
addit
detect
well
moreov
dna
also
detect
subset
fcd
patient
detect
viral
copi
number
vari
across
wide
rang
patient
even
within
given
patient
depend
region
sampl
conclus
new
data
suggest
viral
presenc
patient
fcd
extend
find
patient
mtle
detect
previous
report
kaushiki
biswa
sankar
alexand
paolo
lawrenc
c
kenneth
shindler
randal
jayasri
da
present
author
dassarmaj
iiserkolacin
biolog
scienc
indian
institut
scienc
educ
researchkolkata
iiserk
cancer
centr
thoma
jefferson
univers
philadelphia
pennsylvania
neurolog
univers
colorado
denver
school
medicin
aurora
colorado
anatomi
patholog
cell
biolog
thoma
jefferson
univers
philadelphia
pennsylvania
eye
institut
fm
kirbi
centr
molecular
ophthalmolog
univers
pennsylvania
philadelphia
pennsylvania
biolog
scienc
indian
institut
scienc
educ
researchkolkata
iiserk
depart
ophthalmolog
univers
pennsylvania
philadelphia
pennsylvania
multipl
sclerosi
ms
demyelin
disord
central
nervou
system
cn
believ
autoimmun
natur
characterist
presenc
oligoclon
band
ocb
csf
almost
ms
patient
support
long
stand
hypothesi
viral
etiolog
ocb
found
infecti
cn
disord
antigen
target
repres
caus
agent
definit
target
ocb
ms
patient
remain
obscur
mous
hepat
viru
mhv
induc
neuroinflamm
mice
experiment
model
use
studi
mechan
demyelin
neurotrop
mhv
strain
induc
mening
enceph
myeliti
acut
phase
progress
demyelin
chronic
phase
infect
viral
particl
clear
acut
inflamm
resolv
affymetrix
microarray
analysi
mrna
express
demyelin
mhv
strain
infect
spinal
cord
tissu
reveal
acut
infect
robust
upregul
variou
innat
immun
gene
mainli
involv
antivir
immun
respons
phagolysosom
matur
mhc
classii
express
chronic
infect
upregul
sever
ig
mrna
igj
shift
immun
respons
acut
chronic
inflamm
stage
known
long
time
viral
infect
induc
ig
molecul
mechan
induct
clear
demyelin
mhv
infect
induc
innat
immun
signal
innat
immun
effector
molecul
induc
b
cell
activ
express
sever
oligoclon
gene
could
play
major
role
antibodi
mediat
progress
demyelin
caus
effect
relationship
viral
infect
induct
oligoclon
ig
mrna
pave
way
understand
b
cell
activ
demyelin
find
may
help
advanc
understand
viral
induc
antibodi
mediat
demyelin
ms
ayman
deepika
ryan
luke
neal
andrew
tricia
present
author
burdot
bcedu
biolog
boston
colleg
chestnut
hill
nerv
laboratori
depart
neurolog
john
hopkin
school
medicin
baltimor
md
compar
patholog
new
england
primat
research
center
harvard
medic
school
southborough
symptomat
abnorm
peripher
nervou
system
pn
among
common
complic
infect
although
antiretrovir
success
amelior
constitut
manifest
aid
reduc
sever
mani
neurolog
complic
caus
hiv
infect
signific
impact
incid
sever
hiv
sensori
neuropathi
hivsn
use
sivinfect
deplet
rhesu
macaqu
model
hivsn
uninfect
control
sivinfect
anim
develop
moderatetosever
dorsal
root
ganglia
drg
patholog
drg
tissu
extens
activ
satellit
cell
measur
immunoreact
product
sivinfect
via
immunohistochemistri
brdu
puls
studi
show
increas
monocyt
traffic
bone
marrow
drg
correl
sever
patholog
uninfect
mild
moder
sever
intraepiderm
nerv
fiber
ienf
densiti
determin
biopsi
central
food
pad
signific
declin
ienf
densiti
anim
day
post
infect
averag
loss
fiber
necropsi
posit
correl
percentag
macrophag
surround
sacral
drg
neuron
percent
loss
ienf
densiti
seen
necropsi
r
p
conclud
resid
macrophag
activ
monocyt
infiltr
play
signific
primari
role
drg
damag
hivsn
data
also
suggest
link
macrophag
activ
drg
drg
patholog
ienf
loss
peripheri
rhesu
macaqu
model
aidsinduc
peripher
neuropathi
thu
futur
adjunct
therapi
diminish
macrophag
activ
monocyt
infiltr
may
serv
amelior
hivsn
sever
previous
observ
adriana
ceereena
ubaida
raghothama
linda
richard
moxley
ned
justin
c
norm
avindra
david
r
present
author
jhmiedu
depart
john
hopkin
school
medicin
molecular
compar
pathobiolog
john
hopkin
school
medicin
core
facil
john
hopkin
school
medicin
medicin
john
burn
school
medicin
univers
hawaii
institut
neurolog
disord
stroke
nation
institut
health
hiv
invas
cn
coincid
acut
hiv
infect
persist
due
chronic
infect
longliv
microgli
cell
astrocyt
perivascular
macrophag
cerebrospin
fluid
csf
becom
one
frequent
use
biofluid
physiolog
studi
neurolog
disord
sinc
ultrafiltr
plasma
collect
point
drainag
brain
parenchyma
proteom
studi
use
rel
quantit
method
studi
pool
csf
sampl
hivinfect
patient
cognit
impair
hivinfect
patient
normal
cognit
healthi
individu
goal
identifi
potenti
biomark
cognit
impair
use
advanc
two
dimension
separ
strategi
bioinformat
identifi
total
identif
overal
protein
use
statist
interpret
isobar
tag
rel
absolut
quantit
itraq
report
intens
protein
confid
interv
pvalu
select
base
permut
test
interpret
quantit
use
cut
fold
upregul
fold
downregul
protein
differenti
express
hivinfect
individu
cognit
impair
report
pvalu
seven
protein
previous
describ
hivinteract
protein
includ
endoplasmin
mitochondri
damag
domanin
death
agonist
bid
orosomucoid
apolipoprotein
e
metalloproteinas
inhibitor
nuclear
protein
ruvblik
sever
protein
possibl
neurolog
implic
also
identifi
includ
formingbind
protein
creactiv
protein
leukocyteassoci
immunoglobulin
receptor
renin
receptor
mediat
rna
polymeras
ii
transcript
subunit
alphanacetylglucosaminidas
caldesmon
cadherin
egf
lag
gtype
receptor
suggest
possibl
combin
biomark
highli
correl
predict
neurocognit
statu
hivinfect
patient
might
involv
monocyt
macrophag
activ
thoma
chelsea
peter
dan
igor
chen
sabrina
present
author
ctan
bidmcharvardedu
virolog
vaccin
research
depart
medicin
divis
neurovirolog
depart
neurolog
beth
israel
deaco
medic
center
harvard
medic
school
virolog
vaccin
research
depart
medicin
beth
israel
deaco
medic
center
harvard
medic
school
virolog
vaccin
research
divis
infecti
diseas
depart
medicin
divis
neurovirolog
depart
neurolog
beth
israel
deaco
medic
center
harvard
medic
school
background
jcv
caus
progress
multifoc
leukoencephalopathi
pml
immunocompromis
patient
effect
antivir
therapi
jcv
cellular
immun
respons
crucial
contain
viral
replic
associ
pml
surviv
therefor
prevent
therapeut
vaccin
jcv
elicit
cellular
immun
respons
urgent
need
method
replic
incompet
adenoviru
vaccin
vector
serotyp
gener
insert
jcv
gene
naiv
wildtyp
mice
immun
singl
inject
either
dna
day
immun
mice
sacrif
splenocyt
isol
stimul
overlap
jcv
peptid
pool
assay
intracellular
cytokin
stain
ic
ifngamma
control
mice
inject
pb
jc
virion
result
mice
remain
asymptomat
day
inject
jc
virion
dna
pb
jc
virion
elicit
minim
cellular
immun
respons
dna
significantli
increas
percentag
jcvspecif
tcell
compar
elicit
jc
virion
p
addit
significantli
increas
jcvspecif
tcell
compar
dna
jc
virion
p
furthermor
dna
significantli
increas
jcvspecif
tcell
compar
jc
virion
p
conclus
recombin
adenovector
dna
plasmid
express
jcv
protein
elicit
strong
jcvspecif
cellular
immun
respons
mice
develop
vaccin
may
lead
clinic
applic
prevent
treatment
jcvassoci
brain
diseas
tetyana
joshua
vipulkumar
tyler
kenneth
kristof
denni
benjamin
present
author
tpbuzhdi
utmbedu
patholog
univers
texa
medic
branch
galveston
tx
prevent
medicin
commun
health
univers
texa
medic
branch
galveston
tx
neurolog
univers
pennsylvania
philadelphia
pa
patholog
neurosci
cell
biolog
univers
texa
medic
branch
galveston
tx
hivassoci
neurocognit
disord
hand
preval
patient
given
highli
activ
antiretrovir
therapi
haart
neurotransmitt
system
includ
inhibitori
gabaerg
element
often
neurochem
abnorm
hand
patient
given
haart
survey
gabaerg
inhibitori
neurotransmiss
brain
specimen
subject
hiv
infect
seroneg
control
mrna
two
ratelimit
enzym
gaba
synthesi
glutam
acid
decarboxylas
gap
junctionassoci
transcript
express
select
gabaerg
neuron
assay
use
qpcr
three
gabaassoci
mrna
significantli
decreas
dorsolater
prefront
cortex
dlpfc
hivposit
subject
abnorm
express
distribut
wide
cn
includ
neocortex
neostriatum
cerebellum
patient
without
hiv
enceph
significantli
lower
gabaerg
mrna
patient
die
prior
era
haart
significantli
lower
gabaerg
mrna
low
gabaerg
mrna
correl
significantli
higher
express
mrna
marker
produc
endotheli
cell
includ
vwf
high
express
dopamin
receptor
type
mrna
low
gabaerg
mrna
express
specif
correl
wors
perform
test
verbal
fluenci
immunoblot
immunohistochemistri
show
proteinlevel
chang
hivinfect
brain
specimen
includ
loss
parvalbumin
stain
intens
higher
express
gabaerg
interneuron
swell
endotheli
cell
conclud
abnorm
gabaerg
tone
preval
hiv
infect
patient
broad
anatom
distribut
cn
novel
associ
chang
dopamin
transmiss
endotheli
cell
marker
suggest
role
synapt
plastic
connect
neurovascular
unit
siddappa
swati
prachi
girish
hemashettar
kenta
vanessa
umberto
franci
francoi
ruth
present
author
siddappanbyrareddi
emoryedu
patholog
laboratori
medicin
emori
univers
farber
cancer
institut
harvard
medic
school
nation
primat
research
center
emori
univers
molecular
microbiolog
nation
institut
allergi
infecti
diseas
nation
institut
health
patholog
brigham
women
hospit
thank
increas
panel
antiretrovir
drug
hiv
replic
effect
control
infect
patient
howev
limit
art
immun
activ
fulli
contain
penetr
drug
central
nervou
system
cn
ineffici
thu
neuroaid
case
diminish
hivassoci
neurocognit
disord
hand
becom
far
promin
problem
hiv
neurovirul
associ
viral
tropism
macrophagemicroglia
mg
monocyt
lineag
yet
pauciti
reliabl
anim
model
neurotrop
hiv
address
gap
gener
mgtropic
shiv
name
result
viru
highli
fusogen
replic
high
level
monocytederiv
macrophag
mdm
mg
test
replic
capac
cover
deplet
cell
b
cell
rhesu
pigtail
macaqu
pm
virus
replic
well
vitro
vivo
upon
intraven
intrarect
inocul
reach
peak
viral
load
plasma
csf
copiesml
plasma
vs
copiesml
csf
earlystag
virus
sensit
broadli
neutral
antibodi
solubl
induc
crossclad
neutral
antibodi
respons
latestag
virus
differ
sensit
broadli
neutral
antibodi
remain
tropic
notabl
doubl
deplet
pm
rapidli
progress
diseas
within
month
pm
progress
diseas
year
without
deplet
patholog
chang
brain
pm
includ
astrogliosi
chronic
mening
perivascular
cuf
inflamm
gliosi
infect
mg
suggest
virus
caus
milder
form
neurolog
diseas
summari
macrophagemgtrop
shiv
valuabl
tool
studi
milder
form
neurolog
disord
biolog
relev
primat
model
tina
dionna
w
jacquelin
lilli
peter
j
eliseo
joan
w
present
author
tinacalderon
einsteinyuedu
patholog
albert
einstein
colleg
medicin
health
research
institut
new
jersey
medic
school
rutger
state
univers
new
jersey
patholog
microbiolog
immunolog
albert
einstein
colleg
medicin
studi
suggest
uninfect
hiv
infect
monocyt
transmigr
across
blood
brain
barrier
bbb
mediat
viral
entri
cn
contribut
chronic
neuroinflamm
result
hiv
associ
neurocognit
disord
hand
greater
hiv
infect
peopl
hiv
infect
drug
abus
hand
report
sever
increas
extracellular
cn
dopamin
common
mechan
occur
acut
respons
intermitt
drug
use
report
number
peripher
monocyt
increas
hiv
infect
drug
abus
studi
effect
dopamin
chemokin
mediat
monocyt
influx
cn
uninfect
peripher
blood
monocyt
cultur
nonadher
mcsf
expand
number
cell
cultur
monocyt
express
transmigr
cell
respons
andor
dopamin
character
use
human
bbb
model
unexpectedli
dopamin
alon
increas
monocyt
transmigr
contrast
dopamin
effect
cell
dopamin
receptor
higher
lower
matur
monocyt
compar
cell
agonist
skf
increas
monocyt
transmigr
indic
involv
receptor
dopamin
induc
transmigr
although
dopamin
cross
bbb
monocyt
transmigr
may
increas
dopamin
mediat
effect
bbb
cell
andor
transmigr
process
monocyt
penetr
bbb
respons
chemokin
matur
monocyt
treat
dopamin
determin
direct
effect
dopamin
cellular
process
involv
transmigr
dopamin
increas
migrat
pseudopodia
format
compon
cellular
polar
involv
movement
thu
combin
higher
number
circul
monocyt
elev
dopamin
hiv
infect
drug
abus
may
result
increas
transmigr
cell
cn
contribut
sever
hand
jennif
h
evamaria
patrick
andrew
g
nicol
david
j
andrew
susan
v
r
gilberto
tricia
h
kenneth
c
present
author
bcedu
colleg
medic
school
athinoula
martino
center
biomed
imag
massachusett
gener
hospit
nation
primat
research
center
pathogen
institut
univers
florida
england
region
primat
research
center
background
whether
activ
monocytemacrophag
traffic
hiv
infect
requir
pathogenesi
directli
demonstr
method
use
block
antibodi
tysabri
mgkg
week
three
week
treat
infect
lymphocyt
deplet
monkey
high
viral
load
cn
injuri
day
post
infect
dpi
stop
monocytemacrophag
traffic
addit
treat
anoth
cohort
anim
time
infect
day
stop
product
infect
brain
gut
lymph
node
anim
treat
dpi
metabolit
concentr
nacetylaspart
creatin
naacr
assess
biweekli
mr
spectroscopi
mr
result
tysabri
treatment
dpi
found
stabil
neuron
injuri
naacr
frontal
pariet
cortex
tissu
analysi
reveal
significantli
lower
number
activ
resid
macrophag
recent
recruit
monocytesmacrophag
brdu
product
infect
cell
siv
rna
brain
small
intestin
tysabri
treat
macaqu
compar
control
siv
dna
undetect
one
brain
tissu
sampl
analyz
dpi
tysabri
treat
anim
wherea
similar
concentr
provir
dna
isol
gut
tissu
tysabri
treat
untreat
control
macaqu
anim
treat
tysabri
low
lp
solubl
plasma
ex
vivo
pbmc
treat
macaqu
exhibit
impair
adhes
transmigratori
capabl
respons
proinflammatori
stimul
conclus
studi
use
tysabri
day
postinfect
sivinfect
macaqu
demonstr
stop
monocyt
traffic
stabil
cn
diseas
treat
anim
time
infect
block
traffic
viru
brain
reduc
number
product
infect
cell
small
intestin
rais
possibl
tysabri
may
effect
agent
prevent
format
reservoir
earli
hiv
infect
silvia
simon
serena
matteo
diego
roberto
elena
lucia
francesca
pasqual
present
author
silviacarluccio
unimiit
biomed
surgic
dental
scienc
univers
milan
itali
neurolog
institut
pavia
itali
ettor
sansavini
lugo
itali
studi
clinic
institut
milan
itali
natalizumab
human
monoclon
antibodi
subunit
major
integrin
involv
transendotheli
migrat
despit
sever
trial
studi
show
efficaci
treatment
multipl
sclerosi
ms
natalizumab
use
firstlin
drug
sinc
report
increas
risk
develop
progress
multifoc
leukoencephalopathi
pml
aim
studi
determin
immunolog
chang
natalizumabtr
ms
patient
time
order
better
understand
effect
treatment
peripher
blood
mononuclear
cell
pbmc
subset
purpos
rel
frequenc
differ
leukocyt
subset
express
integrin
investigatedth
analysi
perform
flow
cytometri
pbmc
recov
blood
sampl
ms
patient
treat
natalizumab
follow
two
year
eleven
ms
patient
treat
convent
therapi
healthi
subject
also
enrol
control
groupsth
analysi
rel
frequenc
show
decreas
monocyt
popul
increas
lymphocyt
popul
particular
cell
within
monocyt
popul
could
detect
signific
decreas
classic
increas
classic
associ
cours
treatment
integrin
express
assess
evalu
rel
fluoresc
intens
allow
detect
signific
variat
within
subpopul
popul
addit
patient
stratif
base
urinari
jcv
bkv
dna
excret
done
defin
whether
viral
statu
could
affect
natalizumab
treatment
viceversa
cell
rel
frequenc
increas
patient
excret
virus
rel
frequenc
decreas
breanna
giovanna
raya
bill
steven
present
author
breannacaruso
nihgov
human
tcell
lymphotrop
viru
type
retroviru
etiolog
agent
clinic
neuromyelopathi
known
associ
myelopathytrop
spastic
paraparesi
hamtsp
quantif
amount
viru
patient
sampl
critic
monitor
infect
evalu
efficaci
therapeut
agent
assist
clinic
diagnosi
realtim
pcr
qpcr
standard
method
determin
provir
load
pvl
howev
qpcr
depend
upon
welldefin
standard
calibr
standard
curv
preclud
precis
accur
quantif
particularli
low
cell
concentr
studi
use
third
gener
pcr
techniqu
digit
droplet
pcr
ddpcr
allow
direct
quantif
pvl
dna
sampl
partit
thousand
nanoliters
droplet
amplifi
thermocycl
analyz
fluoresc
signal
normal
housekeep
gene
poisson
distribut
statist
use
determin
absolut
copi
number
independ
standard
curv
found
intraassay
interassay
reliabl
ddpcr
robust
consist
qpcr
moreov
ddpcr
yield
similar
patient
pvl
quantifi
differ
viral
gene
preliminari
data
suggest
ddpcr
also
use
examin
viral
gene
express
key
player
pathogenesi
hamtsp
import
paramet
monitor
therapeut
intervent
condit
reliabl
precis
ddpcr
quantif
wide
acknowledg
might
import
tool
understand
clinic
correl
viral
load
context
hamtsp
relat
condit
howev
investig
requir
determin
efficaci
ddpcr
mrna
analysi
paul
castellano
eliseo
eugenin
present
author
gsbsrutgersedu
depart
microbiolog
molecular
genet
public
health
research
institut
graduat
school
biomed
scienc
rutger
univers
hiv
associ
neurocognit
disord
hand
devast
consequ
hiv
infect
current
antiretrovir
therapi
art
era
pathogenesi
hand
multifactori
sequenc
event
includ
transmigr
hiv
infect
monocyt
cross
blood
brain
barrier
bbb
result
infect
central
nervou
system
cn
resid
cell
macrophag
microglia
small
popul
astrocyt
infect
activ
inflamm
subsequ
cellular
dysfunct
apoptosi
addit
viral
reservoir
gener
within
cn
upon
activ
propag
viral
infect
inflamm
year
primari
infect
thu
elimin
cell
reservoir
essenti
erad
hiv
brain
subsequ
affect
pathogenesi
hand
preliminari
data
indic
hiv
infect
microglia
astrocyt
protect
cell
death
despit
intracellular
proapoptot
signal
mitochondri
dysregul
mitochondri
releas
cytochrom
c
cytoplasm
normal
induc
proapoptot
stimuli
follow
cell
death
howev
infect
microglia
astrocyt
resist
cell
death
even
cytochrom
c
releas
mitochondria
cytoplasm
mechan
hiv
protect
infect
cell
cytoplasm
cytochrom
c
current
unknown
understand
mechan
may
yield
novel
pharmaceut
target
treatment
hand
key
neg
regul
apoptosi
heat
shock
protein
hsp
inhibit
pathway
cytochrom
c
induc
cell
death
hypothesi
hiv
infect
cell
hijack
heat
shock
protein
avoid
apoptosi
induc
cytoplasm
cytochrom
c
target
pathway
util
specif
hiv
infect
cell
gener
potenti
drug
target
treatment
hand
spyridon
xin
dang
evelyn
stephani
marion
philip
jacob
carolina
igor
j
present
author
schalkia
bidmcharvardedu
virolog
vaccin
research
divis
infecti
diseas
beth
israel
deaco
medic
center
harvard
medic
school
boston
neurolog
beth
israel
deaco
medic
center
harvard
medic
school
boston
background
risk
jc
viru
jcv
reactiv
progress
multifoc
encephalopathi
pml
natalizumab
may
increas
durat
exposur
drug
sought
determin
preval
jcv
reactiv
potenti
chang
jcvspecif
cellular
immun
prolong
treatment
method
enrol
jcvseroposit
multipl
sclerosi
ms
patient
includ
natalizumab
monotherapi
month
month
month
interferonbeta
monotherapi
month
untreat
ms
patient
control
perform
qpcr
csf
blood
urin
jcv
dna
determin
jcv
specif
tcell
respons
use
enzymelink
immunospot
elispot
intracellular
cytokin
stain
ic
essay
ex
vivo
vitro
stimul
jcv
peptid
result
jcv
dna
detect
csf
subject
test
month
natalizumab
symptom
mri
lesion
consist
pml
none
subject
jcv
dna
plasma
viruria
detect
patient
jcvspecif
cell
detect
frequent
ic
elispot
ex
vivo
vs
p
vitro
stimul
vs
test
assay
significantli
frequent
posit
vitro
stimul
ex
vivo
p
jcvspecif
tcell
frequent
detect
tcell
vitro
stimul
vs
differ
respons
observ
patient
without
viruria
test
jcv
dna
peripher
blood
mononuclear
cell
progress
conclus
asymptomat
jcv
reactiv
may
occur
csf
natalizumabtr
ms
patient
vitro
stimul
jcv
peptid
allow
enhanc
detect
jcvspecif
cellular
immun
highli
preval
ms
patient
regardless
treatment
mediat
tcell
natali
chen
gokul
swaminathan
julio
martingarcia
present
author
chennata
gmailcom
depart
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
drexel
univers
colleg
medicin
microgli
cell
resid
macrophag
central
nervou
system
cn
play
import
role
maintain
homeostasi
cn
pathogenesi
hivassoci
neurolog
disord
hand
brain
imag
reveal
increas
microgli
activ
patient
chronic
infect
vitro
studi
suggest
alter
microgli
function
may
affect
neuron
health
role
mirna
regul
microglia
activ
context
hand
remain
defin
although
alter
mirna
profil
blood
mononuclear
cell
patient
chronic
infect
report
furthermor
differenti
express
select
mirna
cerebrospin
fluid
hiv
patient
without
enceph
demonstr
date
studi
profil
mirna
chang
primari
human
microglia
upon
infect
exposur
envelop
protein
address
infect
primari
human
fetal
microglia
phfm
macrophagetrop
pseudotyp
bal
vesicular
stomat
virusg
pseudotyp
vsvg
incub
phfm
envelop
glycoprotein
rna
extract
virusenvelop
treat
cell
mock
treat
cell
variou
time
point
abi
openarray
assay
perform
extract
rna
profil
mirna
chang
also
examin
use
taqman
quantit
realtim
pcr
qrtpcr
bal
infect
result
increas
level
post
infect
exposur
signific
effect
level
futur
studi
elucid
whether
observ
chang
mirna
level
contribut
alter
microgli
function
cours
hiv
infect
cn
matthew
cusick
jane
libbey
robert
fujinami
present
author
matthewcusick
pathutahedu
univers
utah
virus
human
immunodefici
viru
hepat
polioviru
coxsackieviru
footandmouth
diseas
viru
use
varieti
mechan
suppress
human
immun
system
order
evad
clearanc
host
therefor
investig
chang
viral
genom
nonleth
viru
lead
alter
diseas
surviv
immunosuppress
death
would
provid
valuabl
inform
viral
pathogenesi
studi
provid
model
murin
viru
da
stain
theiler
murin
encephalomyel
viru
tmev
natur
host
mous
caus
administ
via
peripher
rout
intraperiton
ip
asymptomat
infect
follow
viral
clearanc
last
immun
mice
infect
da
strain
viru
via
intracerebr
ic
rout
develop
acut
enceph
mice
surviv
acut
diseas
clear
viru
mutant
da
strain
tmev
inadvert
creat
result
transcript
error
polymeras
use
modifi
fulllength
infecti
cdna
clone
da
viru
templat
mutant
viru
encod
point
mutat
call
addit
sequenc
viral
genom
also
sever
nucleotid
substitut
untransl
region
well
addit
amino
acid
substitut
capsid
protein
code
region
suggest
number
perturb
viral
genom
mice
infect
mutant
viru
via
peripher
rout
becom
immunosuppress
kill
cell
studi
provid
experiment
evid
viru
clear
natur
host
becom
lethal
due
chang
viral
genom
satind
dahiya
michael
nonnemach
brian
wigdahl
present
author
drexeledu
depart
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
transcript
control
human
immunodefici
viru
type
promot
long
termin
repeat
ltr
achiev
interact
cisact
element
present
upstream
downstream
transcript
start
site
silico
transcript
factor
bind
analysi
subtyp
b
lai
ltr
reveal
potenti
downstream
ccaat
enhanc
bind
protein
cebp
bind
site
element
present
immedi
downstream
nucleosom
viral
promot
suggest
may
function
role
transcript
regul
remodel
nucleosom
crucial
event
transcript
product
infect
cell
analysi
across
subtyp
indic
ltr
downstream
cebp
bind
site
display
high
degre
conserv
term
nucleotid
sequenc
physic
locat
ltr
interestingli
element
overlap
previous
identifi
element
shown
bind
member
nuclear
factor
activ
cell
nfat
famili
protein
nfat
exhibit
higher
rel
affin
element
compar
member
cebp
famili
cebp
alpha
beta
downstream
cebp
element
abl
compet
effici
lowaffin
upstream
cebp
bind
site
respect
cebp
bind
suggest
util
nfat
cebp
moreov
cyclosporin
treatment
shown
prevent
dephosphoryl
nuclear
transloc
nfat
isoform
result
enhanc
cebp
beta
bind
downstream
cebp
bind
site
knockout
mutant
also
demonstr
reduc
ltrdriven
transcript
basal
condit
indic
interact
site
posit
regul
transcript
cell
monocytemacrophag
lineag
work
support
nihnind
nida
nimh
nimh
william
nirzari
michael
vanessa
jean
benjama
shendra
wen
brian
rui
jeffrey
brian
present
author
drexelmededu
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
consult
ltd
biostatist
epidemiolog
center
clinic
epidemiolog
biostatist
univers
pennsylvania
school
medicin
infecti
diseas
hiv
medicin
depart
medicin
drexel
univers
colleg
medicin
drexelm
hivaid
genet
analysi
cohort
philadelphia
pa
current
follow
individu
longitudin
examin
viral
genet
variat
conjunct
clinic
neurolog
diseas
sever
impact
comorbid
like
drug
abus
paramet
substanti
cohort
allow
uniqu
analysi
neurolog
declin
context
substanc
abus
along
standard
clinic
paramet
tcell
count
viral
load
measur
drug
test
modifi
version
hopkin
dementia
bedsid
test
tmhd
perform
due
longitudin
natur
drexelm
cohort
possibl
investig
complex
effect
drug
abus
individu
complex
natur
drug
abus
urban
cohort
complic
tradit
method
group
patient
monous
categori
instead
abandon
tradit
method
favor
markov
chain
chain
model
patient
state
machin
chang
hivd
score
next
visit
function
paramet
measur
current
visit
current
viral
load
tcell
count
adher
haart
therapi
drug
test
result
includ
model
cocain
use
found
detriment
effect
tmhd
score
cannabinoid
exhibit
small
seemingli
measur
protect
effect
studi
progress
work
develop
neurolog
test
protocol
increas
sensit
allow
us
better
understand
effect
polyabus
neurocognit
declin
work
support
nihnind
nida
nimh
nimh
xin
shruti
evelyn
jonathan
igor
present
author
xdang
bidmcharvardedu
neurovirolog
depart
neurolog
center
viru
vaccin
research
depart
medicin
beth
isreal
deaco
medic
center
neurolog
mayo
clinic
arizona
background
natalizumab
block
traffick
leukocyt
brain
associ
reactiv
jc
viru
jcv
lead
progress
multifoc
leukoencephalopathi
pml
multipl
sclerosi
ms
patient
jcv
also
infect
cerebellar
granul
cell
neuron
result
jcvgranul
cell
neuronopathi
jcv
gcn
case
report
yearold
jcvseroposit
gentleman
ms
receiv
infus
natalizumab
monotherapi
present
chang
handwrit
speech
gait
initi
mri
identifi
new
lesion
csf
jcv
pcr
posit
month
symptom
onset
subsequ
mri
show
progress
cerebellar
atrophi
natalizumab
discontinu
receiv
plasma
exchang
iv
steroid
follow
mirtazapin
develop
progress
hyperintens
pon
cerebellar
peduncl
imag
mri
contrastenhanc
suggest
immun
reconstitut
inflammatori
syndrom
iri
csf
jc
viral
load
copiesml
intracellular
cytokin
stain
show
robust
cellular
immun
respons
mediat
jcvspecif
tcell
molecular
analysi
csf
jcv
strain
reveal
three
differ
mutat
cterminu
gene
consist
previous
report
gcn
type
jcv
strain
treat
iv
steroid
follow
decreas
contrast
enhanc
cerebellum
mri
neurolog
function
stabil
concomit
neg
jcv
csf
pcr
repeat
mrimr
spectroscopi
show
stabl
low
grade
cerebellar
enhanc
ratio
cerebellum
consist
subsid
iri
howev
extens
signal
chang
pon
cerebellar
peduncl
conclus
second
patient
natalizumabassoci
jcv
gcn
iri
contrari
initi
casereport
patient
develop
contrast
enhanc
cerebellar
cortex
mri
extens
lesion
cerebellar
white
matter
pon
jcv
gcn
novel
complic
natalizumab
therapi
suspect
ms
patient
develop
cerebellar
dysfunct
brian
lillian
david
robyn
present
author
briandaniel
wustledu
anatomi
neurobiolog
washington
univers
school
medicin
intern
medicin
washington
univers
school
medicin
patholog
immunolog
washington
univers
school
medicin
west
nile
viru
wnv
mosquitoborn
pathogen
capabl
infect
central
nervou
system
cn
caus
lethal
enceph
human
host
howev
mechan
wnv
access
infect
cn
mysteri
pathogen
normal
exclud
cn
blood
brain
barrier
bbb
bbb
complex
assort
vascular
endotheli
cell
join
tight
junction
prevent
circul
pathogen
escap
vasculatur
cn
access
parenchym
nervou
tissu
detect
wnv
circul
host
tissu
elicit
innat
immun
respons
includ
product
typei
interferon
ifn
shown
promot
preserv
bbb
integr
context
cn
autoimmun
util
vitro
model
bbb
demonstr
pathogen
detect
wnv
vascular
endothelia
bbb
promot
barrier
integr
via
typei
ifn
rescu
barrier
dysregul
inflammatori
cytokin
limit
transendotheli
traffick
wnv
via
modul
endotheli
rhogtpas
signal
similarli
mice
diminish
typei
ifn
signal
ifnar
exhibit
enhanc
bbb
permeabl
peripher
wnv
infect
earlier
entri
viru
cn
togeth
data
first
show
function
role
typei
ifn
bbb
context
neurotrop
viral
infect
suggest
new
role
typei
ifn
treatment
neuroinflammatori
infecti
diseas
francesca
de
simon
onder
otlu
ilker
sariy
present
author
isariy
templeedu
depart
neurosci
center
neurovirolog
templ
univers
school
medicin
philadelphia
pa
immunosuppress
caus
patholog
agent
hivaid
regiment
use
treatment
differ
type
diseas
multipl
sclerosi
put
patient
high
risk
group
develop
progress
multifoc
leukoencephalopathi
pml
fatal
demyelin
diseas
white
matter
caus
human
neurotrop
polyomaviru
jcv
viru
establish
latent
infect
reactiv
immunosuppress
condit
unknown
mechan
immunedepend
reactiv
jcv
develop
diseas
suggest
jcv
gene
express
replic
tightli
control
immun
system
latent
infect
cell
potenti
mediat
immun
mediat
tissu
level
develop
vitro
model
studi
role
immunemedi
secret
activ
immun
cell
viral
gene
express
replic
pmbsc
peripher
blood
cultur
activ
tissu
cultur
condit
media
cm
collect
treat
glial
cell
infect
jcv
seri
experi
suggest
cm
induc
uninduc
pbmc
inhibit
propag
viru
suggest
immunemedi
control
viral
life
cycl
studi
reveal
solubl
immun
mediat
pbmc
possess
dual
control
tantigen
express
transcript
posttranscript
level
recent
identifi
altern
splice
factor
potenti
regul
jcv
overexpress
glial
cell
strongli
suppress
viral
gene
express
replic
result
preliminari
studi
suggest
immun
mediat
secret
pbmc
induc
express
inhibit
replic
jcv
observ
suggest
oper
novel
immun
signal
pathway
peripher
immun
cell
glial
cell
control
immedi
earli
stage
jcv
gene
express
cours
viral
reactiv
work
made
possibl
grant
award
nih
ik
serena
francesca
camilla
valentina
silvia
diego
matteo
pasqual
present
author
pasqualeferrant
unimiit
biomed
surgic
dental
scienc
univers
milano
milano
ettor
sansavini
health
scienc
foundat
lugo
gener
neurolog
nation
neurolog
institut
c
mondino
pavia
background
efficaci
natalizumab
treatment
multipl
sclerosi
ms
high
case
progress
multifoc
leukoencephalopathi
pml
report
among
treat
patient
risk
pml
calcul
assess
jc
viru
jcv
seroposit
natalizumabtr
ms
patient
method
total
natalizumabtr
ms
patient
ms
patient
treat
convent
therapi
control
enrol
casecontrol
studi
urin
blood
sampl
collect
monthli
month
natalizumabtr
patient
control
sampl
use
monitor
jcv
bk
viru
bkv
replic
viral
load
assess
use
quantit
realtim
pcr
qpcr
assay
serum
antijcv
antibodi
measur
stratifi
andor
stratifi
dxselect
test
result
jcv
dna
found
urin
sampl
overal
least
urin
sampl
natalizumabtr
patient
howev
jcv
dna
also
detect
control
sampl
p
natalizumabtr
patient
jcv
dna
shed
urin
significantli
increas
month
treatment
bkv
found
urin
natalizumabtr
patient
total
urin
sampl
overal
contrast
viral
genom
detect
blood
addit
jcv
viruria
seroposit
correl
three
virur
patient
seroneg
accord
stratifi
stratifi
dxselect
test
conclus
find
demonstr
natalizumab
therapi
may
increas
rate
jcv
urinari
shed
correct
identif
jcv
carrier
sole
reli
serolog
test
correctli
stratifi
patient
risk
pml
monitor
presenc
jcv
dna
urin
need
satish
deshman
paul
pozniak
kamel
khalili
prasun
datta
present
author
templeedu
depart
neurosci
comprehens
neuroaid
center
templ
univers
neuron
dysfunct
degener
caus
mechan
hivassoci
neurocognit
disord
hand
era
highli
activ
antiretrovir
therapi
haart
studi
assess
effect
exosom
deriv
pma
activ
promonocyt
cell
latent
infect
human
fetal
neuron
exosom
secret
cell
found
enrich
mani
microrna
potenti
affect
express
sever
essenti
gene
neuron
neuron
cultur
treat
exosom
found
sever
compromis
abil
maintain
exist
neuron
network
well
abil
form
neurit
scratchwound
assay
neuron
cultur
treat
deriv
exosom
show
low
level
superoxid
dismutas
activ
indic
heighten
oxid
stress
analysi
cytokinechemokin
profil
exosom
reveal
attenu
level
mif
rant
comparison
deriv
exosom
similar
analysi
medium
obtain
exosometr
neuron
cell
reveal
increas
express
upar
cultur
treat
exosom
furthermor
also
analyz
phosphoryl
statu
mitogenactiv
protein
kinas
mapk
intracellular
protein
kinas
akt
kinas
mtor
creb
import
regul
signal
transduct
cell
prolifer
neuron
treat
exosom
use
antibodi
array
studi
demonstr
mani
signal
pathway
known
crucial
cell
surviv
akt
mtor
found
neg
affect
exosom
treat
neuron
collect
observ
demonstr
exosom
deriv
infect
cell
caus
neuron
dysfunct
degener
target
multipl
pathway
support
comprehens
neuroaid
center
cnac
development
core
grant
pkd
studi
also
util
servic
offer
core
facil
cnac
nimh
grant
kk
satish
deshman
sagarika
banerje
prasun
datta
present
author
templeedu
depart
neurosci
comphrehens
neuroaid
center
templ
univers
neuroinflamm
mediat
proinflammatori
cytokin
interleukin
il
beta
induc
infect
macrophag
microglia
astrocyt
cn
play
critic
role
pathogenesi
neuroaid
dysregul
inflammationassoci
microrna
within
brain
acceler
develop
hiv
associ
neurocognit
disord
hand
thu
investig
role
posttransl
modif
rela
gene
regul
beta
human
fetal
brain
astrocyt
astrogli
cell
line
studi
demonstr
phosphoryl
ikkbeta
ikbalpha
serin
regul
nfkappab
activ
human
fetal
astrocyt
astrogli
cell
line
addit
result
use
phosphoryl
defect
mutant
indic
phosphoryl
statu
serin
residu
differenti
regul
induc
transcript
express
demonstr
role
mitogen
stressactiv
protein
phosphoryl
regul
beta
employ
pharmacolog
inhibitor
studi
demonstr
microm
dose
depend
inhibit
express
collect
observ
demonstr
activ
canon
noncanon
nfkappa
b
pathway
regul
express
astrocyt
therefor
pharmacolog
inhibitor
target
nfkappa
b
pathway
may
therapeut
potenti
treatment
neuroinflamm
work
support
nihnida
grant
pkd
studi
also
util
servic
offer
core
facil
comprehens
neuroaid
center
cnac
nimh
grant
alex
daniel
c
michel
timothi
w
reena
igor
scott
thoma
norman
j
present
author
alexdicken
pharmoxacuk
pharmacolog
univers
oxford
epidemiolog
depart
health
scienc
research
colleg
medicin
mayo
clinic
chemistri
univers
oxford
neurobehavior
research
program
depart
psychiatri
school
medicin
univers
california
neurolog
john
hopkin
univers
current
defin
surrog
measur
determin
hiv
patient
like
develop
cognit
impair
track
effect
potenti
neurotherapeut
analys
csf
sampl
taken
hiv
patient
differ
neurocognit
state
use
spectroscopi
multivari
analysi
identifi
novel
metabolom
biomark
cognit
impair
csf
sampl
hivinfect
patient
collect
time
point
four
distinct
neurocognit
state
defin
tempor
chang
cognit
statu
neurocognit
state
stablynorm
stablyabnorm
improv
worsen
spectroscopi
perform
sampl
use
nmr
system
multivari
partial
least
squar
pl
regress
model
show
signific
separ
neurocognit
state
valu
stablynorm
stablyabnorm
worsen
improv
metabolit
underpin
chang
distinct
group
gener
connect
amino
acid
energi
metabol
use
classif
regress
tree
analysi
identifi
chang
energi
metabolit
pyroglutam
citrat
creatin
alanin
acet
prognost
indic
declin
cognit
statu
sensit
specif
metabolit
prognost
indic
improv
cognit
statu
glutam
pyroglutam
creatin
myoinositol
betaglucos
sensit
specif
linear
regress
show
increas
level
specif
energi
metabolit
associ
poor
perform
task
measur
execut
learn
recal
motor
function
relat
work
memori
perform
find
suggest
declin
cognit
function
accompani
compensatori
increas
specif
energi
metabolit
csf
level
energi
metabolit
may
use
surrog
measur
tempor
shift
cognit
statu
reveal
new
insight
neuropathogenesi
hand
kevin
egan
christina
kollia
brian
wigdahl
stephen
jen
present
author
drexeledu
depart
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
herp
simplex
viru
type
ubiquit
human
pathogen
caus
recurr
mild
orofaci
lesion
infect
individu
acut
infect
initi
mucos
surfac
viru
replic
within
epitheli
cell
follow
propag
viru
site
infect
innerv
sensori
neuron
infect
latent
infect
establish
persist
lifetim
host
immun
system
critic
control
initi
viru
replic
peripheri
limit
infiltr
nervou
system
investig
mechan
immun
cell
use
detect
product
viral
replic
peripheri
knockout
mice
vulner
mortal
wildtyp
wt
control
although
natur
killer
cell
normal
dendrit
cell
tcell
activ
impair
mice
observ
minor
decreas
tcell
respond
viru
infect
knockout
anim
respond
cell
exhibit
impair
product
interferon
gamma
wt
knockout
anim
support
compar
replic
peripheri
knockout
mice
greater
infiltr
nervou
system
suffer
greater
mortal
result
demonstr
import
role
prime
immun
cell
control
acut
infect
futur
investig
role
maintain
immun
control
latenc
tcell
confirm
tcell
trigemin
ganglia
belong
recent
describ
tissu
resid
memori
trm
class
memori
cell
explor
home
mechan
prolif
capac
trm
cell
purpos
enhanc
tcell
level
trigemin
ganglia
increas
presenc
tcell
possibl
therapeut
treatment
option
reduc
reactiv
event
luminita
dan
roxana
gratiela
maria
simona
ronald
igor
cristian
present
author
cachim
ucsdedu
dr
victor
babe
hospit
infecti
tropic
diseas
stefan
nicolau
institut
virolog
carol
davila
univers
medicin
bucharest
neurosci
uc
san
diego
neurobehavior
research
program
depart
psychiatri
uc
san
diego
psychiatri
hnrp
uc
san
diego
object
studi
frequenc
clinic
featur
hivrel
neurolog
complic
romanian
cohort
hiv
clade
f
infect
subject
design
retrospect
longitudin
studi
children
adolesc
hiv
associ
neurolog
complic
follow
januari
june
method
patient
hiv
encephalopathi
hive
hiv
relat
opportunist
infect
includ
evalu
demograph
viral
load
marker
brain
imag
hystolog
describ
clinic
dynam
uniqu
cohort
result
year
surveil
period
total
number
children
young
adolesc
diagnos
neuroaid
defin
diseas
repres
subject
although
number
hiv
associ
cn
complic
decreas
introduct
cart
frequenc
among
aid
defin
diseas
increas
cart
thereaft
uniqu
featur
observ
pml
patient
includ
cerebellar
brainstem
locat
lesion
improv
surviv
cart
regimen
good
cerebrospin
fluid
hiv
viral
control
furthermor
describ
case
seri
patient
diagnos
fatal
clinic
entiti
subacut
myoclon
measl
enceph
smme
occur
two
consecut
outbreak
romania
conclus
found
high
frequenc
hivrel
neurolog
complic
cohort
parenter
infect
children
interestingli
increas
cart
era
also
describ
new
aid
defin
neurolog
complic
measl
sever
immunosuppress
children
smme
frequenc
almost
neurolog
aid
complic
suggest
neurotrop
potenti
hiv
clade
f
yoshimi
enoseakahata
raya
massoud
jussi
virtanen
steven
jacobson
present
author
akahatay
nindsnihgov
viral
immunolog
section
neuroimmunolog
branch
nation
institut
neurolog
disord
stroke
nation
institut
health
intrathec
antibodi
synthesi
welldocu
phenomenon
infecti
neurolog
diseas
well
demyelin
diseas
intrathec
antibodi
synthesi
report
hamtsp
littl
known
role
b
cell
humor
immun
respons
central
nervou
system
cn
hamtsp
patient
demonstr
profil
antibodi
cerebrospin
fluid
csf
hamtsp
patient
hamtsp
patient
antibodi
respons
gag
tax
detect
csf
patient
csfserum
antigag
antibodi
ratio
elev
antitax
antigag
mean
antitax
mean
significantli
correl
provir
load
pbmc
importantli
hamtsp
patient
lesion
atrophi
spinal
cord
show
higher
csfserum
antigag
antibodi
ratio
antibodi
respons
env
detect
csf
patient
csfserum
antienv
ratio
significantli
lower
antigag
antitax
mean
interestingli
b
cell
attract
increas
csf
hamtsp
patient
compar
posit
asymptomat
carrier
associ
higher
antibodi
respons
csf
ex
vivo
experi
cell
hamtsp
patient
show
significantli
higher
express
healthi
normal
donor
addit
stimul
b
cell
differenti
plasma
cell
produc
antibodi
cultur
b
cell
hamtsp
patient
result
highlight
import
b
cell
compart
hamtsp
product
antibodi
may
requir
control
viral
persist
andor
may
associ
hamtsp
diseas
progress
tatro
benchawanna
scott
cristian
present
author
etatro
ucsdedu
psychiatri
univers
california
san
diego
medicin
divis
infecti
diseas
univers
california
san
diego
background
despit
success
suppress
replic
combin
antiretrovir
therapi
chronic
immun
activ
persist
patient
process
may
mediat
latent
infect
cell
variou
compart
includ
central
nervou
system
raltegravir
potent
hiv
integras
inhibitor
previous
shown
inhibit
immun
activ
peripher
blood
goal
present
studi
determin
raltegravir
influenc
proinflammatori
cytokin
product
hivinfect
monocyt
microglia
assess
toxic
neuronglia
cultur
method
primari
human
monocyt
deriv
macrophag
microglia
fetal
brain
tissu
grown
cultur
infect
mtropic
hiv
bal
infect
cultur
treat
nm
raltegravir
vehicl
salin
supernat
remov
period
day
proinflammatori
cytokin
quantifi
use
mesoscal
discoveri
platform
primari
neuronglia
cultur
expos
nm
raltegravir
day
stain
betaiii
tubulin
glial
fibrillari
acid
protein
immunofluoresc
quantifi
result
microglia
monocyt
deriv
macrophag
rate
secret
significantli
lower
hivinfect
cell
treat
raltegravir
pgd
compar
control
pgd
hivinfect
pgd
raltegravir
alon
pgd
determin
analysi
covari
tukey
honestli
signific
differ
test
p
tnfalpha
interferongamma
significantli
differ
neuronglia
cultur
nm
significantli
betaiii
tubulin
area
stepwis
decreas
gfap
area
nm
raltegravir
conclus
raltegravir
context
hiv
infect
lead
diminish
product
potent
proinflammatori
chemoactract
monocyt
microglia
data
suggest
raltegravir
inhibit
astrogliosi
may
neuroprotect
studi
mechan
includ
nfkappa
b
nuclear
transloc
underway
eliseo
eugenin
present
author
eugeniea
umdnjedu
public
health
research
institut
anf
rutger
univers
cell
cell
commun
essenti
develop
multicellular
system
coordin
solubl
factor
membran
associ
protein
gap
junction
channel
recent
describ
tunnel
nanotub
tnt
other
report
tnt
use
pathogen
hiv
commun
cell
howev
character
process
especi
primari
cell
role
hiv
infect
fulli
character
current
data
indic
tnt
compos
sever
smaller
tnt
tnt
macrophag
continu
tube
rather
tnt
establish
contact
other
macrophag
synapt
type
contact
identifi
sever
blocker
tnt
reduc
spread
hiv
hiv
infect
uninfect
cell
transfer
viral
genet
materi
commun
cell
block
format
tnt
use
mild
actin
blocker
sirna
reduc
spread
hiv
among
connect
cell
thu
character
tnt
play
key
role
spread
hiv
among
connect
cell
kristen
n
fantetti
priya
ganesan
apurva
kulkarni
erica
l
gray
lauren
odonnel
present
author
duqedu
depart
pharmaceut
scienc
mylan
school
pharmaci
duquesn
univers
viral
infect
inflamm
central
nervou
system
cn
induc
signific
ill
neuropatholog
particularli
young
though
neonat
capabl
mount
innat
adapt
immun
respons
often
unabl
control
viral
infect
brain
suffer
extens
neuron
loss
tissu
damag
order
studi
neonat
immun
respons
interact
infect
cn
neuron
laboratori
use
transgen
mous
model
neuronrestrict
measl
viru
mv
infect
mice
express
human
isoform
mv
receptor
control
neuron
specif
enolas
nse
allow
infect
cn
neuron
show
adapt
immun
respons
detriment
neonat
viral
infect
cn
neuron
neonat
lack
bcell
mice
surviv
longer
immunocompet
pup
neonat
also
control
viral
load
effect
immunocompet
neonat
result
contrast
adult
mice
surviv
infect
clear
viru
brain
tcell
depend
manner
wherea
adult
mice
succumb
infect
addit
neonat
mice
lack
interferongamma
ifng
requir
viral
clearanc
adult
brain
lose
nestinposit
precursor
cell
contrast
neonat
despit
higher
level
tcell
infiltr
ifngko
neonat
find
suggest
certain
proinflammatori
cytokin
protect
neural
cell
neonat
cn
infect
full
adapt
respons
associ
greater
neuropatholog
current
work
address
defect
neonat
tcell
respons
potenti
role
ifngproduc
natur
killer
cell
limit
viral
spread
studi
aim
better
defin
protect
cytotox
role
innat
adapt
immun
cell
neonat
cn
infect
kalamo
nazira
ryan
fatah
kurt
jonathan
mudit
present
author
tmudit
emailgwuedu
washington
univers
commonwealth
univers
western
reserv
univers
inject
noninject
illicit
drug
use
abus
remain
signific
cofactor
hiv
infect
transmiss
cocain
one
wide
abus
drug
unit
state
impair
normal
function
brain
cell
also
activ
human
immunodefici
viru
hiv
express
central
nervou
system
cn
result
hivinfect
individu
abus
cocain
experi
sever
rapid
onset
neuroaid
nonabus
individu
known
cocain
affect
express
numer
cellular
gene
modul
variou
signal
epigenet
pathway
pathway
also
influenc
express
integr
hiv
provirus
eventu
end
enhanc
hiv
replic
transmiss
known
cocain
activ
nfkappab
given
import
nfkappab
hiv
transcript
imper
understand
underli
molecular
mechan
ultim
result
enhanc
hiv
gene
express
result
establish
cocain
activ
specif
protein
kinas
turn
induc
select
posttransl
modif
nfkappab
extend
understand
regul
hiv
gene
express
via
cocain
induc
nfkappab
system
employ
multilevel
approach
character
effect
cocain
chromatin
state
proviru
run
sever
chip
chromatin
immunoprecipit
assay
overal
result
demonstr
exchang
variou
key
epigenet
modif
associ
factor
hiv
ltr
follow
cocain
treatment
summari
data
provid
direct
evid
cocain
enhanc
hiv
gene
express
activ
transcript
factor
nfkappab
also
induc
variou
select
epigenet
modif
event
eventu
support
establish
transcript
activ
chromatin
structur
hiv
ltr
facilit
hiv
transcript
michael
kori
eugen
present
author
michaelferenczi
nihgov
molecular
medicin
neurosci
nation
institut
neurolog
disord
stroke
nation
institut
health
section
nation
institut
neurolog
disord
stroke
nation
institut
health
jc
viru
jcv
etiolog
agent
human
cn
demyelin
diseas
progress
multifoc
leukoencephalopathi
pml
attempt
identifi
risk
factor
pml
hamper
lack
anim
model
limit
cell
type
cultur
suscept
jcv
infect
understand
jcv
pathogenesi
necessari
develop
new
system
identifi
transcript
regul
import
jcv
lifecycl
develop
pml
tradit
techniqu
protein
overexpress
knockdown
hamper
offtarget
effect
transcript
regul
import
viral
gene
express
target
limit
abil
discern
direct
indirect
effect
underexpress
gene
regul
transcript
regul
interest
use
multipl
cell
cultur
model
differ
permiss
jcv
cellular
gene
express
uninfect
infect
cell
character
multipl
known
novel
transcript
regul
potenti
jcvregulatori
role
identifi
transcriptom
profil
antigen
immort
human
fetal
brain
cell
display
characterist
either
cn
stem
cell
radial
glia
sever
factor
overlap
factor
identifi
differenti
less
permiss
human
fetal
neural
progenitor
progenitor
cell
highli
permiss
progenitorderiv
astrocyt
pda
lymphoid
enhanc
factor
identifi
potenti
novel
neg
regul
jcv
transcript
potenti
bind
site
jcv
regulatori
region
identifi
use
comput
promot
analysi
progenitorderiv
neuron
pdn
pda
use
confirm
import
jcv
transcript
chromatin
immunoprecipit
reveal
bound
jcv
promot
greater
extent
jcvrepress
neuron
jcvpermiss
astrocyt
result
demonstr
human
fetal
brain
deriv
cn
stem
cell
model
combin
bioinformat
approach
facilit
identif
factor
respons
jcv
multipl
potenti
develop
pml
lindsay
chri
brenna
barri
olimpia
present
author
drexeledu
pharmacolog
physiolog
drexel
univers
colleg
medicin
neurobiolog
anatomi
drexel
univers
colleg
medicin
pharmacolog
physiolog
microbiolog
immunolog
drexel
univers
colleg
medicin
molecular
mechan
involv
hivinduc
synaptodendrit
injuri
structur
basi
hivassoci
neurocognit
disord
yet
fulli
elucid
studi
propos
hiv
protein
inflammatori
cytokin
induc
dendrit
injuri
alter
neuron
express
protein
ferritin
heavi
chain
fhc
known
neg
regul
signal
pair
previou
work
lab
suggest
import
increas
dendrit
spine
densiti
well
modul
express
specif
glutam
receptor
subunit
addit
found
opiat
includ
morphin
neg
regul
signal
fhc
vivo
data
brain
tissu
hivdrug
abus
sivinfectedmorphinetr
macaqu
show
increas
neuron
fhc
subsequ
decreas
activ
phosphoryl
thu
sought
investig
whether
compon
hiv
infect
could
modul
fhc
result
suggest
tnfalpha
beta
well
hiv
envelop
glycoprotein
upregul
fhc
neuron
cytokin
alter
neuron
fhc
presenc
absenc
glia
howev
caus
signific
increas
neuronalgli
bilaminar
cocultur
suggest
glia
requir
chang
fhc
protein
level
support
presenc
beta
neutral
antibodi
receptor
antagonist
bilaminar
cultur
abrog
effect
two
vivo
model
hiv
infect
inject
hivtg
rat
saw
signific
reduct
cortic
neuron
dendrit
spine
densiti
compar
agematch
control
overal
studi
suggest
effect
proinflammatori
cytokin
opiat
may
converg
dendrit
spine
fhc
augment
synapt
injuri
hivdrug
abus
patient
mariana
figuera
norman
camilo
barbara
present
author
jhmiedu
scienc
institut
neurotransl
drug
discoveri
program
depart
neurolog
john
hopkin
univers
school
medicin
johnson
divis
neuroimmunolog
neurolog
infect
depart
neurolog
john
hopkin
univers
school
medicin
perturb
brain
lipid
metabol
accumul
bioactiv
lipid
ceramid
occur
earli
cours
human
immunodefici
viru
associ
neurocognit
disord
hand
elev
ceramid
thought
contribut
neuron
dysfunct
biophys
effect
alter
membran
excit
molecular
respons
stress
ceramid
rapidli
gener
respons
inflammatori
stimuli
coat
protein
action
mediat
sphingomyelin
phosphodiesteras
neutral
sphingomyelinas
express
activ
elev
brain
tissu
infect
patient
conjunct
cognit
impair
suggest
inhibit
may
preserv
neuron
function
prevent
increas
ceramid
inde
chemic
genet
modul
express
activ
neuroprotect
make
enzym
attract
therapeut
target
known
inhibitor
includ
natur
product
small
molecul
compound
lack
specif
insolubl
andor
exhibit
low
potenc
identifi
novel
inhibitor
specif
human
screen
pharmacolog
activ
compound
approv
drug
inhibitor
acid
sphingomyelinas
format
enzym
activ
monitor
increas
fluoresc
emiss
product
gener
three
consecut
coupl
reaction
involv
alkalin
phosphatas
cholin
oxidas
horseradish
peroxidas
hit
confirm
use
direct
assay
sphingomyelin
sm
substrat
sever
inhibitor
low
micromolar
potenc
identifi
distinct
chemic
seri
identifi
compound
optim
structureact
relationship
studi
small
molecul
inhibitor
may
use
therapeut
agent
could
dampen
neuromolecular
respons
associ
inflamm
mariana
figuera
losada
camilo
roja
barbara
slusher
present
author
jhmiedu
john
hopkin
univers
brain
human
immunodefici
patient
show
sign
chronic
inflamm
includ
microglia
activ
part
lead
neurodegener
manifest
neurocognit
disord
hand
activ
microglia
macrophag
releas
excess
glutam
caus
excitotox
ultim
result
neuron
dysfunct
death
two
protein
cystineglutam
antiport
xct
phosphateactiv
glutaminas
thought
partial
respons
excess
glutam
releas
activ
microglia
xct
sodium
independ
amino
acid
transport
import
extracellular
cystin
export
intracellular
glutam
glutaminas
mitochondri
enzym
catalyz
product
glutam
glutamin
shown
increas
activ
andor
express
level
follow
infect
microglia
macrophag
activ
viral
protein
tat
develop
cellbas
phenotyp
assay
format
screen
novel
xct
glutaminas
compound
abil
inhibit
glutam
releas
lipopolysaccharid
lp
activ
microglia
primari
microglia
obtain
newborn
rat
cultur
day
treat
ngml
lp
induc
productionreleas
glutam
dosedepend
manner
fold
increas
extracellular
glutam
respons
time
h
cell
numberdepend
cellswel
prototyp
xct
inhibitor
erastin
glutaminas
inhibitor
show
dose
depend
inhibit
glutam
releaseproduct
valu
nm
microm
respect
commensur
weaker
xct
inhibitori
capac
sulfasalazin
significantli
less
potent
erastin
nm
phenotyp
assay
follow
excess
glutam
releas
induc
microglia
activ
repres
novel
way
screen
agent
treat
neuroaid
neuroinflammatori
disord
sylvia
joy
pamela
kurt
hamid
present
author
sfit
vcuedu
pharmacol
toxicol
coll
medicin
virginia
commonwealth
univ
anat
neurobiol
coll
medicin
virginia
commonwealth
univ
human
immunodefici
viru
hiv
infect
continu
major
clinic
manifest
combin
antiretrovir
therapi
era
cart
enhanc
opioiddrug
abus
gastrointestin
gi
mucosa
play
major
role
hivinfect
hiv
mostli
transmit
across
mucos
surfac
enter
nervou
system
en
control
sever
gi
process
includ
motil
secret
specif
affect
hivinfect
patient
morphin
opioid
directli
affect
en
caus
sever
constip
viru
infect
neuron
suggest
viral
toxin
tat
modul
neuron
function
patient
tat
shown
increas
neuron
excit
much
known
effect
tat
enter
neuron
combin
drug
abus
recent
experiment
studi
lab
shown
tat
increas
enter
neuron
excit
shift
voltagedepend
activ
sodium
channel
neg
potenti
contrast
morphin
alon
decreas
avail
sodium
channel
enter
neuron
reduc
excit
voltag
gate
sodium
channel
vgsc
respons
gener
propag
action
potenti
neuron
order
determin
effect
tat
nm
combin
morphin
um
um
voltag
depend
steadyst
activationinactiv
sodium
channel
use
doublepuls
protocol
variabl
condit
puls
appli
mv
mv
mv
step
ms
follow
test
puls
tattreat
neuron
sensit
morphin
significantli
enhanc
steadyst
inactiv
shift
tattreat
neuron
um
morphin
decreas
maxim
avail
mv
morphin
alter
steadyst
activ
taken
togeth
data
suggest
tat
increas
sensit
morphin
enter
neuron
may
exacerb
deleteri
effect
morphin
gi
motil
cari
william
present
author
cfritzf
emoryedu
depart
emori
univers
neurolog
emori
univers
school
medicin
elev
level
interferonalpha
ifnalpha
central
nervou
system
cn
link
cognit
dysfunct
patient
inflammatori
cn
diseas
hivassoci
dementia
previou
studi
show
ifnalpha
treatment
neuron
cultur
caus
dose
depend
decreas
dendrit
branch
length
prevent
pretreat
ifnalpha
neutral
antibodi
antagonist
ndma
receptor
also
found
partial
protect
ifnalpha
induc
neurotox
begin
determin
mechan
ifnalpha
induc
neurotox
cell
signal
pathway
involv
ifnalpha
receptor
ifnar
evalu
demonstr
increas
interferon
stimul
gene
express
indic
jakstat
cascad
activ
ifnalpha
stimul
inhibit
ifnar
found
partial
protect
neuron
ifnalpha
neurotox
effici
neutral
antibodi
ifnalpha
preliminari
studi
suggest
ifnalpha
part
act
receptor
well
nmdar
reduc
dendrit
arbor
neuron
studi
need
determin
signal
pathway
may
involv
ifnalpha
induc
neurotox
determin
mechan
ifnalpha
neurotox
could
lead
therapi
cognit
dysfunct
neuroinflamm
peter
j
joan
w
present
author
petergaskil
einsteinyuedu
patholog
albert
einstein
colleg
medicin
patholog
microbiolog
immunolog
albert
einstein
colleg
medicin
macrophag
one
principl
cell
type
infect
hiv
primari
sourc
viru
mani
tissu
includ
cn
within
brain
macrophag
expos
neurotransmitt
dopamin
dopamin
elev
use
drug
abus
cocain
methamphetamin
show
previous
macrophag
express
dopamin
receptor
dopaminerg
protein
exposur
dopamin
increas
hiv
replic
macrophag
alter
cytokin
product
mapk
signal
current
data
demonstr
dopamin
mediat
increas
hiv
replic
due
increas
abil
hiv
enter
macrophag
effect
dose
depend
occur
greater
nm
dopamin
affect
dopamin
metabolit
pandopamin
receptor
antagonist
abrog
effect
indic
dopamin
receptor
activ
necessari
increas
entri
infect
presenc
dopamin
receptor
agonist
show
increas
induc
activ
dopamin
receptor
subtyp
antagon
complet
block
entri
indic
dopamin
mediat
effect
entri
process
howev
increas
suscept
entri
due
increas
surfac
data
demonstr
macrophag
dopaminerg
system
play
import
role
hiv
infect
cell
develop
neuroinflamm
hand
may
acceler
effect
dopamin
macrophag
effect
mayb
exacerb
drug
abus
addit
although
differ
drug
abus
act
distinct
pharmacolog
mechan
dopamin
mediat
addict
reinforc
effect
mani
drug
abus
may
common
mechan
drug
abus
contribut
hiv
associ
neuropathogenesi
benjamin
joshua
tetyana
vipulkumar
tyler
denni
kristof
present
author
bgelman
utmbedu
patholog
neurosci
cell
biolog
univers
texa
medic
branch
galveston
tx
neurolog
univers
pennsylvania
philadelphia
pa
prevent
medicin
commun
health
hiv
dna
integr
human
genom
dna
hivint
may
becom
transcript
repress
immunolog
inert
infect
peopl
viru
replic
suppress
highli
activ
antiretrovir
therapi
haart
latent
pool
hivint
repres
key
obstacl
cure
hiv
infect
rese
bodi
replic
hiv
haart
stop
littl
known
neuroimmunolog
factor
involv
support
latent
pool
hivint
brain
measur
hivint
genom
dna
extract
frontal
neocortex
hiv
infect
patient
use
doherti
alugag
twostep
assay
case
divid
two
equal
group
either
high
proport
hivint
replic
rate
brain
versu
low
group
equival
rate
hiv
transcript
hiv
rna
load
brain
specimen
panel
neuroimmun
marker
mrna
quantifi
use
qpcr
group
group
high
hivint
significantli
greater
express
interleukin
interferon
regulatori
factor
mrna
sever
neuroimmunolog
marker
mrna
significantli
differ
two
protein
associ
vitro
polar
macrophag
toward
phenotyp
typic
marker
mrna
includ
assay
express
significantli
higher
rate
specimen
high
hivint
conclus
high
hivint
brain
associ
express
play
key
role
macrophag
polar
suggest
hivint
accumul
preferenti
numer
minut
subtyp
polar
macrophag
brain
identifi
cellular
sourc
latent
hiv
brain
screen
specimen
surfac
marker
specif
segreg
high
hivint
load
yamil
raissa
richard
rosa
sebastian
claudia
claribel
avindra
valeri
present
author
yamilgerena
upredu
pharmaceut
scienc
pharmacolog
neuroaid
research
program
univers
puerto
ricomed
scienc
campu
research
program
univers
puerto
ricomed
scienc
campu
orthopaed
surgeri
john
hopkin
univers
physic
medicin
rehabilit
neuroaid
research
program
univers
puerto
ricomed
scienc
campu
medicin
univers
puerto
ricomed
scienc
campu
biolog
univers
puerto
ricorio
piedra
campu
nation
institut
neurolog
disord
stroke
intern
medicin
neurolog
divis
neuroaid
research
program
univers
puerto
ricomed
scienc
campu
background
insulin
resist
present
hivseroposit
peopl
use
combin
antiretrovir
treatment
cart
associ
hand
howev
mechan
involv
well
understood
recent
report
higher
plasma
solubl
insulin
receptor
sir
level
associ
presenc
sever
hand
cohort
hivseroposit
women
cart
studi
investig
solubl
insulinlik
growth
receptor
plasma
hivinfect
woman
associ
hand
correl
plasma
sir
level
method
plasma
level
assay
hivseroposit
women
stratifi
hand
normal
cognit
nc
asymptomat
impair
ai
symptomat
impair
si
five
control
without
histori
diabet
solubl
level
fulllength
intact
quantifi
elisa
patient
also
character
plasma
sir
tnfalpha
level
determin
elisa
nonparametr
statist
use
result
higher
level
plasma
associ
wors
cognit
perform
among
hivseroposit
women
stratifi
hand
signific
differ
observ
level
control
hivseroposit
women
nc
howev
signific
differ
seen
nc
ai
nc
si
group
posit
correl
observ
plasma
sir
level
correl
observ
age
viralimmun
profil
antiretrovir
therapi
tnfalpha
level
conclus
studi
provid
evid
secret
increas
hivinfect
women
may
role
progress
hand
find
also
suggest
similar
coordin
cellular
mechan
may
respons
secret
sir
plasma
patient
could
repres
biomark
presenc
sever
hand
work
support
lindsey
joseph
ellen
traci
present
author
lindseyg
templeedu
neurosci
templ
univers
school
medicin
biolog
templ
univers
medicin
templ
univers
school
medicin
chronic
neuroinflamm
infect
believ
contribut
develop
hivassoci
neurocognit
disord
hand
previou
work
laboratori
other
suggest
accumul
activ
central
nervou
system
cn
associ
macrophag
resid
microglia
result
invas
differenti
peripher
blood
monocyt
process
signific
pathogenesi
hand
cell
constitut
princip
cellular
reservoir
cn
importantli
hiv
infect
result
alter
monocytemacrophag
homeostasi
evidenc
skew
monocyt
phenotyp
activ
statu
may
support
develop
mainten
neuroinvas
monocyt
subset
previous
report
expans
monocyt
peripher
blood
hiv
patient
phenotyp
similar
macrophagesmicroglia
accumul
cn
hiv
infect
howev
whether
cell
sourc
new
infect
remain
unclear
test
hypothesi
specif
monocyt
popul
predilect
invas
preferenti
infect
compar
cellular
locat
monocyt
subset
isol
peripher
blood
cohort
chronic
infect
donor
document
histori
combin
antiretrovir
therapi
cart
adher
without
detect
plasma
viremia
base
express
explor
therapeut
strategi
target
monocyt
subset
use
experiment
fdaapprov
tyrosin
kinas
inhibitor
tki
select
cfm
type
iii
receptor
tyrosin
kinas
shown
promot
monocyt
phenotyp
vitro
anticip
studi
provid
novel
insight
role
alter
monocytemacrophag
homeostasi
hiv
diseas
identifi
novel
strategi
target
longliv
cellular
reservoir
hiv
restor
immun
homeostasi
nelli
alexand
philip
deni
charl
robert
pratima
anna
victoria
vikram
maria
present
author
dongilden
ucdenveredu
neurolog
microbiolog
univers
colorado
school
medicin
neurolog
univers
colorado
school
medicin
patholog
univers
colorado
school
medicin
patholog
centr
hospitali
universitair
du
nord
franc
neuropatholog
john
hopkin
univers
school
medicin
patholog
mount
sinai
medic
center
miami
fl
ophthalmolog
univers
colorado
school
medicin
giant
cell
arter
gca
multifoc
varicella
zoster
viru
vzv
vasculopathi
tempor
arteri
ta
infect
overlap
clinic
featur
laboratori
abnorm
analysi
ta
patholog
neg
gca
gca
reveal
vzv
antigen
ta
viral
antigen
found
mostli
exclus
adventitia
continu
search
vzv
antigen
gca
ta
abund
vzv
antigen
found
multipl
region
skip
area
arteri
led
addit
patholog
analysi
section
adjac
contain
vzv
antigen
reexamin
reveal
patholog
chang
inflamm
involv
arteri
media
abund
multinucl
giant
cell
characterist
gca
analyz
ta
patholog
confirm
gca
gca
vzv
antigen
found
ta
also
despit
formalinfix
presenc
vzv
ta
confirm
detect
vzv
dna
ta
contain
vzv
antigen
none
normal
ta
subject
age
contain
vzv
antigen
vzv
dna
detect
vzv
antigen
note
gca
ta
inflamm
multinucl
giant
cell
andor
epithelioid
macrophag
damag
media
andor
intern
elast
lamina
present
contrast
littl
inflamm
adventitia
gca
ta
indic
continuum
diseas
overal
reactiv
latenc
ganglia
vzv
travel
transaxon
initi
infect
arteri
adventitia
result
clinic
featur
lead
ta
biopsi
even
though
classic
patholog
featur
gca
describ
yet
develop
time
gca
patholog
develop
ta
contain
vzv
vzv
major
caus
gca
alexand
stephani
colleen
benjamin
denni
present
author
agil
mailmedupennedu
neurolog
perelman
school
medicin
univers
pennsylvania
patholog
univers
texa
medic
branch
although
antiretrovir
therapi
art
significantli
improv
clinic
outcom
hiv
patient
preval
associ
morbid
hivassoci
neurocognit
disord
hand
remain
high
thu
adjunct
neuroprotect
therapeut
target
address
patholog
process
persist
arttreat
individu
need
lab
identifi
heme
sentinel
cytoprotect
protein
host
factor
protect
hivmedi
neurodegener
defici
cn
hiv
individu
current
studi
quantifi
protein
express
prefront
cortex
hiv
hiv
hiv
encephalit
brain
protein
level
defici
prefront
cortex
hiv
patient
compar
hiv
control
p
sever
defici
observ
hiv
enceph
patient
p
furthermor
defici
correl
significantli
cn
viral
load
well
brain
parenchym
marker
macrophag
innat
immun
activ
result
suggest
cn
hiv
infect
reduc
protein
express
prefront
cortex
notabl
defici
significantli
wors
patient
hand
compar
hiv
individu
normal
cognit
correl
neurocognit
impair
execut
speed
process
domain
suggest
defici
may
play
role
neurocognit
impair
hand
patient
use
vitro
model
hivmedi
neurodegener
hivinfect
monocytederiv
macrophag
hivmdm
releas
neurotox
level
glutam
shown
hiv
infect
mdm
drastic
decreas
protein
express
moreov
pharmacolog
induct
decreas
hivmdm
neurotoxin
product
glutam
releas
contrast
inhibit
increas
neurotoxin
product
summari
find
report
defici
brain
hiv
individu
identifi
potenti
modul
macrophagemedi
neurodegener
hand
therefor
pharmacolog
induc
studi
potenti
reduc
persist
preval
hand
arttreat
individu
thoma
maureen
nikolau
benedikt
randal
present
author
randallcohr
ucdenveredu
modelingtissu
analogu
laboratori
nasa
johnson
space
center
houston
tx
usa
fur
virologi
freie
universitat
berlin
berlin
germani
neurolog
microbiolog
univers
colorado
school
medicin
co
usa
varicella
zoster
viru
vzv
ubiquit
neurotrop
alphaherpesviru
primari
infect
typic
caus
childhood
varicella
viru
becom
latent
ganglion
neuron
along
entir
neuraxi
cellmedi
immun
vzv
declin
age
immunosuppress
vzv
reactiv
caus
zoster
seriou
neurolog
ocular
diseas
unfortun
model
avail
studi
vzv
latenc
sinc
viru
infect
human
latenc
establish
neuron
success
maintain
normal
human
neural
progenitor
cell
nhnp
tissuelik
assembl
tla
cultur
month
nhnp
tla
mixtur
cell
express
marker
neuron
progenitor
cell
nestin
termin
differenti
neuron
betaiiitubulin
well
nonneuron
cell
gfap
vzv
infect
nhnptla
remain
viabl
month
time
vzv
dna
replic
vzv
gene
orf
transcrib
infecti
vzv
sporad
releas
abil
maintain
vzv
infect
nhnp
cell
cultur
extend
time
provid
uniqu
opportun
studi
molecular
interact
vzv
neuron
extent
previous
unattain
jennif
brian
ilker
jessica
kamel
barbara
present
author
krynskb
tuhstempleedu
neurosci
center
neurovirolog
templ
univers
school
medicin
neurolog
templ
univers
school
medicin
neurosci
center
neurovirolog
depart
neurolog
center
neural
repair
rehabilit
shriner
hospit
pediatr
research
center
templ
univers
school
medicin
jc
viru
jcv
ubiquit
human
polyomaviru
etiolog
agent
progress
multifoc
leukoencephalopathi
pml
addit
role
pml
observ
increas
frequenc
multipl
sclerosi
patient
monoclon
antibodi
therapi
jcv
associ
sever
human
cancer
jcv
infect
like
occur
childhood
hypothes
viru
abl
persist
within
bone
marrow
howev
identif
bone
marrow
cell
popul
harbor
persist
viru
may
therefor
facilit
spread
viru
differ
organ
includ
brain
hamper
heterogen
cell
popul
within
bone
marrow
recent
isol
distinct
popul
nonhematopoiet
bone
marrow
deriv
cell
jcv
tantigen
transgen
mice
cell
neural
crest
lineag
demonstr
express
jcv
tantigen
activ
popul
bone
marrow
cell
upon
exposur
neural
environ
jcv
tantigen
posit
cell
exhibit
neural
crest
characterist
demonstr
nestin
posit
jcv
tantigen
posit
cell
could
success
cultur
longterm
maintain
neural
crest
characterist
furthermor
cell
induc
differenti
neural
crest
deriv
jcv
tantigen
express
downregul
cell
differenti
bone
maintain
glial
cell
express
gfap
conclud
jcv
tantigen
stabli
express
within
fraction
bone
marrow
cell
differenti
along
neural
crestglial
lineag
cell
cultur
vitro
thu
identifi
previous
unrecogn
bone
marrowderiv
neural
crest
stem
cell
popul
permiss
jcv
earli
gene
express
suggest
possibl
cell
could
support
viral
infect
thu
provid
clue
toward
understand
role
bone
marrow
jcv
persist
reactiv
iren
rachel
van
kylen
moham
ravi
elizabeth
gavin
svetlana
leonard
aarthi
hao
sergey
benjamin
chen
fatah
present
author
fkashanc
gmuedu
molecular
microbiolog
nation
center
biodefens
infecti
diseas
georg
mason
univers
depart
microbiolog
immunolog
tropic
medicin
georg
washington
univers
school
medicin
jackson
laboratori
physic
georg
washington
univers
nanosci
inc
physic
huazhong
univers
scienc
technolog
implement
new
antiretrovir
therapi
target
transcript
earli
viral
protein
postintegr
aid
overcom
current
therapi
limit
use
high
throughput
screen
assay
previous
describ
novel
tatdepend
transcript
inhibitor
name
screen
deriv
yield
uniqu
compound
show
potent
inhibit
transcript
identifi
second
gener
deriv
call
inhibitor
tatdepend
transcript
tzmbl
cell
potent
inhibitor
kinas
vitro
structur
half
molecular
weight
structur
compar
parent
compound
importantli
also
found
differenti
complex
present
infect
cell
uninfect
cell
present
complex
molecular
weight
kda
like
compos
either
homo
heterodim
conjunct
possibl
chaperon
protein
bound
protein
howev
infect
cell
display
extend
set
smaller
molecular
weight
complex
addit
domin
kda
complex
preferenti
inhibit
novel
kinas
complex
infect
cell
nanomolar
concentr
observ
efficaci
replic
inhibit
human
mous
model
mgkg
measur
revers
transcriptas
activ
treat
anim
longitudin
measur
span
day
show
effect
viral
suppress
mgkg
shortli
treatment
left
untreat
viru
would
resum
replic
compar
respons
cart
requir
daili
dosag
effect
plasma
control
viral
load
final
observ
neuron
cultur
treat
tat
protein
protect
tatmedi
cytotox
treat
overal
data
suggest
tatdepend
transcript
sensit
small
molecul
inhibit
debjani
guha
lili
franci
todd
reinhart
velpandi
ayyavoo
present
author
pittedu
dept
infecti
diseas
microbiolog
gsph
univers
pittsburgh
invad
central
nervou
system
cn
establish
infect
brain
infect
monocytesmacrophag
microglia
infect
monocyt
macrophag
releas
cytokinechemokin
recruit
cell
brain
studi
focus
highli
express
chemokin
potent
chemoattract
neutrophil
neutrophil
maintain
innat
immun
surveil
normal
condit
wherea
inflamm
caus
tissu
damag
investig
role
well
neutrophil
infect
brain
monocytederiv
macrophag
mdm
infect
show
signific
upregul
rna
protein
level
compar
uninfectedmock
mdm
cultur
signific
upregul
infect
mdm
partli
influenc
overexpress
neutral
antibodi
reduc
express
infect
mdm
compar
mock
infect
increas
product
also
part
regul
phosphoryl
statu
associ
product
confirm
block
mapk
prevent
elev
infect
mdm
uninfect
cultur
function
analys
suggest
increas
level
directli
correl
infiltr
neutrophil
chemotaxi
assay
furthermor
increas
level
enhanc
infiltr
activ
neutrophil
express
myeloperoxidas
mpo
also
observ
brain
tissu
posit
subject
assess
consequ
mpo
neuron
infect
primari
neuron
treat
infect
control
mdm
supernat
presenc
absenc
mpo
result
indic
mpo
reduc
neuron
surviv
dose
depend
manner
collect
result
suggest
profound
effect
impair
innat
immun
function
infect
brain
neutrophil
infiltr
affect
final
outcom
infect
archana
bing
han
brian
lynn
present
author
drexeledu
microbiolog
immunolog
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
philadelphia
pa
depart
laboratori
medicin
veteran
affair
medic
center
san
francisco
laboratori
medicin
veteran
affair
medic
center
san
francisco
microbiolog
immunolog
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
philadelphia
pa
recent
report
subject
hcv
virallysuppress
hiv
infect
coinfect
cognit
impair
importantli
show
peripher
monocyt
coinfect
distinct
typei
interferon
ifn
activ
profil
sinc
hcv
consid
neurotrop
suggest
indirect
viral
mechan
may
respons
neural
cell
dysfunct
sever
line
evid
indic
exosom
facilit
celltocel
commun
wherein
host
rna
includ
mirna
protein
transfer
recipi
cell
hypothes
ifnactiv
monocytemacrophag
mediat
neurocognit
impair
coinfect
transfer
exosom
mirna
neural
cell
subsequ
dysregul
function
support
hypothesi
show
monocytederiv
exosom
intern
primari
human
astrocyt
addit
mirna
profil
exosom
shed
monocyt
hivhcvinfect
subject
reveal
vesicl
highli
enrich
develop
vitro
model
recapitul
activ
state
monocyt
coinfect
subject
ifnactiv
monocytederiv
exosom
greatli
abund
well
incub
human
astrocytoma
cell
result
signific
elev
intracellular
level
result
suggest
monocytederiv
exosom
transfer
mirna
neural
cell
potenti
alter
cellular
environ
latter
transfer
mirna
activ
monocyt
astrocyt
via
exosom
may
explain
part
neurolog
abnorm
associ
coinfect
chri
matt
jed
vanessa
brian
barri
present
author
drexeledu
neurobiolog
anatomi
drexel
univers
colleg
medicin
microbiolog
immunolog
drexel
univers
colleg
medicin
discov
caus
potenti
therapi
hivassoci
neurocognit
disord
hand
increas
import
hiv
popul
continu
age
hand
mark
impair
attent
memori
well
decreas
cognit
flexibl
viral
envelop
glycoprotein
implic
develop
hand
previou
studi
shown
deficit
acquisit
phase
morri
water
maze
task
follow
intracerebroventricular
icv
infus
rat
present
work
sought
extend
find
domain
cognit
function
adult
male
rat
implant
bilater
cannula
later
ventricl
recoveri
surgeri
daili
infus
ngmicrolit
bovin
serum
albumin
bsa
vehicl
solut
administ
day
anim
food
restrict
day
final
infus
test
attent
setshift
task
adapt
birrel
brown
day
later
succeed
task
anim
must
discrimin
sensori
cue
determin
locat
food
reward
subject
also
requir
ignor
cue
reward
previou
trial
longer
indic
reward
locat
anim
expos
significantli
impair
revers
learn
within
modal
shift
abil
make
extradimension
shift
crossmod
switch
suggest
behavior
inflex
establish
rat
model
hand
mimic
cognit
deficit
observ
clinic
popul
provid
insight
regard
mechan
well
guid
develop
potenti
therapi
work
support
nihnimh
nimh
nicol
haverland
pawel
ciborowski
present
author
pciborowski
unmcedu
univers
nebraska
medic
center
human
immunodefici
viru
type
remain
worldwid
epidem
vaccin
therapi
capabl
erad
viru
avail
although
infect
gener
associ
widespread
destruct
tcell
monocyt
macrophag
play
import
role
infect
process
serv
viral
reservoir
capabl
harbor
latent
viru
well
dissemin
viru
throughout
bodi
novel
therapeut
avenu
would
target
host
factor
transcript
regul
involv
host
respons
viral
infect
bypass
normal
cellular
function
approach
could
circumv
current
limit
antiretrovir
therapi
hypothes
transcript
regul
protein
includ
transcript
factor
cofactor
promot
enhanc
repressor
protein
involv
chromatin
structur
modif
differenti
express
macrophag
test
hypothesi
use
novel
proteom
platform
swathm
target
quantit
proteom
analysi
transcript
regul
captur
quantit
proteom
data
specif
select
transcript
regul
protein
use
inhous
gener
databas
compos
known
put
transcript
regul
use
swathm
approach
identifi
quantifi
transcript
regul
uninfect
monocytederiv
macrophag
appli
novel
statist
test
proteom
data
use
method
previous
establish
intensitybas
microarray
data
analysi
identifi
transcript
regul
significantli
p
alter
follow
infect
bioinformat
analysi
alter
transcript
regul
reveal
function
enrich
protein
involv
chromatin
structur
epigenet
modif
find
highlight
novel
subset
transcript
regul
protein
involv
infect
demand
investig
addit
studi
provid
new
experiment
paradigm
readili
appli
broad
group
scientist
understand
host
respons
microbi
infect
jasmin
herz
dorian
mcgavern
present
author
herzjn
mailnihgov
nih
nind
sever
virus
infect
mammalian
nervou
system
devast
consequ
other
littl
overt
patholog
adopt
immunotherapi
approach
involv
administr
antivir
cell
shown
promis
clinic
studi
treatment
cmv
ebv
adenoviru
infect
laboratori
model
adopt
immunotherapi
transfer
antivir
memori
cell
mice
persist
infect
birth
lymphocyt
choriomening
viru
demonstr
memori
cell
complet
purg
brain
persist
infect
mice
without
caus
blood
brain
barrier
breakdown
sever
tissu
damag
accomplish
tailor
releas
chemoattract
recruit
adapt
immun
cell
pathogen
innat
immun
cell
neutrophil
inflammatori
monocyt
interestingli
memori
cell
enlist
support
nearli
brain
resid
myeloid
cell
microglia
convert
antigenpres
cell
apc
twophoton
imag
studi
reveal
antivir
cell
like
deceler
form
stabl
interact
brainresid
apc
cell
importantli
microglia
undergo
cell
death
follow
cell
engag
appear
protect
upregul
serin
proteas
inhibitor
like
propos
noncytopath
viral
clearanc
brain
therapeut
memori
cell
result
tailor
chemoattract
product
interact
resid
myeloid
cell
protect
wenhui
hu
rafal
kaminski
yonggang
zhang
fan
yang
kamel
khalili
present
author
whu
templeedu
depart
neurosci
center
neurovirolog
templ
univers
school
medicin
introduct
combin
antiretrovir
therapi
cart
greatli
improv
surviv
rate
among
aid
patient
substanti
portion
infect
individu
remain
risk
develop
full
blown
aid
result
reactiv
latent
infect
cell
partli
due
nonadher
medic
emerg
drug
resist
virus
moreov
posit
long
term
survivor
continu
develop
comorbid
includ
acceler
age
process
neurocognit
disord
heart
failur
other
virolog
point
view
none
current
treatment
suppress
viral
gene
transcript
suspect
low
yet
continu
level
viral
earli
protein
regulatori
pathogen
activ
may
contribut
develop
qualiti
lifethreaten
ill
sadli
effort
toward
develop
vaccin
shown
promis
outcom
thu
cure
aid
erad
genom
infect
subject
requir
novel
strategi
specif
highli
effect
irrevers
sustain
recent
adapt
genet
approach
use
cluster
regulatori
interspac
short
palindrom
repeatassoci
system
ca
short
complementari
singlestrand
rna
call
guid
rna
grna
specif
target
region
long
term
repeat
ltr
promot
precis
excis
segment
viral
regulatori
sequenc
requir
express
addit
employ
singl
multiplex
grna
system
show
promis
result
includ
erad
entir
genom
latent
infect
microgli
cell
thu
abrog
viral
gene
express
reactiv
base
observ
propos
work
model
develop
rnaguid
act
molecular
scissor
disrupt
variou
region
ltr
andor
remov
entir
viral
genom
abrog
reactiv
viru
macrophag
microglia
astrocyt
serv
viral
reservoir
brain
work
support
nih
grant
comprehens
neuroaid
center
grant
award
kk
liang
xuesong
norman
jonathan
present
author
jonathangeig
medundedu
biomed
scienc
univers
north
dakota
school
medicin
health
scienc
neurolog
psychiatri
john
hopkin
school
medicin
tat
continu
implic
caus
agent
associ
neurocognit
disord
hand
found
previous
tat
elev
endolysosom
ph
alter
structur
function
neuron
endolysosom
promin
earli
patholog
featur
hand
show
enlarg
neuron
endolysosom
occur
induc
tat
transgen
model
hand
determin
underli
mechan
wherebi
tat
induc
endolysosom
dysfunct
observ
tat
elev
endolysosom
ph
indic
tat
escap
endolysosom
appear
link
proton
leakag
endolysosom
suggest
protondepend
peptid
transport
might
involv
known
protondepend
peptid
transport
demonstr
protoncoupl
oligopeptid
transport
present
neuron
endolysosom
sirna
knockdown
block
tatinduc
enlarg
endolysosom
thu
might
protondepend
peptid
transport
tat
affect
endolysosom
ph
might
involv
tat
escap
endolysosom
elev
endolysosom
ph
could
also
affect
endolysosom
calcium
homeostasi
show
elev
endolysosom
ph
induc
calcium
releas
endolysosom
also
activ
novel
endolysosomedepend
calcium
influx
across
plasma
membran
phenomenon
term
acid
storeoper
calcium
entri
given
observ
tat
elev
endolysosom
ph
increas
calcium
releas
intracellular
store
enhanc
calcium
influx
across
plasma
membran
tat
could
activ
novel
endolysosomedepend
calcium
regulatori
mechan
may
involv
action
tat
neuron
endolysosom
contribut
pathogenesi
hand
support
sergey
rachel
van
gavin
sampey
kelsi
fabio
fatah
present
author
gmailcom
molecular
microbiolog
nation
center
biodefens
infecti
diseas
georg
mason
univers
interact
section
hiv
drug
resist
program
nation
cancer
institut
nih
human
virolog
univers
maryland
school
medicin
highli
activ
antiretrovir
therapi
reduc
hiv
rna
plasma
undetect
level
howev
viru
continu
persist
rest
cell
cn
reservoir
perivascular
macrophag
microglia
astrocyt
select
reactiv
erad
hiv
cn
reservoir
critic
problem
current
hiv
therapi
xray
irradi
ir
welldefin
stress
signal
wide
use
mani
therapeut
purpos
earlier
shown
capabl
activ
increas
transcript
progeni
virion
format
eventu
apoptosi
infect
cell
use
infect
monocytederiv
macrophag
mdm
model
cell
pmaactiv
nsg
human
mice
infect
dualtrop
strain
examin
effect
irinduc
cellular
stress
replic
viabil
infect
cell
treatment
pbmc
mdm
differ
ir
dose
led
dramat
increas
transcript
evidenc
presenc
pol
ii
reduct
promot
use
chip
assay
coincid
increas
level
intracellular
rna
incub
irtreat
cell
proteasom
inhibitor
alln
calpain
inhibitor
result
addit
increas
transcript
probabl
due
tat
protein
stabil
interestingli
analysi
infect
progeni
virion
use
tzmbl
report
cell
show
decreas
infect
viru
produc
irradi
cell
suggest
along
activ
replic
ir
increas
product
defect
viral
particl
treatment
infect
human
mice
display
viral
rna
plasma
pbmc
ir
result
signific
increas
rna
plasma
lung
especi
brain
tissu
taken
togeth
current
data
suggest
irinduc
cellular
stress
activ
express
infect
mdm
differ
mdmrich
tissu
includ
brain
facilit
apoptot
death
infect
cell
possibl
via
tatdepend
phosphoryl
protein
elizabeth
aarthi
rachel
van
sergey
moham
ravi
philipp
gavin
shabana
myung
anasta
bindesh
ako
renaud
fatah
present
author
msaifuddinbd
yahoocom
molecular
microbiolog
nation
center
biodefens
infecti
diseas
georg
mason
univers
georg
washington
univers
medic
center
depidemiologi
et
physiopathologi
de
viru
oncogen
depart
de
virologi
institut
pasteur
cnr
chemistri
georg
washington
univers
microscopi
imag
analysi
georg
washington
univers
medic
center
oncogenes
retroviral
equip
labelise
ligu
national
contr
le
cancer
intern
center
research
infectiolog
human
tlymphotrop
viru
type
caus
agent
adult
tcell
leukemia
atl
myelopathi
ham
tropic
spastic
paraparesi
tsp
transactiv
protein
tax
control
mani
critic
cellular
pathway
includ
host
cell
dna
damag
respons
mechan
cell
cycl
progress
apoptosi
recent
extracellular
vesicl
call
exosom
shown
play
critic
role
pathogen
viral
infect
deliveri
vehicl
host
viral
compon
includ
protein
mrna
mirna
hypothes
exosom
deriv
infect
cell
contain
uniqu
host
viral
protein
may
contribut
pathogenesi
found
exosom
deriv
infect
cell
contain
oncogen
tax
protein
proinflammatori
mediat
well
viral
mrna
transcript
tax
hbz
env
also
observ
drastic
reduct
rant
exosom
infect
cell
exosom
infect
cell
deliv
function
protein
naiv
recipi
cell
induc
ro
product
furthermor
observ
exosom
releas
infect
taxexpress
cell
contribut
enhanc
surviv
target
cell
treat
fa
antibodi
depend
cell
receiv
tax
contain
exosom
also
protect
apoptosi
similar
experi
pbmc
also
show
protect
cell
day
cultur
absenc
collect
result
suggest
exosom
may
play
import
role
extracellular
deliveri
function
protein
especi
tax
mrna
recipi
cell
contribut
oncogenesi
recipi
cell
elizabeth
nazli
rachel
van
moham
sergey
kylen
benjamin
fatah
present
author
fkashanc
gmuedu
molecular
microbiolog
nation
center
biodefens
infecti
diseas
georg
mason
univers
microbiolog
immunolog
tropic
medicin
georg
washington
univers
medic
center
nanosci
infect
result
chronic
incur
ill
sinc
longterm
haart
keep
viru
undetect
level
discontinu
therapi
rapidli
increas
viru
burden
moreov
patient
haart
frequent
develop
variou
metabol
disord
also
hivassoci
neuron
diseas
today
main
challeng
hiv
research
elimin
residu
viru
infect
individu
current
diagnost
larg
compris
serolog
nucleic
acid
base
technolog
goal
integr
nanoparticl
technolog
standard
research
tool
allow
highli
sensit
detect
hiv
infect
studi
demonstr
major
virion
tatnef
protein
spike
cultur
medium
captur
nanoparticl
especi
low
concentr
nanoparticl
provid
dramat
increas
detect
level
standard
assay
determin
bind
specif
differ
affin
bait
incub
target
molecul
nanoparticl
room
temperatur
short
sequestr
materi
either
elut
use
downstream
assay
buffer
remain
attach
nanoparticl
prior
analysi
uniqu
affin
bait
nanoparticl
preferenti
bound
materi
exclud
albumin
specif
captur
fulllength
tat
tat
peptid
spike
cell
cultur
medium
nanoparticl
measur
wb
intracellular
nef
protein
captur
membraneassoci
nef
captur
whole
viru
captur
enrich
nanoparticl
captur
infecti
viru
demonstr
tat
transactiv
tzmbl
cell
also
demonstr
specif
captur
exosom
deriv
infect
cell
measur
tarrna
qrtpcr
collect
data
indic
nanoparticl
select
captur
specif
target
molecul
infect
propos
use
technolog
platform
enhanc
detect
concentr
viral
protein
infecti
materi
infect
sampl
tori
gloria
von
richa
ned
justin
scott
rodrigo
carol
david
ashok
avindra
present
author
toryjohnson
nihgov
nih
nih
nih
hopkin
school
medicin
depart
neurolog
california
san
diego
texa
houston
miami
jackson
memori
hospit
background
effect
hivtat
protein
neurogli
function
well
studi
role
tat
mediat
persist
proinflammatori
respons
cn
virolog
control
individu
art
well
known
persist
low
level
inflamm
demonstr
major
individu
chronic
hiv
infect
even
avirem
patient
well
control
art
develop
immun
reconstitut
inflammatori
syndrom
iri
method
immunostain
brain
biopsi
tissu
tat
antigen
cell
marker
two
hiv
patient
art
develop
cn
iri
compar
autopsi
brain
tissu
seven
hivinfect
individu
good
virolog
control
art
without
iri
one
hiv
enceph
hive
art
tat
level
also
examin
csf
patient
art
peripher
blood
mononuclear
cell
pbmc
infect
hiv
treat
darunavir
result
monocyt
infiltr
strongli
stain
tat
patient
iri
howev
immunostain
neg
hiv
patient
without
iri
tat
present
individu
patient
hive
tat
express
macrophag
microgli
nodul
perivascular
region
iri
patient
infiltr
consist
tcell
predominantli
cell
occasion
cell
tat
detect
csf
sampl
elisa
hivinfect
individu
control
art
tat
confirm
subset
csf
sampl
western
blot
analysi
darunavir
block
viral
product
hivinfect
pbmc
howev
tat
product
unimpair
conclus
robust
product
tat
note
brain
individu
cnsiri
csf
one
third
individu
control
art
art
control
hiv
replic
impact
tat
product
therapeut
develop
prevent
tat
product
necessari
asha
jame
christoph
benjamin
present
author
kalliaa
ccforg
genom
medicin
lerner
research
institut
cleveland
clinic
lerner
colleg
medicin
cleveland
clinic
cleveland
oh
neurosurgeri
penn
state
milton
hershey
medic
center
hershey
pa
psycholog
univers
wisconsin
madison
wi
patholog
univers
texa
medic
branch
galveston
tx
background
iron
dysregul
brain
consist
poorli
understood
featur
neurocognit
disord
function
neuron
iron
defici
implic
certain
dementia
hypothes
hivassoci
neurocognit
disord
hand
pathophysiolog
involv
brain
iron
defici
reflect
increas
transferrin
receptor
tfr
rna
express
brain
method
subject
die
hivaid
particip
nation
neuroaid
tissu
consortium
nntc
studi
underw
uniform
autopsyneuropatholog
protocol
comprehens
neurocognit
assess
within
month
antemortem
total
rna
extract
purifi
frozen
brain
tissu
frontal
neocortex
brodmann
area
tfr
messeng
rna
quantifi
rtpcr
associ
tfr
rna
express
hand
standard
neurocognit
domain
score
assess
use
multivari
regress
adjust
potenti
confound
result
among
evalu
deced
nntc
brain
bank
mean
age
median
cell
count
hand
occur
rang
mild
neurocognit
impair
dementia
tfr
rna
express
level
avail
subject
unrel
brain
viral
burden
tfr
rna
express
neocortex
associ
hand
p
p
associ
dementia
unadjust
analys
tfr
rna
level
higher
hand
case
control
median
iqr
vs
respect
associ
persist
multivari
adjust
odd
ratio
ci
p
hand
case
ci
p
dementia
speed
inform
process
attent
work
memori
global
standard
tscore
neg
associ
tfr
rna
express
betacoeffici
ci
global
tscore
conclus
tfr
rna
express
frontal
neocortex
independ
associ
mild
sever
neurocognit
impair
among
individu
die
hivaid
suggest
role
brain
iron
defici
hand
etiolog
andor
progress
rafal
kaminski
prasun
k
datta
hassen
wolllebo
kamel
khalili
present
author
rafalkim
templeedu
depart
neurosci
center
neurovirolog
templ
univers
school
medicin
philadelphia
pa
transcript
promot
control
seri
ubiquit
induc
cellular
protein
abil
enter
nucleu
interact
specif
dna
sequenc
span
long
termin
repeat
ltr
demonstr
abil
key
regul
homolog
recombin
pathway
dna
repair
stimul
transcript
promot
span
within
long
termin
repeat
ltr
result
show
activ
nfkb
pathway
pma
treatment
overexpress
subunit
promot
associ
ltr
sequenc
accordingli
stimul
viral
promot
reli
part
interplay
nfkb
pathway
treatment
cell
pma
promot
nuclear
entri
inactiv
nfkb
pathway
domin
neg
mutant
ikbalpha
modul
abil
stimul
ltr
transcript
infect
primari
peripher
blood
mononuclear
cell
indic
express
treatment
infect
cell
inhibitor
suppress
lentivir
replic
cell
suggest
oper
posit
feedback
pathway
observ
ascrib
new
role
transcript
genom
offer
new
avenu
develop
therapeut
support
grant
kamel
khalili
studi
util
servic
offer
core
facil
comprehens
neuroaid
center
cnac
nih
kathleen
sarah
kelli
metcalf
suzann
jami
robert
patrick
joseph
present
author
jmankow
jhmiedu
molecular
compar
pathobiolog
john
hopkin
univers
biostatist
texa
tech
univers
school
medicin
given
associ
hivinduc
cn
diseas
replic
hiv
macrophag
brain
antagonist
could
attenu
cn
diseas
limit
hiv
replic
macrophag
downmodul
inflammatori
signal
mediat
interact
determin
whether
inhibit
alter
cn
diseas
progress
independ
treatment
class
antiretrovir
drug
cn
outcom
compar
sivinfect
anim
treat
maraviroc
monotherapi
versu
untreat
sivinfect
anim
siv
rna
siv
dna
level
brain
markedli
lower
maraviroc
treat
sivinfect
macaqu
versu
untreat
sivinfect
macaqu
demonstr
maraviroc
monotherapi
limit
replic
siv
cn
may
reduc
cn
latent
viral
reservoir
addit
maraviroc
treatment
lower
monocyt
macrophag
activ
repres
cn
immunostain
plasma
level
reduc
tnfalpha
rna
express
brain
maraviroc
treatment
also
reduc
axon
amyloid
precursor
protein
app
immunostain
level
present
uninfect
anim
demonstr
protect
develop
neuron
dysfunct
although
maraviroc
therapi
reduc
plasma
viral
load
siv
rna
level
spleen
rel
decreas
less
substanti
cn
declin
underscor
import
assess
cnsspecif
outcom
evalu
efficaci
inhibit
addit
inhibitor
combin
antiretrovir
regimen
may
effect
prevent
neurolog
disord
hivinfect
individu
also
may
reduc
cn
viral
reservoir
shawn
keogan
shendra
passic
brian
wigdahl
fred
c
kreb
present
author
gmailcom
depart
microbiolog
immunolog
center
molecular
therapeut
resist
center
sexual
transmit
diseas
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
philadelphia
pa
absenc
effect
microbicid
reduc
elimin
risk
human
immunodefici
type
transmiss
develop
new
drug
remain
prioriti
cell
penetr
peptid
cpp
short
peptid
capabl
cross
plasma
membran
live
cell
develop
deliveri
vehicl
therapeut
agent
enter
cell
one
wellstudi
cpp
acid
peptid
deriv
human
immunodefici
viru
type
tat
protein
experi
test
hypothesi
multipl
cation
amino
acid
within
tat
peptid
confer
antivir
activ
introduct
tat
peptid
result
concentrationdepend
inhibit
iiib
infect
yet
minim
antivir
activ
bal
contrast
tat
peptid
variant
contain
arginin
substitut
two
nonion
residu
two
lysin
residu
demonstr
direct
relationship
cation
charg
antivir
potenc
inhibit
experi
studi
tat
peptid
antivir
agent
rais
new
question
role
tat
replic
provid
start
point
develop
cpp
novel
inhibitor
kati
adriano
eric
michael
brian
present
author
bcondran
drexelmededu
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
human
retrovirolog
institut
de
recherch
cliniqu
de
montreal
depart
microbiolog
immunolog
univers
de
montreal
patient
infect
human
immunodefici
viru
type
often
display
neurolog
complic
late
stage
diseas
increas
viral
load
directli
correl
higher
concentr
extracellular
protein
r
vpr
blood
serum
cerebrospin
fluid
addit
patient
low
tlymphocyt
count
display
lower
concentr
reduc
glutathion
gsh
main
intracellular
antioxid
molecul
lower
level
surviv
condit
media
obtain
human
endotheli
kidney
hek
cell
line
transfect
either
absenc
presenc
vpr
contain
free
vpr
exposur
mg
cell
condit
media
decreas
intracellular
level
adenosin
triphosph
atp
gsh
observ
recapitul
use
purifi
recombin
vpr
mg
primari
human
fetal
astrocyt
dose
timedepend
manner
vprinduc
oxid
stress
could
partli
restor
cotreat
antioxid
molecul
nacetylcystein
nac
addit
free
vpr
augment
product
reactiv
oxygen
speci
due
increas
level
oxid
glutathion
gssg
event
almost
entir
suppress
treatment
antivpr
antibodi
cotreat
nac
studi
confirm
role
extracellular
vpr
decreas
level
intracellular
atp
gsh
astrocyt
studi
underway
better
understand
intric
correl
reduct
atp
gsh
metabolit
impact
exert
neuron
surviv
endstag
diseas
work
support
nihnind
nida
nimh
nimh
michael
david
shruti
rolf
christian
mailan
david
long
matthew
igor
present
author
sagnihot
bidmcharvardedu
neurovirolog
depart
neurolog
center
virolog
vaccin
research
beth
israel
deaco
medic
center
radiolog
beth
israel
deaco
medic
center
patholog
beth
israel
deaco
medic
center
medicin
beth
israel
deaco
medic
center
object
determin
frequenc
hyperintens
cortic
signal
hct
mri
progress
multifoc
leukoencephalopathi
pml
patient
associ
seizur
risk
immun
reconstitut
inflammatori
syndrom
iri
patholog
correl
background
pml
caus
jc
viru
jcv
affect
predomin
white
matter
seizur
point
cortic
origin
add
increas
evid
gray
matter
involv
pml
hct
radiolog
marker
cortic
laminar
necrosi
describ
hypoxia
hypoglycemia
statu
epilepticu
method
review
clinic
data
includ
seizur
histori
presenc
iri
mri
scan
pml
patient
evalu
institut
case
diagnos
either
csf
jcv
pcr
brain
biopsi
autopsi
mri
imag
avail
includ
analysi
compar
patholog
find
area
brain
two
patient
display
hct
isointens
cortex
individu
result
patient
seizur
hct
adjac
subcort
pml
lesion
mri
pml
patient
seizur
hct
compar
patient
without
seizur
p
patient
iri
hct
compar
without
iri
hct
predict
seizur
odd
ratio
confid
interv
ci
togeth
hct
iri
predict
seizur
ci
histolog
examin
hct
area
show
evid
ischemia
associ
strike
demyelin
subcort
ufib
signific
macrophag
infiltr
pronounc
reactiv
gliosi
deep
cortic
layer
conclus
seizur
frequent
complic
pml
hct
associ
seizur
well
iri
correl
histolog
cortic
segment
astrogliosi
michael
sarah
long
xiaoen
david
igor
present
author
ikoralni
bidmcharvardedu
virolog
vaccin
research
depart
neurolog
beth
israel
deaco
medic
center
harvard
medic
school
virolog
vaccin
research
depart
neurolog
beth
israel
deaco
medic
center
harvard
medic
school
current
affili
biogen
idec
medicin
beth
israel
deaco
medic
center
harvard
medic
school
radiolog
beth
israel
deaco
medic
center
harvard
medic
school
object
sought
character
perfus
pattern
progress
multifoc
leukoencephalopathi
pml
lesion
arteri
spin
label
asl
perfus
magnet
reson
imag
analyz
associ
immun
reconstitut
inflammatori
syndrom
surviv
background
asl
use
magnet
field
alter
magnet
water
inflow
arteri
blood
measur
effect
inflow
alter
magnet
tissu
signal
tracer
use
endogen
blood
water
asl
requir
inject
contrast
agent
method
total
patient
pml
underw
clinic
evalu
well
magnet
reson
imag
brain
within
day
symptom
onset
presenc
immun
reconstitut
inflammatori
syndrom
determin
base
clinic
laboratori
criteria
perfus
within
pml
lesion
determin
arteri
spin
label
magnet
reson
imag
result
observ
intens
hyperperfus
within
edg
pml
lesion
subset
subject
hyperperfus
quantifi
measur
fraction
lesion
volum
show
perfus
excess
twice
normal
appear
gray
matter
hyperperfus
lesion
fraction
significantli
greater
pml
progressor
survivor
vs
correspond
rel
risk
progress
individu
hyperperfus
lesion
fraction
ci
presenc
hyperperfus
invers
relat
occurr
immun
reconstitut
inflammatori
syndrom
time
scan
inde
within
three
month
symptom
onset
hyperperfus
posit
predict
valu
absenc
immun
reconstitut
inflammatori
syndrom
conclus
arteri
spin
label
magnet
reson
imag
recogn
region
elev
perfus
within
lesion
pml
region
might
repres
virolog
activ
area
oper
absenc
effect
adapt
immun
respons
correspond
wors
prognosi
tijana
nana
jennif
joseph
arthur
matthew
shohreh
kamel
present
author
tijana
templeedu
biolog
colleg
scienc
technolog
templ
univers
neurosci
center
neurovirolog
templ
univers
school
medicin
medicin
section
nephrolog
kidney
transplant
center
translat
medicin
templ
univers
school
medicin
medicin
section
cardiolog
depart
physiolog
templ
univers
school
medicin
medic
genet
program
school
medicin
divis
cardiolog
univers
colorado
anschutz
medic
campu
long
term
combin
antiretrovir
therapi
cart
greatli
improv
surviv
rate
among
aid
patient
substanti
proport
infect
individu
continu
develop
comorbid
includ
heart
failur
hf
secondari
left
ventricular
dysfunct
higher
rate
individu
underli
mechan
wherebi
increas
suscept
hf
remain
poorli
understood
respect
tat
produc
releas
latent
viral
reservoir
upon
circul
taken
uninfect
cell
receiv
special
attent
due
abil
induc
array
dysregulatori
event
perturb
cell
organ
function
demonstr
tat
physic
associ
stress
induc
protein
involv
protein
qualiti
control
modul
autophagi
apoptosi
critic
normal
cardiac
develop
mainten
knockout
mice
develop
left
ventricular
lv
dysfunct
shorten
lifespan
furthermor
recent
studi
identifi
potenti
role
patient
hf
heterozyg
mutat
decreas
level
lead
develop
herit
form
dilat
cardiomyopathi
moreov
ventricular
myocardium
isol
fail
human
heart
examin
time
heart
transplant
exhibit
nearli
reduct
level
cardiac
tissu
support
import
healthi
heart
function
import
regul
filamin
myopodin
regul
protein
turnov
autophagi
cardiomyocyt
provid
evid
suggest
interplay
tat
impact
abil
regul
sever
pathway
involv
structur
function
integr
cardiomyocyt
thu
one
envis
model
inactiv
upon
associ
tat
recapitul
clinic
manifest
seen
patient
heart
failur
associ
lowdysfunct
christina
elizabeth
blankenhorn
brian
stephen
present
author
drexeledu
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
microbiolog
immunolog
center
immunogenet
inflammatori
diseas
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
ubiquit
neurotrop
human
pathogen
caus
diseas
rang
mild
orofaci
lesion
potenti
fatal
enceph
cell
present
infect
site
express
pattern
recognit
receptor
includ
tolllik
receptor
detect
infect
produc
antivir
cytokin
limit
viral
invas
nervou
system
assess
role
resist
enceph
natur
lip
infect
model
multipl
cell
type
express
recogn
glycoprotein
show
mice
highli
suscept
mortal
natur
killer
cell
respond
normal
mice
exhibit
impair
dendrit
cell
tcell
activ
viru
replic
within
lip
differ
spread
trigemin
ganglia
effici
group
addit
cn
entri
exacerb
knockout
viral
load
posit
correl
diseas
sever
elev
cn
viral
load
precipit
upregul
induc
nitric
oxid
synthas
nitric
oxid
neurotox
high
concentr
presum
contribut
mortal
knockout
anim
assess
infiltr
leukocyt
infect
cn
studi
impact
diseas
neutrophil
contribut
irrepar
inflamm
viral
enceph
observ
cerebr
cortex
mice
exhibit
signific
sign
diseas
irrespect
statu
lastli
util
intracrani
infect
model
specif
assess
role
within
cn
viru
strain
util
prove
virul
reveal
phenotyp
differ
summari
critic
import
control
level
spread
cn
viru
access
brain
respons
contribut
heighten
inflamm
observ
knockout
anim
futur
studi
focu
identif
respons
cell
type
colleen
surendra
alexand
benjamin
denni
present
author
collk
mailmedupennedu
neurolog
perelman
school
medicin
univers
pennsylvania
patholog
univers
texa
medic
branch
despit
widespread
use
antiretrovir
therapi
hivassoci
neurocognit
disord
hand
continu
persist
signifi
need
develop
adjunct
therapeut
strategi
identifi
antioxid
antiinflammatori
enzym
heme
potenti
therapeut
target
hand
recent
character
within
prefront
cortex
hiv
individu
found
protein
defici
hiv
individu
correl
neurocognit
impair
howev
rna
increas
compar
hiv
control
previous
shown
protein
also
defici
hivinfect
monocyt
deriv
macrophag
hivmdm
defici
associ
enhanc
glutam
releas
neurotox
explain
protein
defici
observ
hand
patient
probe
mechan
defici
may
contribut
neurotox
examin
regul
within
astrocyt
predomin
sourc
within
brain
critic
mediat
glutam
handl
primari
rat
human
astrocyt
treat
immun
activ
relev
hiv
pathogenesi
ifngamma
lipopolysachharid
lp
tnfalpha
express
assess
acut
hour
chronic
day
exposur
chronic
acut
treatment
significantli
reduc
protein
express
rat
human
astrocyt
cultur
rna
alter
throughout
treatment
furthermor
chronic
treatment
alter
express
antioxid
protein
suggest
reduct
protein
driven
immun
activ
specif
due
global
suppress
antioxid
respons
result
demonstr
chronic
immun
activ
suppress
protein
within
astrocyt
suggest
mechan
chronic
hiv
infect
lead
global
defici
within
frontal
cortex
reduc
within
astrocyt
may
import
function
consequ
glutam
regul
subsequ
neurodegener
address
futur
studi
jane
kovalevich
ahmet
ozdemir
william
yen
diann
langford
present
author
tdl
templeedu
templ
univers
school
medicin
depart
neurosci
sinc
begin
aid
epidem
hiv
infect
substanc
abus
link
risk
contract
hiv
transmit
hiv
increas
significantli
cocain
use
neurocognit
disord
associ
cocain
abus
hiv
infect
exacerb
patient
hiv
use
cocain
cocain
hiv
infect
induc
proinflammatori
cytokin
tumor
necrosi
factor
alpha
tnfalpha
ultim
lead
disrupt
numer
neuron
signal
pathway
retino
acid
ra
signal
pathway
import
number
cellular
process
hiv
patient
pathway
disrupt
data
show
first
time
cocain
hiv
protein
tat
significantli
disrupt
pathway
cn
retinoid
x
receptor
rxr
homodimer
serv
requir
heterodimer
partner
number
ligandactiv
nuclear
receptor
recogn
specif
dna
sequenc
target
gene
regul
transcript
activ
data
show
cocain
significantli
downregul
rxrgamma
brain
cocain
treatedmic
tat
transgen
mice
neuron
vitro
addit
gene
regul
rxr
signal
neurogranin
encod
protein
requir
adult
neuroplast
significantli
regul
cocaineinduc
degrad
rxrgamma
proteasom
depend
involv
nuclear
export
protein
addit
data
show
inhibit
tnfalpha
signal
block
downstream
tnfalpha
effector
kinas
jnk
attenu
cocainemedi
decreas
rxrgamma
level
data
studi
provid
first
evid
exposur
cocain
tat
disrupt
rxrgamma
signal
cn
tnfalpha
activ
like
play
role
rxr
dysfunct
implic
number
neurodegen
diseas
psychiatr
disord
find
may
extend
neuropatholog
condit
character
neuroinflammatori
compon
fred
adriano
michael
brian
present
author
fredkreb
drexelmededu
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
microbiolog
immunolog
drexel
univers
colleg
medicin
school
biomed
engin
scienc
health
system
drexel
univers
extracellular
human
immunodefici
viru
type
type
viral
protein
r
vpr
pleiotrop
protein
accomplish
sever
function
within
viral
life
cycl
vpr
describ
extens
intracellular
protein
littl
known
role
extracellular
protein
fact
vpr
detect
blood
serum
cerebrospin
fluid
patient
concentr
increasingli
higher
latestag
diseas
determin
role
exogen
vpr
play
hivassoci
central
nervou
system
dysfunct
primari
human
fetal
astrocyt
expos
recombin
vpr
time
dosedepend
decreas
demonstr
two
fundament
intracellular
metabolit
atp
glutathion
gsh
addit
exposur
exogen
vpr
led
increas
caspas
activ
secret
proinflammatori
cytokin
chemoattract
monocyt
chemotact
migrat
inhibit
factor
extracellular
vpr
also
dampen
glycolyt
pathway
impair
gapdh
activ
caus
declin
level
atp
reduct
intracellular
atp
increas
reactiv
oxygen
speci
buildup
decreas
gsh
concentr
affect
sever
gene
oxid
stress
pathway
addit
exposur
sknsh
neuroblastoma
cell
line
condit
medium
exogen
vprtreat
astrocyt
decreas
synthesi
gsh
lead
apoptosi
observ
point
role
vpr
play
alter
astrocyt
metabol
indirectli
affect
neuron
surviv
propos
model
may
explain
neurolog
damag
therefor
neurocognit
impair
observ
cours
diseas
work
support
nihnind
nida
nimh
nimh
jessica
krueger
jessica
ott
mari
barb
jennif
gordon
present
author
jennifergordon
templeedu
depart
neurosci
center
neurovirolog
templ
univers
school
medicin
puralpha
highli
conserv
sequenc
specif
dna
rna
bind
protein
establish
role
dna
replic
rna
translat
cell
cycl
regul
mainten
neuron
differenti
puralpha
also
import
mediat
gene
express
strong
interact
regulatori
tat
protein
neurotox
associ
tat
mediat
least
part
puralpha
postnat
express
puralpha
brain
essenti
normal
develop
neuron
synapt
format
hippocampu
cerebellum
homozyg
delet
puralpha
caus
prematur
death
adolesc
anim
heterozyg
puralpha
demonstr
haploinsuffici
significantli
reduc
level
puralpha
brain
expir
one
year
age
suggest
chronic
reduct
puralpha
lead
neuropathogen
effect
present
first
time
assess
behavior
phenotyp
mice
heterozyg
puralpha
knockout
allel
due
observ
motor
discoordin
cerebellar
chang
model
less
physic
demand
barn
maze
use
assess
spatial
learn
locomotor
activ
revers
protocol
maze
use
investig
anim
retent
spatial
memori
longterm
well
capac
new
memori
format
second
spatial
learn
paradigm
low
differ
motor
demand
novel
object
locat
test
use
character
spatial
memori
function
third
test
probe
sensori
alter
use
freetwochoic
thermal
gradient
assess
peripher
nerv
chang
taken
togeth
find
behavior
histochem
assay
implic
puralpha
mediat
neurodegener
context
infect
thu
puralpha
knockout
mice
may
provid
welldefin
anim
model
studi
mechan
associ
neurolog
disord
includ
cognit
defici
peripher
neuropathi
core
facil
servic
support
cnac
templ
nimh
adarsh
raymond
jesu
eridania
mahendra
present
author
akumar
medmiamiedu
psychiatri
behavior
scienc
miller
school
medicin
univers
miami
fl
psychiatri
behavior
medicin
nova
southeastern
univers
fort
lauderdal
fl
background
associ
neurodegener
dysfunct
neurobiolog
system
cn
pre
postcart
era
investig
multitud
studi
includ
howev
studi
scarc
impact
cn
serotonin
system
major
neurotransmitt
system
regul
behavior
earlier
studi
carri
csf
individu
precart
era
report
dramat
decreas
concentr
without
chang
postcart
era
howev
impact
cn
serotonin
system
remain
elus
although
infect
individu
continu
experi
spectrum
neuropsychiatr
disord
includ
depress
affect
qualiti
life
medic
adher
diseas
progress
object
investig
impact
cn
serotonin
statu
well
rna
load
differ
region
frontal
cortex
basal
ganglia
hippocampu
hypothalamu
raph
nuclei
amygdal
substantria
nigra
postmortem
brain
individu
life
receiv
cart
evalu
neuropsychiatr
disord
compar
statu
brain
region
noninfect
individu
result
found
variabl
chang
concentr
differ
brain
region
individu
respect
compar
noninfect
person
variabl
chang
found
concentr
differ
brain
region
individu
studi
contrari
dramat
decreas
csf
individu
precart
era
cart
influenc
cn
turnov
conclus
data
suggest
serotonin
system
cn
vulner
infect
postcart
era
studi
warrant
effect
cart
multipl
indic
cn
serotonerg
system
diann
ahmet
radhika
william
melissa
alexandra
pallavi
present
author
tdl
templeedu
univers
school
medicin
depart
neurosci
statist
analysi
depart
statist
fox
school
busi
grow
evid
point
signific
mechanist
overlap
hivassoci
neurocognit
disord
hand
agerel
neurodegener
hiv
infect
individu
diagnos
decad
ago
begin
face
agerel
neurodegener
combin
viral
infect
longterm
exposur
cart
neurodegener
exacerb
cellular
dysfunct
involv
accumul
aberr
protein
loss
protein
qualiti
control
among
import
caus
diseas
agerel
neurolog
declin
accumul
hyperphosphoryl
tau
hptau
neuropatholog
featur
age
hiv
enceph
hive
neurodegen
disord
like
alzheim
diseas
discov
adaptor
protein
call
pinch
import
signal
cascad
hivrel
tauopathi
multipl
level
includ
cell
signal
clinic
correl
cn
diseas
sever
pinch
nearli
undetect
healthi
cn
hiv
infect
robustli
express
neuron
vitro
vivo
human
data
show
pinch
bind
directli
hptau
associ
loss
tau
solubl
diseas
uniqu
isoform
pinch
detect
csf
hiv
patient
pilot
data
suggest
csf
level
pinch
may
correspond
part
immun
recoveri
rather
viral
burden
pinch
inhibit
phosphatas
compet
tat
bind
tat
induc
tau
transloc
somatodendrit
compart
human
primari
neuron
decreas
pinch
express
result
detect
less
hptau
understand
contribut
increas
pinch
hivassoci
tauopathi
may
provid
new
therapeut
avenu
reduc
level
hptau
brain
moreov
character
clinic
signific
pinch
csf
may
warrant
includ
pinch
member
biomark
panel
assess
sever
progress
hivassoci
neurocognit
alter
gabriel
mark
wendelin
traci
jay
present
author
lehmick
templeedu
univers
incorpor
previous
demonstr
expans
monocyt
hiv
siv
infect
sinc
percentag
monocyt
subset
correl
viral
load
cell
count
suggest
role
aid
cn
pathogenesi
cell
like
also
promot
persist
macrophag
reservoir
viral
infect
cn
well
peripheri
investig
dynam
product
clearanc
total
monocyt
use
vivo
brdu
cfse
label
rhesu
macaqu
infect
three
group
anim
includ
siv
deplet
siv
brdu
cfse
brdu
cfse
inject
intraven
month
postinfect
group
order
label
prolifer
ie
bone
marrow
peripher
circul
leukocyt
respect
blood
specimen
drawn
minut
day
postbrducfs
administr
analyz
flow
cytometri
increas
product
brdu
monocyt
observ
day
deplet
macaqu
monocyt
emerg
brdu
virtual
hour
post
brdu
administr
despit
increas
product
total
monocyt
deplet
anim
time
point
subsequ
time
point
howev
percentag
monocyt
increas
peak
day
group
result
like
suggest
alter
distribut
prolifer
monocyt
precursor
within
bone
marrow
monocyt
clearanc
similar
group
determin
cfse
label
taken
togeth
result
suggest
import
alter
monocyt
product
bone
marrow
well
matur
peripher
compart
lead
overal
expans
monocyt
aid
analysi
cell
turnov
also
provid
novel
insight
regard
tcell
dynam
aid
emili
leibovitch
giovanna
brunetto
breanna
caruso
kaylan
fenton
joan
ohayon
daniel
reich
steven
jacobson
present
author
emilyleibovitch
nihgov
nation
institut
health
nind
human
herpesvirus
wide
distribut
adult
popul
though
specif
associ
sever
disord
central
nervou
system
cn
includ
multipl
sclerosi
ms
associ
virus
neurolog
diseas
partli
establish
detect
elev
viral
dna
level
patient
compar
control
despit
high
nucleotid
homolog
recent
reclassifi
separ
speci
owe
mount
evid
biolog
differ
especi
relev
investig
viru
separ
investig
coinfect
human
biolog
materi
use
novel
quantit
pcr
technolog
call
digit
droplet
pcr
ddpcr
ddpcr
enabl
absolut
quantif
target
dna
molecul
highli
sensit
lowlevel
target
investig
coinfect
design
assay
pcr
amplifi
virus
compar
kinet
small
amount
one
could
distinguish
presenc
larg
amount
use
approach
observ
heretoforeunderappreci
frequenc
coinfect
serum
pbmc
saliva
healthi
donor
interestingli
upon
compar
adult
ms
patient
healthi
donor
detect
significantli
elev
frequenc
coinfect
ms
saliva
current
explor
whether
clinic
correl
coinfect
assess
saliva
sampl
pediatr
ms
patient
control
identifi
quantifi
speci
may
provid
clinic
relev
inform
learn
viru
health
diseas
observ
coinfect
may
profound
implic
andrew
steve
eric
elys
paul
gayl
otoniel
mallori
peter
present
author
ajlevin
mednetuclaedu
neurolog
david
geffen
school
medicin
univers
california
lo
angel
human
genet
david
geffen
school
medicin
univers
california
lo
angel
depart
biostatist
univers
california
lo
angel
psychiatri
biobehavior
scienc
david
geffen
school
medicin
univers
california
lo
angel
neurolog
nation
neurolog
aid
bank
david
geffen
school
medicin
univers
california
lo
angel
medicin
divis
infecti
diseas
intern
medicin
depart
psychiatri
behavior
medicin
univers
south
florida
morsani
colleg
medicin
tampa
medicin
david
geffen
school
medicin
univers
california
lo
angel
obstetr
gynecolog
depart
microbiolog
immunolog
molecular
genet
david
geffen
school
medicin
univers
california
lo
angel
depart
epidemiolog
ucla
field
school
public
health
geffen
school
medicin
univers
california
lo
angel
lo
angel
biomed
research
institut
harborucla
medic
center
human
genet
david
geffen
school
medicin
univers
california
lo
angel
immunolog
dysfunct
mediat
via
monocyt
activ
implic
develop
hivassoci
neurocognit
disord
hand
hypothes
transcriptom
chang
peripher
blood
monocyt
relat
neurocognit
function
hiv
individu
alter
could
use
biomark
worsen
hand
method
mrna
isol
monocyt
hiv
adult
analyz
illumina
express
beadchip
neurocognit
function
hand
diagnosi
clinic
virolog
variabl
determin
data
analyz
use
standard
express
analysi
weight
gene
coexpress
network
analysi
wgcna
result
neurocognit
function
correl
multipl
gene
transcript
standard
express
analysi
wgcna
identifi
two
nomin
signific
coexpress
modul
associ
neurocognit
function
enrich
gene
involv
mitot
process
translat
elong
conclus
multipl
modifi
gene
transcript
involv
inflamm
cytoprotect
neurodegener
correl
neurocognit
function
associ
strong
enough
justifi
use
biomark
hand
howev
associ
two
coexpress
modul
neurocognit
function
warrant
explor
wenxu
li
richa
tyagi
lisa
henderson
avindra
nath
present
author
mailnihgov
section
infect
nervou
system
nation
institut
neurolog
diseas
stroke
nation
institut
health
amyotroph
later
sclerosi
al
progress
neurolog
diseas
affect
upper
lower
motor
neuron
patient
develop
gradual
loss
voluntari
muscl
strength
eventu
die
respiratori
failur
al
case
sporad
may
inherit
although
number
gene
mutat
identifi
famili
form
al
etiolog
al
still
larg
unclear
group
other
report
human
endogen
retrovirus
type
k
hervk
activ
al
patient
indic
possibl
involv
hervk
pathogenesi
al
herv
fossil
sequenc
retroviru
infect
integr
human
germlin
chromosom
million
year
ago
herv
defect
mutat
howev
type
k
herv
rel
preserv
genom
sequenc
may
activ
produc
viral
particl
certain
physiolog
patholog
condit
revers
transcriptas
activ
herv
serum
detect
al
patient
increas
hervk
pol
gene
also
found
brain
al
patient
studi
studi
express
hervk
gene
autopsi
brain
tissu
al
patient
use
quantit
real
time
pcr
determin
express
level
hervk
gag
pol
env
frontal
cortex
al
patient
significantli
higher
express
level
hervk
gene
compar
control
express
three
hervk
gene
correl
result
confirm
activ
hervk
brain
al
patient
warrant
investig
activ
mechan
winston
liu
raya
massoud
daniel
reich
govind
nair
steve
jacobson
present
author
winstonwliu
gmailcom
nation
institut
neurolog
disord
stroke
human
tcell
lymphotrop
associ
myelopathytrop
spastic
paraparesi
hamtsp
multipl
sclerosi
ms
lead
progress
inflammatori
myelopathi
although
spinal
cord
atrophi
qualit
detect
routin
clinic
mri
robust
sensit
method
quantifi
chang
spinal
cord
size
might
improv
character
diseas
sever
progress
method
could
help
develop
imag
marker
diseas
serv
surrog
end
point
clinic
trial
mri
perform
hamtsp
ms
healthi
volunt
siemen
skyra
system
equip
headneck
spine
array
coil
crosssect
area
spinal
cord
measur
use
novel
algorithm
develop
inhous
trace
axial
contour
perpendicular
cordedg
point
vertebr
bodi
segment
averag
crosssect
area
tspine
cspine
significantli
lower
hamtsp
patient
cspine
tspine
compar
healthi
control
cspine
p
tspine
p
howev
crosssect
area
significantli
differ
tspine
compar
hamtsp
ms
patient
cspine
tspine
p
hamtsp
crosssect
area
multipl
cord
segment
correl
diseas
durat
extend
disabl
statu
scale
edss
hauser
ambul
index
correl
observ
hamtsp
crosssect
area
provir
load
ms
crosssect
area
correl
edss
result
suggest
pattern
spinal
cord
tissu
damag
specif
underli
diseas
find
direct
implic
use
averag
crosssect
spinal
cord
area
surrog
end
point
clinic
trial
longitudin
studi
underway
help
improv
understand
diseas
process
kyle
lord
yuji
liu
michael
nonnemach
brian
wigdahl
present
author
kylealexanderlord
drexeledu
depart
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
human
immunodefici
viru
type
subtyp
c
predomin
subtyp
subsaharan
africa
well
asia
india
also
preval
subtyp
worldwid
larg
number
transcript
factor
famili
shown
involv
regul
gene
express
tlymphocyt
cell
monocytemacrophag
lineag
among
protein
ccaatenhanc
bind
protein
cebp
famili
particular
import
regul
gene
express
within
cell
monocyt
lineag
cours
hematolog
develop
cellular
activ
studi
examin
role
cebp
long
termin
repeat
ltr
direct
viral
gene
express
subtyp
subtyp
b
within
subtyp
b
virus
two
function
cebp
site
locat
upstream
tata
box
requir
effici
viral
replic
cell
monocytemacrophag
lineag
report
identif
three
put
subtyp
c
cebp
site
upstream
site
downstream
site
shown
form
specif
dnaprotein
complex
member
cebp
famili
cebp
alpha
beta
gamma
function
within
monocyt
cell
line
subtyp
b
c
ltr
shown
equal
respons
cebp
although
basal
activ
subtyp
c
ltr
appear
higher
furthermor
synergist
interact
cebp
tat
subtyp
c
ltr
also
observ
cell
previous
demonstr
subtyp
b
ltr
work
support
nihnind
nida
nimh
nimh
grace
bruce
krista
brian
lucett
present
author
bbrew
stvincentscomau
new
south
wale
st
vincent
hospit
clinic
school
sydney
australia
new
south
wale
st
vincent
hospit
sydney
australia
st
vincent
centr
appli
medic
research
vincent
hospit
sydney
australia
psychiatri
univers
new
south
wale
sydney
australia
new
south
wale
st
vincent
hospit
clinic
school
sydney
australia
neurosci
research
australia
sydney
australia
st
vincent
hospit
sydney
australia
st
vincent
centr
appli
medic
research
sydney
australia
background
hiv
dementia
scale
hd
recommend
crosssect
screen
identifi
hivassoci
neurocognit
disord
hand
longitudin
use
establish
method
hiv
particip
age
male
underw
baselin
followup
hd
screen
month
standard
neuropsycholog
np
evalu
baselin
clinic
laboratori
examin
baselin
met
gold
standard
hand
diagnost
definit
base
longitudin
publish
norm
standard
show
statist
signific
declin
gold
standard
declin
base
confid
interv
includ
mild
declin
systemat
assess
hd
criterion
valid
np
gold
standard
determin
hd
baselin
impair
statu
base
three
publish
hd
cutoff
demographicallycorrect
hd
tscore
determin
statist
signific
declin
hd
confid
interv
develop
standard
hd
regressionbas
chang
score
arcsineroot
transform
normal
data
distribut
hd
longitudin
criterion
valid
determin
compar
hdsbase
declin
gold
standard
npbase
declin
use
index
sensit
specif
result
baselin
hd
cutoff
yield
highest
sensit
specif
sensit
specif
compar
cutoff
sensit
specif
tscore
sensit
specif
magnitud
hd
reliabl
larg
p
found
declin
hd
case
congruent
identifi
median
raw
median
hdschang
score
hd
show
sensit
specif
detect
clinic
meaning
declin
signifi
case
declin
moder
congruent
identifi
hand
diagnosi
baselin
sever
hand
diagnosi
associ
greater
chanc
declin
p
hiv
biomark
associ
declin
conclus
first
studi
optim
demonstr
hd
reliabl
detect
least
moder
neurocognit
declin
victoria
lutgen
sriniva
narasipura
stephani
min
maureen
richard
lena
alharthi
present
author
victorialutgen
rushedu
rush
univers
medic
center
neurolog
disord
includ
hivassoci
neurocognit
disord
hand
link
abnorm
excitatori
neurotransmiss
perturb
glutam
cycl
profound
impact
normal
activ
lead
excitotox
creat
exacerb
impair
diseas
astrocyt
play
key
role
excitatori
signal
clear
glutam
synapt
cleft
hous
enzym
respons
glutam
convers
glutamin
howev
mechan
respons
regul
glutam
cycl
includ
main
astrocyt
glutam
transport
excitatori
amino
acid
transport
rodent
glutamin
synthetas
gs
catalyz
atpdepend
reaction
glutam
ammonia
glutamin
remain
larg
undefin
previous
demonstr
betacatenin
transcript
coactiv
central
mediat
wntbetacatenin
signal
pathway
regul
gs
express
astrocyt
vitro
assess
whether
betacatenin
regul
two
protein
vivo
toward
end
inject
vivomorpholino
knockdown
betacatenin
express
control
morpholino
prefront
cortex
coordin
ml
dv
week
old
male
mice
use
stereotax
microinject
techniqu
morpholino
block
translat
initi
gene
target
inject
day
day
day
six
post
first
inject
small
chunk
brain
tissu
inject
site
collect
process
protein
isol
use
ripa
buffer
analyz
western
blot
demonstr
knockdown
betacatenin
result
signific
reduct
gs
protein
express
percent
respect
studi
confirm
betacatenin
regul
key
protein
respons
excitatori
glutam
neurotransmiss
vivo
reveal
therapeut
potenti
wntbetacatenin
modul
treat
diseas
abnorm
glutamaterg
neurotransmiss
excitotox
work
support
la
shaili
malik
rinki
saha
pankaj
seth
present
author
pseth
nbrcacin
molecular
cellular
neurosci
nation
brain
research
centr
comorbid
illicit
drug
modul
properti
neural
precursor
cell
npc
attempt
gain
insight
pathway
may
mediat
comorbid
human
fetal
brain
deriv
neural
precursor
cell
hnpc
expos
hiv
transactiv
protein
tat
illicit
opioid
morphin
variou
dose
time
point
alter
hnpc
prolifer
tat
morphin
exposur
assess
brdu
immunoreact
treat
cell
chang
prolif
gene
analyz
rna
protein
level
sever
molecular
mediat
investig
use
cell
biolog
molecular
approach
observ
chronic
treatment
hiv
protein
tat
morphin
affect
hnpc
prolifer
dna
content
analysi
fac
decreas
brdu
level
tatmorphin
treat
hnpc
indic
perturb
sphase
cell
cycl
hivtat
morphin
attenu
increas
express
cdk
inhibitor
therebi
reduc
activ
divid
popul
hnpc
found
govern
extracellular
signalregul
found
essenti
tat
morphin
induc
decreas
npc
prolifer
synergi
tat
morphin
induc
chang
hnpc
prolifer
mostli
observ
chronic
exposur
oppos
acut
exposur
neurotox
agent
interferongamma
ifng
level
also
elev
npc
tat
morphin
exposur
lead
alter
signal
transduc
activ
transcript
stat
level
derang
pathway
growth
arrest
hnpc
may
far
reach
clinic
implic
may
lead
impair
abil
cell
maintain
pool
well
compromis
replenish
damag
brain
cell
author
acknowledg
financi
support
depart
biotechnolog
icmr
nbrc
ps
univers
grant
commiss
new
delhi
fellowship
sm
giusepp
luciana
elena
alessandra
caterina
giordano
roberto
antonina
present
author
doleivir
unissit
biomed
scienc
univers
sassari
clinic
experiment
medicin
univers
sassari
biomed
scienc
univers
sassari
immunopathogen
phenomena
lead
neurodegener
multipl
sclerosi
ms
thought
trigger
environment
factor
oper
predispos
genet
background
among
propos
cofactor
ebv
potenti
neuropathogen
endogen
retrovirus
ascertain
ebvm
link
late
primari
infect
possibl
infecti
mononucleosi
im
high
titer
preonset
antiebna
igg
ms
msspecif
ebv
express
continu
express
hervw
occur
parallel
ms
stage
activeremiss
phase
therapi
outcom
vitro
data
express
withwithout
exposur
ebv
studi
pbmc
healthi
volunt
ms
patient
astrocyt
express
amplifi
untreat
ms
patient
dramat
reduc
therapi
pbmc
msrvenv
transcript
activ
b
cell
monocyt
cell
highli
express
nk
cell
b
vivo
data
hospit
young
adult
im
symptom
analyz
express
hervwmsrv
transcript
protein
healthi
control
either
ebvneg
latent
ebvinfect
withwithout
high
titer
igg
hervwmsrv
activ
pbmc
im
patient
increas
respect
ebvneg
control
healthi
control
stratifi
high
low
igg
titer
direct
correl
occur
msrv
express
flow
cytometri
show
increas
percentag
cell
expos
surfac
hervwenv
protein
occur
differ
specif
cell
subset
acut
diseas
past
infect
conclus
vitro
ebv
activ
potenti
immunopathogen
neuropathogen
cell
deriv
blood
brain
vivo
two
main
link
ebv
ms
im
high
titer
parallel
hervwmsrv
activ
novel
find
suggest
hervwmsrv
activ
miss
link
ebv
ms
may
open
new
avenu
intervent
lisa
jami
jonathan
joseph
present
author
jhmiedu
molecular
compar
pathobiolog
retroviru
laboratori
john
hopkin
univers
human
immunodefici
virusassoci
peripher
neuropathi
hivpn
current
frequent
neurolog
complic
hiv
infect
affect
individu
live
hiv
hivpn
lengthdepend
small
sensori
fiber
neuropathi
typifi
bilater
numb
tingl
burn
sensat
lower
leg
electrophysiolog
insensit
chang
small
unmeylin
fiber
microscop
evalu
epiderm
nerv
fiber
densiti
skin
biopsi
becom
standard
diagnosi
hivpn
howev
longitudin
assess
limit
invas
techniqu
noninvas
assess
corneal
sensori
nerv
proven
clinic
use
diagnos
monitor
peripher
neuropath
condit
diabet
neuropathi
corneal
nerv
alter
hiv
yet
character
studi
base
sivmacaqu
model
first
develop
betaiii
tubulin
immunostain
protocol
detect
corneal
nerv
develop
manual
autom
count
method
measur
corneal
nerv
densiti
count
method
demonstr
significantli
lower
subbas
corneal
nerv
fiber
count
among
sivinfect
anim
rapidli
progress
aid
compar
slow
progressor
concomit
decreas
corneal
nerv
fiber
densiti
rapid
progressor
increas
level
siv
rna
macrophag
gfap
express
glial
satellit
cell
trigemin
ganglia
find
demonstr
corneal
nerv
assess
great
potenti
diagnos
monitor
hivinduc
peripher
neuropathi
set
stage
introduc
noninvas
techniqu
evalu
pn
damag
hiv
clinic
set
sivabalan
barbara
dian
e
present
author
smanivan
jhsphedu
molecular
microbiolog
immunolog
john
hopkin
bloomberg
school
public
health
neurolog
psychiatri
john
hopkin
brain
scienc
institut
john
hopkin
school
medicin
inflamm
nervou
system
necessari
part
respons
cn
infect
also
caus
neuron
damag
infecti
autoimmun
diseas
cn
sindbi
viru
envelop
positivestrand
rna
viru
caus
acut
encephalomyel
fatal
paralysi
mice
adult
mice
inocul
neurovirul
strain
sindbi
viru
nsv
succumb
fatal
paralysi
despit
clear
infecti
viru
central
nervou
system
show
low
daili
dose
nonrevers
glutamin
antagonist
rescu
mice
fatal
paralysi
inhibit
inflammatori
immun
respons
dontreat
mice
fail
induc
adapt
immun
respons
viru
deep
cervic
lymphnod
show
decreas
lymphocyt
infiltr
brain
delay
viral
clearanc
compar
vehicletr
control
dontreat
mice
show
significantli
reduc
mrna
express
neurotox
inflammatori
cytokin
tnfalpha
ifngamma
cours
viral
infect
brain
compar
vehicl
control
addit
vitro
studi
use
purifi
tcell
show
inhibit
growth
prolifer
activ
primari
mous
tcell
respons
stimul
follow
stimul
dontreat
lymphocyt
show
defect
phosphoryl
downstream
mtor
pathway
target
suggest
impair
protein
translat
primari
lymphocyt
stimul
dontreat
tcell
lower
protein
product
despit
similar
level
mrna
compar
vehicl
control
studi
suggest
small
molecul
antagon
glutamin
metabol
immunomodulatori
could
benefici
treatment
neuroinflammatori
diseas
eileen
raul
jasmin
present
author
eileenmartin
rushedu
univers
medic
center
intern
univers
illinoi
drug
abus
common
among
hivseroposit
person
question
aris
hiv
neurocognit
effect
distinguish
nonspecif
effect
drug
depend
associ
comorbid
preliminari
studi
administ
four
cognit
neuropsycholog
task
sampl
hiv
hiv
men
women
histori
drug
depend
wellmatch
demograph
characterist
hiv
hiv
individu
lifetim
dsmivdiagnos
cocain
opioid
depend
drug
use
group
well
match
demograph
substanc
use
sever
potenti
confound
comorbid
disord
includ
ptsd
depress
adhd
antisoci
trait
current
nadir
count
viral
suppress
differ
significantli
hiv
drug
user
nonus
subject
perform
motor
cognit
procedur
learn
task
depend
integr
neostriatum
two
measur
impuls
behavior
typic
perform
poorli
drug
user
hiv
affect
neostriat
system
rel
drug
depend
typic
engag
ventrallimb
striatal
process
reason
hiv
group
would
perform
procedur
learn
task
poorli
hiv
group
regardless
drug
histori
seri
hiv
serostatu
x
drug
histori
analys
varianc
found
signific
main
effect
poorer
perform
drug
use
hiv
serostatu
inhibitori
task
p
task
signific
main
effect
hiv
serostatu
drug
histori
procedur
learn
task
p
test
demonstr
provid
proof
concept
theori
driven
cognit
neuropsycholog
task
may
capac
detect
effect
hiv
neurocognit
attribut
sole
drug
depend
howev
conclus
definit
requir
sophist
statist
approach
raya
yoshimi
joan
kaylan
iren
steven
thoma
present
author
rayamassoud
nihgov
common
beta
subunit
share
receptor
two
cytokin
implic
immunopathogenesi
associ
myelopathi
tropic
spastic
paraparesi
hamtsp
sever
vitro
find
suggest
might
therapeut
target
condit
hamtsp
tcell
show
increas
express
baselin
addit
monoclon
antibodi
cultur
hamtsp
peripher
blood
mononuclear
cell
pbmc
decreas
endogen
phosphoryl
spontan
degranul
spontan
lymphoprolifer
reduc
frequenc
cytotox
taxspecif
base
find
current
evalu
safeti
clinic
immunolog
effect
monoclon
antibodi
therapi
patient
hamtsp
today
three
subject
treat
dose
show
satur
receptor
therapi
seem
well
toler
detect
reduct
multipl
ex
vivo
immun
activ
marker
spontan
degranul
phosphoryl
spontan
lymphocyt
prolifer
notabl
one
patient
report
resolut
neurogen
bladder
symptom
observ
object
clinic
improv
two
three
treat
patient
ruturaj
nazira
kurt
pamela
joyc
present
author
masvekarrr
vcuedu
anatomi
neurobiolog
pharmacolog
toxicolog
drug
alcohol
studi
virginia
commonwealth
univers
richmond
va
hiv
disrupt
normal
immun
system
function
also
induc
wide
rang
neurolog
deficit
collect
known
hivassoci
neurocognit
disord
hand
previou
work
shown
neurotox
effect
induc
protein
tat
variabl
enhanc
coexposur
morphin
opiat
preferenti
act
muopioid
receptor
mor
mimic
comorbid
neurolog
effect
observ
opiateabus
hiv
patient
occur
even
patient
receiv
haart
previou
studi
shown
hiv
induc
abnorm
activ
lead
neurotox
littl
known
role
hivopi
interact
effect
tauimmunoreact
tangl
found
brain
young
opiat
abus
predict
crosstalk
mormedi
signal
pathway
mimic
diseas
process
close
current
studi
use
supernat
hivinfect
monocyt
instead
singl
hiv
protein
human
leukem
monocyt
lymphoma
cell
infect
strain
supernat
collect
level
measur
elisa
assess
infect
adjust
titer
ad
cultur
murin
striatal
neuron
presenc
absenc
morphin
treatment
carri
either
presenc
absenc
vpa
inhibitor
xxvi
determin
role
process
lethal
subleth
effect
neuron
assess
popul
also
timelaps
imag
individu
cell
h
infect
supernat
pgml
induc
neurotox
affect
surviv
neurit
arbor
select
neurotox
measur
signific
interact
morphin
importantli
significantli
reduc
hivmedi
neurotox
also
negat
interact
effect
morphin
result
suggest
activ
point
converg
therapeut
target
opiat
hivmedi
neurocognit
deficit
moniqu
mariann
vanessa
wei
rui
brian
michael
present
author
drexeledu
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
biostatist
epidemiolog
center
clinic
epidemiolog
biostatist
univers
pennsylvania
school
medicin
approxim
onethird
human
immunodefici
viru
type
case
result
acquir
immunodefici
syndrom
aid
unit
state
associ
inject
drug
use
within
popul
specif
opioid
abus
within
popul
exacerb
diseas
progress
includ
increas
viral
replic
peripher
viral
load
well
incid
sever
neurocognit
impair
compar
nonus
bloodbrain
barrier
bbb
alter
compon
patholog
associ
process
ultim
result
hivassoci
neurocognit
disord
hand
protein
well
select
drug
abus
implic
compromis
bbb
previou
studi
suggest
exposur
muopioid
alter
bbb
permeabl
result
increas
cellular
transmigr
well
overal
barrier
leaki
studi
human
brain
microvascular
endotheli
cell
hbmec
line
util
establish
vitro
transwel
model
bbb
investig
effect
chronic
h
morphin
exposur
tight
junction
protein
tjp
bbb
observ
cell
form
confluent
monolay
basal
rate
passag
kda
tracer
molecul
compar
primari
hbmec
although
chronic
morphin
exposur
induc
overal
barrier
leaki
chang
mrna
transcript
tight
junction
protein
observ
throughout
cours
exposur
protein
level
tjp
local
analyz
follow
cell
fraction
western
immunoblot
analysi
overal
studi
demonstr
prolong
morphin
exposur
induc
chang
tjp
express
pattern
mrna
protein
level
work
support
nihnind
nida
nimh
nimh
ricki
melani
ana
natalia
kathryn
maya
iren
cari
cyru
de
gwenn
rossella
amanda
roy
marcu
present
author
mkaul
sanfordburnhamorg
inflammatori
diseas
center
sanfordburnham
medic
research
institut
age
stem
cell
research
center
sanfordburnham
medic
research
institut
neurolog
univers
washington
seattl
pharmacobiolog
univers
calabria
arcavacata
di
rend
cellular
neurosci
depart
scripp
research
institut
share
resourc
sanfordburnham
medic
research
institut
infect
continu
caus
associ
neurocognit
disord
hand
despit
success
combin
antiretrovir
therapi
cart
cellular
mechan
underli
develop
hand
poorli
understood
virusassoci
solubl
viral
envelop
glycoprotein
interact
conjunct
lead
infect
andor
cellular
signal
studi
role
viral
coreceptor
hivassoci
brain
injuri
mice
express
transgen
brain
share
key
neuropatholog
featur
aid
patient
loss
neurit
synaps
pronounc
astrocytosi
activ
microglia
howev
genet
knockout
mice
abrog
neuron
injuri
microgli
activ
astrocytosi
order
character
protect
effect
perform
gene
express
analysi
brain
mice
nontg
control
microarray
studi
reveal
brain
mice
hiv
patient
neurocognit
impair
without
enceph
hive
share
signific
part
differenti
gene
regul
furthermor
brain
mice
express
marker
innat
immun
respons
one
significantli
upregul
factor
acut
phase
protein
followup
vitro
experi
found
neurotox
fashion
wherea
expect
blockad
alon
fail
block
neurotox
howev
combin
disrupt
signal
caus
signific
loss
microgli
cell
time
complet
abrog
neurotox
induc
altogeth
studi
identifi
potenti
novel
player
hivassoci
brain
injuri
provid
mechan
could
protect
neurotox
support
nih
grant
mk
michelin
rebeca
ricardo
roberto
biju
present
author
mmccarth
medmiamiedu
neurolog
miller
school
medicin
univers
miami
miami
va
medic
center
va
medic
center
comprehens
cancer
center
miller
school
medicin
univ
miami
hiv
enter
brain
earli
infect
induc
chronic
inflammatori
state
result
neurolog
abnorm
rang
mild
cognit
dysfunct
sever
enceph
better
understand
effect
hiv
neural
cell
use
vitro
model
consist
human
neuroepitheli
progenitor
nep
cell
undergo
direct
differenti
astrocyt
neuron
presenc
cultur
supernat
matur
neuron
apolipoprotein
allel
lower
total
neurit
length
per
cell
moder
reduc
level
neurofila
protein
investig
whether
apolipoprotein
e
genotyp
influenc
chang
gene
express
hivexpos
nep
cultur
gene
express
detect
use
microarray
illumina
platform
array
perform
independ
cultur
genotyp
independ
cultur
genotyp
approach
identifi
gene
specif
upregul
fold
chang
exposur
viru
relat
interferon
induc
respons
antigen
present
interestingli
innat
immun
respons
robust
apolipoprotein
genotyp
cultur
apolipoprotein
counterpart
biolog
process
defin
gene
ontolog
go
program
corrobor
observ
process
relat
antigen
present
action
interferon
also
differ
among
apo
cultur
differ
manifest
number
gene
affect
well
signific
go
process
particip
higher
signific
data
suggest
matur
nep
cultur
respond
hiv
mount
innat
immun
respons
vigor
influenc
apolipoprotein
e
genotyp
cell
laura
edward
j
olimpia
traci
jay
wendelin
present
author
lauramccourt
templeedu
univers
school
medicin
univers
school
public
health
univers
school
medicin
incorpor
ectonucleotidas
hydrolyz
extracellular
atp
adpamp
adenosin
respect
adenosin
exert
suppress
effect
effector
cell
via
interact
receptor
furthermor
promot
polar
macrophag
via
receptor
convers
atp
exert
immun
stimulatori
effect
hydrolysi
atp
extracellular
investig
context
certain
tumor
microenviron
propos
provid
import
mechan
evas
immun
surveil
cancer
hiv
establish
chronic
persist
infect
resist
erad
via
adapt
immun
mechan
may
also
promot
immun
suppress
via
hydrolysi
extracellular
atp
initi
pilot
studi
level
evalu
qualit
quantit
frontal
white
matter
rhesu
macaqu
immunohistochemistri
primarili
express
within
microglia
perivascular
macrophag
microgli
nodul
latter
brain
tissu
anim
siv
enceph
sampl
macaqu
siv
infect
without
enceph
exhibit
increas
express
compar
uninfect
control
specimen
result
suggest
role
ectonucleotidas
pathogenesi
aid
may
provid
mechan
persist
hivsiv
infect
reservoir
within
cn
potenti
compart
acknowledg
work
support
grant
nihnimh
jr
acknowledg
support
comprehens
neuroaid
center
kamel
khalili
phd
program
director
basic
scienc
core
ii
provid
neuropatholog
consult
servic
yuri
persidski
md
phd
jennif
alexand
steven
denni
present
author
agil
mailmedupennedu
neurolog
children
hospit
philadelphia
philadelphia
pa
center
epidemiolog
biostatist
perelman
school
medicin
univers
pennsylvania
philadelphia
pa
neurolog
perelman
school
medicin
univers
pennsylvania
philadelphia
pa
allergi
immunolog
children
hospit
philadelphia
philadelphia
pa
children
hospit
philadelphia
research
institut
philadelphia
pa
depart
pediatr
perelman
school
medicin
univers
pennsyl
neurolog
perelman
school
medicin
univers
pennsylvania
philadelphia
pa
background
hivassoci
neurocognit
disord
hand
affect
hivinfect
adult
independ
predict
hiv
morbiditymort
patholog
associ
neuron
damag
monocyt
activ
csf
neurofila
nfl
pnfh
sensit
surrog
marker
neuron
damag
diseas
hiv
csf
nfl
elev
untreat
howev
csf
nflpnfh
express
character
milder
form
hand
mnd
ani
addit
relationship
neurofila
csfplasma
marker
monocyt
activ
fulli
explor
object
determin
csf
nflpnfh
express
across
hand
stage
neurocognit
normal
ncn
hiv
control
determin
relationship
csf
nflpnfh
csfplasma
marker
monocyt
activ
method
retrospect
descript
crosssect
studi
includ
hivinfect
adult
animndncn
art
enrol
charter
biomark
measur
valid
elisa
csf
nflpnfh
pair
csfplasma
plasma
intergroup
comparison
perform
use
kruskalw
wilcoxan
ranksum
test
spearman
correl
coeffici
compar
differ
biomark
profil
result
csf
nflpnfh
significantli
differ
across
differ
subgroup
hand
unadjust
virem
cohort
howev
among
individu
nadir
csf
nfl
level
elev
compar
ncn
ani
mnd
plasma
vari
significantli
across
differ
subgroup
hand
contrast
previou
studi
virologicallysuppress
individu
art
csf
nfl
significantli
posit
correl
csf
conclus
studi
first
correl
csf
nfl
express
csf
virem
hivinfect
individu
art
elimin
unanticip
direct
effect
art
inflamm
neurodegener
addit
first
studi
examin
nfl
across
differ
subgroup
hand
result
confirm
system
hiv
replic
strongli
correl
cn
monocyt
activ
neurodegener
individu
histori
sever
deplet
rick
lola
heidi
present
author
meekerr
neurologyuncedu
neurolog
curriculum
neurobiolog
univers
north
carolina
chapel
hill
nc
veterinari
medicin
north
carolina
state
univers
raleigh
nc
scienc
immunodefici
lentivirus
includ
fiv
readili
penetr
host
central
nervou
system
cn
establish
protect
reservoir
infect
macrophag
microglia
reservoir
difficult
control
combin
antiretrovir
therapi
cart
due
part
limit
cn
penetr
current
antiretrovir
compound
use
fiv
model
explor
therapeut
potenti
novel
antiretrovir
compound
effort
reduc
elimin
cn
infect
minim
toxic
proprietari
compound
target
strictli
conserv
region
nucleocapsid
protein
share
fiv
siv
hiv
bind
drug
appear
disrupt
viru
particl
assembl
allow
control
infecti
viru
product
previous
infect
cell
distribut
tissu
appar
long
plasma
csf
halflif
day
respect
dose
mgkg
plasma
concentr
peak
um
csf
concentr
variabl
peak
valu
rang
um
clinic
patholog
demonstr
signific
renal
liver
red
blood
cellwhit
blood
cell
abnorm
vitro
neurotox
rel
low
median
toxic
concentr
um
inhibit
fiv
replic
felin
macrophag
vitro
control
establish
antivir
efficaci
vivo
six
cat
previous
intracrani
infect
fiv
plu
sham
infect
cat
treat
mgkg
dmso
intraven
twice
per
week
week
period
viru
load
plasma
csf
proviru
load
significantli
reduc
baselin
remain
origin
viru
burden
even
week
treatment
complet
result
show
signific
antivir
activ
sustain
long
period
may
includ
effect
progress
reduc
provir
burden
cell
support
nih
grant
bezawit
dionna
mike
toni
joan
present
author
bezawitmegra
phdeinsteinyuedu
patholog
albert
einstein
colleg
medicin
medicin
medic
center
univers
washington
patholog
depart
microbiolog
immunolog
albert
einstein
colleg
medicin
enter
cn
soon
peripher
infect
caus
chronic
inflamm
cn
damag
lead
cognit
impair
greater
hiv
infect
peopl
even
success
cart
treatment
prpc
proteas
resist
prion
protein
nonpathogen
cellular
isoform
human
prion
protein
constitut
express
cn
involv
sever
physiolog
process
disrupt
hiv
neuropathogenesi
prpc
also
express
monocyt
brain
microvascular
endotheli
cell
bmvec
essenti
transmigr
monocyt
across
blood
brain
barrier
bbb
surfac
express
prpc
increas
hiv
infect
monocyt
detect
flow
cytometri
analysi
previous
laboratori
show
solubl
prpc
sprpc
level
increas
csf
peopl
specif
hiv
associ
neurocognit
disord
hand
vitro
studi
also
show
hiv
infect
well
treatment
cn
cell
chemokin
caus
increas
prpc
shed
data
suggest
sprpc
particip
mechan
mediat
neuroaid
determin
effect
shed
prpc
transmigr
monocyt
across
bbb
use
vitro
bbb
model
consist
astrocyt
endotheli
cell
cocultur
opposit
side
pore
tissu
cultur
insert
studi
demonstr
sprpc
treatment
block
transmigr
monocyt
across
bbb
suggest
could
initi
mechan
protect
influx
monocyt
across
barrier
earli
stage
hiv
infect
thu
prpc
may
protect
neuroinflammatori
depend
upon
tempor
spatial
express
hiv
neuropathogenesi
raissa
yamil
joyc
richard
l
javier
claudia
claribel
valeri
present
author
raissamenendez
upredu
research
program
univers
puerto
ricomed
scienc
campu
pharmaceut
scienc
pharmacolog
neuroaid
research
program
univers
puerto
ricomed
scienc
campu
orthopaed
surgeri
john
hopkin
univers
biolog
univers
puerto
ricorio
piedra
campu
research
program
intern
medicin
neurolog
divis
univers
puerto
ricomed
scienc
campu
background
hivassoci
neurocognit
disord
hand
associ
abnorm
glucos
metabol
cohort
show
high
solubl
insulin
receptor
sir
level
posit
associ
hand
recent
observ
sir
secret
human
neuron
cell
influenc
csf
compon
hivseroposit
women
object
investig
csf
cytokin
level
hivseroposit
women
influenc
sir
secret
human
neuron
cell
method
csf
cytokin
level
determin
hivseroposit
women
stratifi
hand
normal
cognit
nc
asymptomat
impair
ai
symptomat
impair
si
control
cytokin
level
tnfalpha
ifngamma
quantifi
cba
immunoassay
kit
flow
cytometri
neuron
cell
cell
cultur
presenc
cytokin
hour
use
concentr
similar
quantifi
csf
hivseroposit
women
secret
sir
level
assay
elisa
result
csf
level
tnfalpha
ifngamma
increas
si
ai
compar
nc
p
level
significantli
increas
si
compar
nc
p
signific
differ
observ
csf
level
among
group
sir
level
secret
neuron
increas
significantli
exposur
tnfalpha
although
exposur
slight
decreas
sir
secret
signific
p
ifngamma
induc
chang
sir
secret
compar
control
conclus
studi
suggest
csf
cytokin
level
hivseroposit
women
alter
neuron
sir
secret
may
contribut
insulin
resist
hand
patient
partial
support
nana
ilker
michael
caterina
kamel
present
author
mnana
templeedu
neurosci
center
neurovirolog
templ
univers
school
medicin
neurosurgeri
templ
univers
school
medicin
medicin
surgeri
univers
salerno
fisciano
sa
autophagi
evolutionari
conserv
select
degrad
pathway
cellular
compon
import
mainten
cell
homeostasi
healthi
patholog
condit
demonstr
increas
level
result
stimul
autophagi
glioblastoma
cell
member
cochaperon
famili
protein
associ
conserv
bag
domain
posit
cterminu
protein
express
induc
varieti
environment
chang
caus
stress
cell
result
show
interact
key
regul
autophagi
uniqu
ww
domain
posit
nterminu
protein
addit
similar
associ
play
import
role
prolifer
apoptosi
induct
associ
diminish
interact
interestingli
elev
level
also
promot
cleavag
caspas
suggest
dual
role
modul
autophagi
apoptosi
observ
place
uniqu
posit
suggest
interplay
function
consequ
coordin
stage
autophagi
apoptosi
glioma
cell
landh
moran
rosemari
booz
charl
f
mactutu
present
author
moranl
emailscedu
depart
psycholog
univers
south
carolina
approxim
individu
afflict
neurocognit
disord
hand
despit
effect
combin
antiretrovir
therapi
cart
reduc
preval
sever
neurocognit
impair
ie
dementia
deficit
execut
function
distinguish
featur
hand
cart
era
decay
rapidli
hiv
diseas
progress
cognit
domain
present
studi
ovariectom
femal
fischer
tg
control
rat
test
sustain
attent
task
compon
execut
function
rat
train
discrimin
signal
illumin
msec
durat
nonsign
illumin
reinforc
sucros
pellet
press
lever
correspond
event
hit
correct
reject
vs
miss
fals
alarm
decreas
hit
increas
miss
function
decreas
signal
durat
observ
group
howev
tg
group
advers
affect
shorter
signal
durat
contrast
perform
control
tg
rat
display
differenti
target
detect
hit
vs
miss
msec
durat
subsequ
daili
oral
dose
sequol
mg
vehicl
metabolit
produc
via
gut
microbiom
follow
ingest
soy
isoflavon
daidzein
administ
determin
potenti
therapeut
effect
day
treatment
tg
anim
receiv
mg
dose
sequol
miss
significantli
fewer
signal
across
stimulu
durat
compar
predos
perform
improv
twofold
control
group
phytoestrogen
metabolit
sequol
may
use
therapeut
attent
deficit
hand
fund
nih
grant
lita
dorothi
debbi
pedro
kri
renno
john
tom
hugh
jean
present
author
litamurphi
roslinedacuk
divis
roslin
institut
univers
edinburgh
easter
bush
campu
midlothian
biolog
evalu
research
food
drug
administr
rockvil
md
usa
pirbright
institut
ash
road
woke
biolog
scienc
univers
southampton
southampton
gener
hospit
southampton
understand
mechan
environment
influenc
shape
develop
neurodegen
diseas
alzheim
import
given
trend
age
popul
major
neurodegen
diseas
involv
abnorm
protein
deposit
within
cn
degener
synaps
neuron
activ
astrocyt
microglia
suggest
microglia
brain
ongo
chronic
neurodegen
diseas
suscept
system
inflammatori
signal
switch
cell
atyp
antiinflammatori
phenotyp
one
caus
neuron
damag
defin
impact
environment
factor
infect
diseas
brain
profound
implic
protect
neuron
use
well
characteris
tse
agent
model
neurodegen
diseas
locu
time
initi
neurodegener
precis
experiment
control
rodent
model
diseas
display
featur
chronic
neurodegen
process
challeng
mice
vivo
transient
neuroinvas
viral
infect
semliki
forest
viru
pre
post
inocul
ask
prime
immun
system
viral
infect
clear
host
prior
onset
neurodegen
diseas
would
alter
pattern
progress
neurodegen
diseas
observ
coinfect
sfv
earli
phase
neurodegener
chang
diseas
incub
time
result
subtl
chang
clinic
diseas
onset
interestingli
see
signific
alter
earli
stage
diseas
patholog
chang
pattern
prpsc
deposit
gliosi
addit
address
viral
infect
prior
onset
chronic
neurodegener
switch
innat
immun
respons
microglia
neuroprotect
tissu
damag
phenotyp
exacerb
neurodegen
diseas
progress
manohar
mutnal
shuxian
hu
scott
schachtel
jame
lokensgard
present
author
umnedu
neuroimmunolog
laboratori
center
infecti
diseas
microbiolog
translat
research
depart
medicin
univers
minnesota
mn
vivo
vitro
experi
undertaken
elucid
role
regulatori
b
lymphocyt
control
neuroinflamm
follow
brain
infect
murin
cytomegaloviru
mcmv
uniqu
subset
hi
bcell
found
infiltr
brain
chronic
infect
anim
reach
highest
level
latest
time
point
test
pi
bcelldefici
jh
mice
bko
display
exacerb
neuroimmun
respons
compar
infect
wildtyp
wt
anim
measur
enhanc
accumul
andor
retent
lymphocyt
within
brain
well
increas
level
microgli
cell
activ
mhc
class
ii
convers
level
regulatori
tcell
treg
found
significantli
lower
infect
bko
mice
compar
wt
anim
experi
show
vitro
gener
interleukin
il
breg
cell
abl
inhibit
cytokin
chemokin
respons
microglia
follow
stimul
viral
antigen
addit
vitro
gener
breg
also
found
promot
convers
tcell
regulatori
tcell
phenotyp
final
gainoffunct
experi
demonstr
reconstitut
bcell
bko
mice
restor
neuroimmun
respons
level
exhibit
infect
wt
anim
taken
togeth
result
demonstr
regulatori
bcell
modul
lymphocyt
well
microgli
cell
respons
within
brain
promot
tcell
transit
treg
phenotyp
timothi
nacarelli
ashley
azar
elizabeth
crow
claudio
torr
christian
sell
present
author
drexeledu
drexel
univers
colleg
medicin
hiv
patient
current
treat
highli
activ
antiretrovir
therapi
haart
employ
nucleosid
revers
transcriptas
inhibitor
nrti
although
success
decreas
hiv
viralload
rate
infect
nrti
predispos
patient
increas
risk
develop
patholog
associ
age
agerel
patholog
thought
aris
mitochondri
toxic
attribut
nrtimedi
inhibit
mitochondri
dna
polymeras
gamma
newer
gener
nrti
current
use
haart
tenofovir
emtricitabin
tdfftc
contain
decreas
inhibitori
affin
dna
polymeras
gamma
mitochondri
toxic
remain
emin
postul
tdfftc
impair
mitochondria
primari
human
fibroblast
primari
human
fibroblast
relev
model
studi
age
vitro
contain
finit
prolif
capac
enter
cellular
senesc
irrevers
growth
arrest
recapitul
age
cellular
level
cellular
senesc
activ
oxid
stress
could
contribut
reactiv
oxygen
speci
ro
produc
impair
mitochondria
therefor
also
examin
whether
tdfftc
increas
mitochondri
cellular
ro
induc
prematur
senesc
previou
studi
laboratori
shown
treatment
rapamycin
inhibitor
promot
mitochondri
homeostasi
decreas
oxid
stress
delay
senesc
age
primari
human
fibroblast
examin
whether
rapamycin
could
allevi
nrtiinduc
effect
treatment
tdfftc
found
mitochondri
integr
impair
ro
increas
prematur
senesc
induc
howev
alter
amelior
presenc
rapamycin
result
demonstr
latest
gener
nrti
impair
mitochondria
induc
senesc
vitro
maria
ann
alexand
igor
evgenia
present
author
marianagel
ucdenveredu
neurolog
univers
colorado
school
medicin
pediatr
univers
colorado
school
medicin
varicella
zoster
viru
vzv
vasculopathi
caus
product
infect
cerebr
arteri
lead
patholog
vascular
remodel
stroke
purinerg
signal
mediat
atp
metabolit
emerg
import
vascular
remodel
addit
purinerg
signal
involv
rna
viru
infect
role
dna
viru
infect
unknown
thu
hypothes
specif
purinoreceptor
involv
vzv
infect
cerebr
arteri
vascular
remodel
arteri
adventitia
initi
vascular
site
infect
vzv
viru
reactiv
treat
vzvinfect
primari
human
brain
vascular
adventiti
fibroblast
braf
antagonist
purinoreceptor
three
day
later
viral
dna
quantifi
qpcr
compar
untreat
infect
control
antagonist
significantli
downregul
vzv
dna
antagonist
signific
differ
found
purinoreceptor
antagonist
antagonist
clopidogrel
produc
greatest
reduct
vzv
dna
also
studi
effect
braf
clopidogrel
significantli
downregul
compar
untreat
infect
control
furthermor
clopidogrel
reduc
titer
infecti
viru
three
alphaherpesvirus
overal
demonstr
purinoreceptor
antagonist
decreas
vzv
dna
infect
braf
clinic
effect
antagonist
clopidogrel
remain
determin
aarthi
elizabeth
rachel
van
sergey
moham
ravi
philipp
gavin
myung
anasta
bindesh
ako
renaud
fatah
present
author
fkashanc
gmuedu
molecular
microbiolog
nation
center
biodefens
infecti
diseas
georg
mason
univers
georg
washington
univers
medic
center
depidemiologi
et
physiopathologi
de
viru
oncogen
depart
de
virologi
institut
pasteur
cnr
chemistri
georg
washington
univers
microscopi
imag
analysi
georg
washington
univers
medic
center
oncogenes
retroviral
equip
labelise
ligu
national
contr
le
cancer
intern
center
research
infectiolog
recent
much
interest
develop
regard
mechan
extracellular
deliveri
nucleic
acid
protein
among
viral
infect
recipi
cell
role
exosom
viral
pathogenesi
diseas
state
remain
larg
unknown
wide
accept
exosom
play
import
role
intercellular
commun
cellular
inflamm
antigen
present
program
cell
death
pathogenesi
encod
mirna
regul
viral
host
gene
express
abund
mirna
first
report
us
later
other
use
deep
sequenc
tar
transactiv
respons
element
mirna
recent
found
presenc
tar
rna
exosom
cell
cultur
supernat
infect
cell
patient
sera
report
transport
tar
rna
nucleu
exosom
activ
process
prior
exposur
naiv
cell
exosom
infect
cell
increas
suscept
recipi
cell
infect
exosom
tar
rna
regul
apoptosi
lower
bim
protein
recipi
cell
found
copiesml
tar
rna
exosom
deriv
infect
cultur
supernat
copiesml
tar
rna
serum
exosom
highli
activ
antiretrovir
therapi
haart
treat
patient
long
term
nonprogressor
ltnp
recent
found
tar
abl
activ
cytokin
recipi
cell
increas
nuclear
accumul
compon
nfkb
complex
increas
may
relat
newli
form
ikkb
tar
treat
cell
may
result
tlr
activ
tar
discuss
effect
biochem
step
recipi
macrophag
cell
result
alter
cytokin
part
may
explain
neuroinflamm
observ
aid
patient
haart
treatment
bradley
nash
juhi
motiani
olimpia
meucci
present
author
drexeledu
drexel
univers
colleg
medicin
depart
pharmacolog
physiolog
ferritin
heavi
chain
fhc
subunit
ubiquit
express
iron
storag
complex
ferritin
recent
shown
upregul
central
nervou
system
cn
respons
hivsiv
infect
illicit
drug
abus
previou
research
suggest
unexpect
consequ
increas
cn
fhc
lie
abil
inhibit
homeostat
signal
chemokin
receptor
result
decreas
dendrit
spine
densiti
cortic
neuron
interestingli
initi
studi
indic
chang
correl
diseas
progress
behavior
symptom
observ
hiv
associ
neurocognit
disord
hand
opiat
includ
morphin
damgo
abl
upregul
fhc
mu
opioid
receptor
depend
manner
suggest
novel
avenu
regul
via
opioid
signal
previou
experi
shown
chronic
morphin
treatment
vitro
vivo
caus
gener
upregul
fhc
cortic
neuron
correspond
decreas
level
phosphoryl
activ
decreas
activ
downstream
signal
ie
akt
howev
interact
yet
studi
cn
cell
type
astrocyt
express
mor
critic
involv
neuron
function
addit
character
morphineinduc
chang
subcellular
distribut
fhc
neuron
cn
cell
may
provid
clue
natur
interact
addit
role
fhc
hand
neurodegen
diseas
debasi
nayak
dorian
mcgavern
present
author
nayakdn
nindsnihgov
nind
nih
tetherin
bone
marrow
stromal
antigen
interferoninduc
plasma
membran
protein
recent
emerg
key
innat
mammalian
restrict
factor
imped
releas
envelop
virus
physic
tether
nascent
bud
virion
plasma
membran
sever
vitro
studi
demonstr
potent
antivir
act
upon
mani
virul
envelop
virus
retrovirus
hiv
arenavirus
lassa
filovirus
ebola
paramyxovirus
sendai
orthomyxovirus
influenza
rhabdovirus
vsv
etc
howev
remain
unclear
import
innat
immun
protein
particip
sequest
persist
viral
infect
vivo
studi
use
lymphocyt
choriomening
viru
lcmv
clone
model
persist
viral
infect
evalu
role
facilit
transit
innat
viruscontrol
adapt
immun
respons
importantli
knockout
mice
impair
abil
control
lcmv
peripher
tissu
well
central
nervou
system
cn
viral
clearanc
delay
one
month
sera
never
purg
cn
anatom
express
map
plasmacytoid
dendrit
cell
dc
myeloid
dc
brain
resid
microglia
consist
impair
abil
mice
sequest
lcmv
antigen
splenic
margin
zone
brain
infect
analysi
adapt
immun
respons
reveal
mice
gener
less
polyfunct
virusspecif
cell
show
reduc
expans
compar
wild
type
control
mice
demonstr
import
particip
bridg
innat
adapt
immun
collect
data
indic
play
essenti
role
control
persist
viral
infect
explain
mani
virus
develop
strategi
thwart
activ
potent
antivir
protein
diego
ojeda
mauricio
caroben
jorg
quarleri
present
author
diegosebastianojeda
gmailcom
inbir
infect
lead
wide
spectrum
neurodegen
diseas
among
central
nervou
system
cell
astrocyt
shown
suscept
infect
vpr
accessori
protein
neg
affect
highli
control
cn
compart
induc
astrocyt
apoptosi
secret
neurotoxin
caus
neuron
loss
telomeras
cellular
ribonucleoprotein
complex
key
control
cellular
senesc
involv
inhibit
apoptosi
improv
dna
repair
consid
shown
modifi
cellular
age
process
interf
telomeras
activ
ta
aim
studi
evalu
impact
vpr
protein
express
ta
astrocyt
vpr
code
sequenc
strain
pcramplifi
clone
express
vector
astrocyt
cell
transfect
pegfpvpr
vector
ta
evalu
realtim
pcr
express
rel
telomeras
activ
rta
h
posttransfect
transfect
effici
express
percentag
gfpposit
cell
measur
fac
statist
differ
calcul
tstudent
test
telomeras
activ
rta
found
significantli
reduc
astrocyt
cell
transfect
vprexpress
vector
rta
p
compar
untransfect
consid
rta
cell
rta
mean
transfect
effici
pegfpvpr
transfect
cell
respect
determin
percentag
gfpposit
cell
evalu
fac
data
present
indic
express
vpr
neg
impact
astrocityc
ta
given
critic
role
cell
type
play
creat
threedimension
framework
cn
maintain
barrier
neural
metabol
activ
observ
phenomenon
relev
context
understand
astrocyt
biolog
chang
could
involv
neurodegen
process
observ
infect
diego
ojeda
mauricio
caroben
jorg
quarleri
present
author
diegosebastianojeda
gmailcom
inbir
apoptosi
play
critic
role
neuropathogenesi
develop
multipl
strategi
modul
apoptosi
relatedpathway
infect
cell
thu
promot
surviv
favor
role
viral
reservoir
establish
infect
astrocyt
cn
caus
minim
cytopatholog
longliv
cell
studi
aim
evalu
hiv
infect
impact
apoptosi
cascad
infect
astrocyt
neighbor
uninfect
cell
hiv
infecti
molecular
clone
tag
gfp
name
hivgfp
construct
also
pseudotyp
vsvg
glycoprotein
cotransfect
cell
human
astrocyt
cell
use
vitro
model
astrocyt
infect
detect
apoptot
event
day
post
infect
dpi
costain
annexinv
perform
singlecel
analysi
aim
simultan
identifi
apoptoticinfect
anngfp
apoptoticuninfect
anngfp
neighbor
cell
fac
valu
express
statist
analysi
perform
student
test
p
valu
consid
signific
initi
level
apoptosi
annexin
v
dpi
depict
differ
p
product
infect
astrocyt
gfp
respect
neighbor
uninfect
cell
gfp
respect
contrast
compar
level
apoptosi
annexinv
dpi
infect
vs
neighbor
uninfect
astrocyt
gfpgfp
signific
decreas
p
respect
observ
differ
independ
level
viral
replic
gfp
cell
hiv
infect
astrocyt
result
surviv
infect
astrocyt
apoptosi
neighbor
uninfect
cell
antiapoptot
effect
independ
viral
replic
magnitud
kinet
exhibit
biphas
pattern
accord
infect
progress
advanc
stage
infect
resist
apoptosi
pronounc
could
support
gener
hiv
reservoir
nirzari
william
rui
shendra
wen
benjama
vanessa
michael
jeffrey
brian
present
author
drexeledu
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
biostatist
epidemiolog
center
clinic
epidemiolog
biostatist
univers
pennsylvania
school
medicin
infecti
diseas
hiv
medicin
depart
medicin
drexel
univers
colleg
medicin
studi
evalu
relationship
illicit
drug
use
diseas
sever
patient
enrol
drexelm
hivaid
genet
analysi
cohort
sinc
cocain
known
immunomodulatori
effect
cytokin
profil
preferenti
nonus
pn
cocain
user
pco
multidrug
user
mdu
analyz
understand
effect
cocain
cytokin
modul
diseas
sever
patient
within
cohort
assess
approxim
everi
month
clinic
paramet
histori
illicit
drug
alcohol
tobacco
use
luminex
human
cytokin
panel
use
cytokin
quantif
analysi
perform
use
newli
develop
biostatist
model
substanc
abus
found
common
within
cohort
util
drug
screen
time
visit
determin
cohort
could
categor
pn
pco
mdu
overal
health
pn
popul
better
pco
popul
peak
current
viral
load
pn
substanti
lower
pco
mdu
patient
among
cytokin
investig
differenti
cytokin
profil
establish
within
three
popul
cytokin
known
play
critic
role
infect
posit
associ
increas
cocain
use
clinic
paramet
latest
viral
load
tcell
count
ratio
also
significantli
associ
cocain
use
base
assess
cocain
use
appear
associ
sever
diseas
work
support
nihnind
nida
nimh
nimh
michael
thuong
rasha
el
andrea
jame
caitlin
irwin
dora
fengbin
patrick
charl
allen
zafar
pooja
present
author
zafarkhan
drexelmededu
institut
biotechnolog
virolog
research
depart
microbiolog
immunolog
drexel
univers
colleg
medicin
hepat
viru
research
hepat
b
foundat
immunoregul
nation
institut
allergi
infecti
diseas
biochemistri
molecular
biolog
drexel
univers
colleg
medicin
chase
chemic
divers
center
inc
pennsylvania
biotechnolog
center
drug
discoveri
consult
llc
biopharma
llc
fox
chasechem
divers
center
inc
dcsign
dendrit
cell
specif
nonintegrin
membran
protein
ctype
lectin
famili
found
high
level
monocytederiv
dc
macrophag
activ
b
cell
vivo
dcsignposit
cell
found
lymph
node
tonsil
skin
subepitheli
region
cervix
respect
transmiss
dcsign
shown
serv
ligand
effici
bind
concentr
mediat
transfer
viru
mucos
surfac
cell
subepitheli
dc
express
dcsign
demonstr
play
import
role
cervicovagin
transmiss
addit
studi
examin
process
dcsignmedi
transmiss
variou
pathogen
suggest
target
cell
surfac
molecul
may
serv
potenti
therapeut
strategi
dcsign
bind
mannos
fucos
moieti
present
hiv
envelop
glycoprotein
high
affin
block
interact
site
primari
infect
could
potenti
prophylact
andor
serv
potenti
microbicid
target
develop
novel
high
throughput
screen
assay
ht
identifi
inhibitor
dcsign
interact
valid
assay
use
quinoxazolin
small
molecul
block
mannos
dimer
bind
dcsign
demonstr
ht
noncarbohydr
librari
produc
micromolar
lower
noncarbohydr
hit
complet
virtual
screen
divers
librari
small
molecul
inhibitor
dock
calciumbind
domain
dcsign
crystal
structur
subject
virtual
hit
ht
assay
addit
began
novel
approach
bindingsit
direct
lipophil
mine
hypothesisdriven
drug
discoveri
andrea
partridg
elizabeth
crow
claudio
torr
julio
martingarcia
present
author
drexeledu
drexel
univers
colleg
medicin
context
infect
senesc
acceler
facilit
opportunist
infect
increas
viral
replic
cellular
senesc
irrevers
growth
arrest
lifetim
cell
although
increas
macrophag
tropism
replic
shown
contribut
macrophag
process
clearli
establish
chang
microrna
mirna
express
cellular
senesc
andor
age
also
describ
mirna
seem
contribut
age
process
level
cellular
senesc
tissu
age
lifespan
whole
organ
howev
specif
role
mirna
macrophag
age
yet
establish
alter
mirna
profil
cellular
senesc
may
affect
infect
potenti
infect
could
well
affect
cellular
senesc
mirna
modul
induc
senesc
primari
human
macrophag
macrophag
oxid
damag
treatment
confirm
presenc
senesc
phenotyp
use
senescenceassoci
betagalactosidas
sa
betag
assay
western
blot
analysi
level
shown
increas
senesc
cell
determin
age
senescenceinduc
macrophag
display
senescentlik
phenotyp
consist
increas
express
enlarg
flatten
morpholog
posit
stain
sa
betag
studi
includ
analysi
cytokin
chemokin
secret
profil
determin
whether
exhibit
senescenceassoci
secretori
phenotyp
investig
chang
mirna
profil
due
infect
senesc
yuri
persidski
jeremi
hill
holli
dykstra
nanci
reichenbach
slava
rom
servio
ramirez
present
author
yuripersidski
tuhstempleedu
depart
patholog
laboratori
medicin
templ
univers
school
medicin
despit
combin
antiretrovir
therapi
achiev
effici
hiv
replic
control
neurocognit
complic
defin
hand
continu
highli
preval
hiv
infect
one
explan
could
constant
compromis
blood
brain
barrier
bbb
function
driven
chronic
inflammatori
respons
document
hiv
infect
individu
even
wellcontrol
viru
replic
yet
hand
progress
brain
endotheli
cell
injuri
underli
mechan
explor
last
year
howev
chang
cell
constitut
bbb
like
pericyt
studi
detail
context
infectionw
found
partial
pericyt
loss
regul
key
receptor
cell
brain
tissu
infect
patient
even
without
detect
cn
infect
hunsg
mice
parallel
bbb
compromis
neuroinflamm
primari
human
brain
pericyt
treat
beta
tnfalpha
demonstr
decreas
secret
transform
growth
factorbeta
diminish
express
pdgfr
beta
control
pericyt
surviv
recruit
bbb
connexin
critic
establish
gap
junction
pericyt
brain
microvascular
endotheli
cell
bmvec
pericyt
expos
betatnf
alpha
show
enhanc
express
numer
proinflammatori
factor
relev
neuropathogenesi
adhes
molecul
parallel
increas
adhes
monocyt
pericyt
monolay
use
bbb
model
compos
bmvecpericyt
show
increas
monocyt
migrat
across
bbb
construct
respons
relev
chemokin
betatnf
alpha
treatment
pericyt
diminish
abil
migrat
provid
potenti
mechan
decreas
brain
tissu
infect
patient
taken
togeth
data
point
major
decreas
barrier
support
function
enhanc
inflammatori
respons
brain
pericyt
exposur
relev
cytokin
brain
tissu
infect
patient
sudheesh
pilakkakanthikeel
andrea
raymond
venkata
subba
rao
atluri
vidya
sagar
upal
roy
madhavan
nair
present
author
spilakka
fiuedu
dept
immunolog
institut
neuroimmun
pharmacolog
herbert
wertheim
colleg
medicin
florida
intern
univers
miami
human
immunodefici
viru
remain
one
lead
caus
death
worldwid
hiv
penetr
cn
earli
infect
establish
viral
reservoir
even
though
astrocyt
infect
hiv
unlik
microglia
brain
macrophag
product
infect
nonproduct
infect
could
signific
neuropathogenesi
although
potent
antiretrovir
therapi
significantli
improv
morbid
hiv
patient
biggest
challeng
inabl
haart
erad
viru
reservoir
mechan
govern
establish
hiv
reservoir
vivo
still
fulli
understood
brain
also
target
organ
cocain
cocain
enhanc
express
suscept
cell
serv
cofactor
suscept
progress
infect
recent
identifi
restrict
factor
hydrolys
dntp
shown
restrict
hiv
infect
rest
cell
base
previou
report
literatur
hypothes
increas
express
astrocyt
result
suppress
cellular
dntp
subsequ
hamper
retroviru
revers
transcript
turn
lead
nonproduct
infect
examin
constitut
express
astrocyt
microglia
gene
protein
level
modul
cocain
astrocyt
display
higher
express
level
compar
microglia
suggest
play
role
astrocyt
facilit
maintain
nonproduct
infect
cocain
degrad
turn
increas
viral
replic
astrocyt
suppress
level
astrocyt
cocain
reactiv
latent
viru
astrocyt
vanessa
michael
william
benjama
jean
sonia
shendra
brandon
wen
brian
rui
jeffrey
brian
present
author
vanessapirron
drexelmededu
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
consult
ltd
biostatist
epidemiolog
center
clinic
epidemiolog
biostatist
univers
school
medicin
infecti
diseas
hiv
medicin
depart
medicin
drexel
univers
colleg
medicin
long
termin
repeat
ltr
regul
gene
express
interact
multipl
host
viral
factor
crosssect
studi
prehaart
era
demonstr
snp
cebp
site
sp
site
iii
peripher
bloodderiv
ltr
increas
frequenc
diseas
sever
increas
correl
dementia
current
studi
focu
identif
ltr
signatur
deriv
peripher
blood
viru
use
molecular
marker
identifi
individu
prone
develop
advanc
stage
diseas
andor
neurolog
diseas
prospect
longitudin
studi
conduct
seroposit
patient
current
enrol
drexelm
hivaid
genet
analysi
cohort
philadelphia
pa
histori
clinic
paramet
comorb
obtain
approxim
everi
month
collect
extens
clinic
paramet
patient
allow
crosssect
longitudin
analys
impact
paramet
develop
snp
cours
diseas
date
snp
identifi
associ
tcell
count
viral
load
snp
identifi
snp
posit
signific
correl
gain
transcript
factor
bind
result
suggest
genom
swarm
may
evolv
cours
diseas
respons
select
pressur
lead
chang
preval
ltr
snp
may
predict
advanc
stage
hiv
diseas
may
result
alter
viral
function
work
support
nihnind
nida
nimh
nimh
alina
popescu
joseph
emilio
avindra
present
author
alinapopescu
nihgov
section
infect
nervou
system
bethesda
md
scan
probe
microscopi
unit
bethesda
md
show
amyloid
beta
aggreg
physiolog
condit
presenc
hivtat
protein
present
signific
structur
chang
atom
forc
microscopi
imag
show
predomin
typic
singular
uniform
amyloid
fibril
form
micromolar
amyloid
concentr
turn
popul
doubl
twist
fiber
micromolar
hivtat
present
higher
tat
concentr
micromolar
turn
thick
unstructur
filament
nonspecif
aggreg
larg
patch
molar
ratio
hivtat
per
amyloid
beta
incub
fibril
much
larger
irregular
along
length
compar
amyloid
fibril
dimens
similar
amyloid
fibril
form
extrem
concentr
mm
without
uniformli
striat
structur
importantli
presenc
tat
amyloid
fibril
significantli
increas
neurotox
amyloid
fibril
shown
neuron
cell
cultur
experi
futur
studi
involv
local
tat
molecul
throughout
amyloid
filament
aggreg
better
understand
interact
hivtat
protein
amyloid
beta
peptid
maureen
h
richard
melani
seaton
stephani
min
victoria
lutgen
lena
alharthi
present
author
maureenrichard
rushedu
depart
immunologymicrobiolog
rush
univers
medic
center
hiv
invad
cn
shortli
infect
despit
antiretrovir
therapi
lead
spectrum
neurolog
complic
term
hivassoci
neurocognit
disord
hand
extens
studi
probe
cellular
molecular
mechan
drive
hivmedi
neuropathogenesi
littl
known
complex
interact
infiltr
immun
cell
resid
brain
cell
especi
astrocyt
evalu
interact
peripher
blood
mononuclear
cell
pbmc
astrocyt
show
condit
media
primari
human
progenitorderiv
astrocyt
pda
induc
betacatenin
express
pbmc
inhibit
hiv
replic
cell
induc
express
cell
gener
doubl
posit
dp
cell
phenotyp
deplet
pda
condit
media
wnt
ligand
wnt
abrog
respons
indic
wnt
ligand
secret
astrocyt
mediat
chang
cell
convers
condit
pbmc
media
activ
pda
indic
elev
express
ifngamma
hladr
reduc
betacatenin
express
pda
enhanc
hiv
replic
pda
data
indic
feedback
loop
wherebi
activ
pbmc
alter
astrocyt
phenotyp
suscept
hiv
infect
astrocyt
alter
phenotyp
function
cell
propos
model
crosstalk
occur
astrocyt
infiltr
immun
cell
shape
microenviron
brain
perturb
function
potenti
cell
type
work
support
rosa
janet
miriam
rosa
karim
myraida
jacob
valeri
present
author
upredu
puerto
rico
albizu
univers
health
scienc
univers
purpos
era
combin
antiretrovir
treatment
hivseroposit
patient
live
longer
increas
surviv
observ
high
preval
neurocognit
impair
memori
island
mi
comput
base
test
use
identifi
suscept
cognit
impair
especi
spatial
learn
memori
advantag
noninvas
test
easili
administ
sinc
mi
affect
cultur
valid
character
neurocognit
disord
could
repres
good
screen
test
hand
main
object
studi
determin
valid
use
mi
reliabl
instrument
character
spatial
learn
memori
hivseroposit
women
design
method
women
evalu
hivseroposit
control
hivseroneg
viralimmun
profil
mi
neuropsycholog
test
parametr
nonparametr
statist
perform
result
group
differ
speed
navig
visibl
hidden
target
trial
visibl
target
trial
differ
abil
two
group
locat
target
locat
howev
hidden
trial
hivseroposit
women
requir
time
move
longer
distanc
control
thu
hivseroposit
women
less
effici
acquisit
learn
wors
perform
compar
hivseroneg
women
spatial
memori
retent
assess
probe
trial
target
present
hivseroposit
women
spent
less
time
part
island
quadrant
contain
target
previous
control
conclus
use
mi
test
valid
detect
spatial
learn
memori
deficit
hivseroposit
women
mi
resembl
find
morri
water
maze
serv
new
translat
technolog
use
valid
instrument
spatial
memori
screen
fiorella
rossi
gokul
swaminathan
julio
present
author
drexeledu
drexel
univers
colleg
medicin
human
immunodefici
viru
transmit
predominantli
vagin
rectal
mucosa
dendrit
cell
dc
among
first
cell
interact
viru
addit
support
viral
replic
dc
facilit
viral
dissemin
contribut
pathogenesi
migrat
lymph
node
assist
infect
cell
dc
show
less
suscept
infect
depend
type
stimuli
matur
stage
upon
dc
matur
variou
cellular
host
factor
apolipoprotein
b
mrna
edit
enzym
highli
upregul
howev
upregul
context
elucid
dc
goal
determin
mechan
explain
matur
dc
caus
suppress
infect
vitro
immatur
dc
activ
differ
tolllik
receptor
ligand
tlrl
obtain
matur
phenotyp
determin
express
level
suscept
dc
recombin
viru
adafluc
observ
upregul
express
factor
upon
stimul
comparison
nonstimul
cell
tlrl
upregul
dc
correl
increas
express
matur
marker
hladr
complet
suppress
infect
use
inhibitor
silenc
phenotyp
revers
wild
type
infect
suggest
factor
also
involv
suppress
infect
upon
stimul
futur
studi
address
mechan
involv
process
jessica
rotschaf
erin
roach
dianna
cheneypet
maxim
cheeran
present
author
cheeran
umnedu
veterinari
popul
medicin
depart
colleg
veterinari
medicin
univers
minnesota
activ
macrophag
microglia
critic
compon
host
respons
follow
brain
damag
previou
studi
laboratori
demonstr
brain
infect
stimul
neural
stemprogenitor
cell
nsc
prolifer
pi
concurr
macrophag
infiltr
present
studi
examin
role
macrophag
activ
phenotyp
nsc
prolifer
evalu
infiltr
macrophag
hi
reveal
cell
hi
pi
express
marker
fivefold
higher
phenotyp
marker
hi
macrophag
pi
indic
altern
activ
phenotyp
determin
macrophag
polar
modul
neurogenesi
nsc
cultur
supernat
polar
bonemarrow
deriv
macrophag
nsc
cultur
treat
condit
media
prolifer
cell
compar
cultur
control
media
cell
treatment
group
maintain
stem
cell
phenotyp
nestin
collect
treat
nsc
continu
increas
number
h
posttreat
significantli
higher
number
cell
phase
cell
divis
transplant
macrophag
later
ventricl
uninfect
mice
result
increas
nsc
prolifer
total
number
nsc
doubl
compar
salin
heatkil
cell
control
posttreat
interestingli
express
significantli
increas
polar
macrophag
treatment
either
inhibitor
neutral
antibodi
suppress
nsc
prolifer
control
level
final
gene
express
infect
brain
increas
pi
coincid
increas
neurogenesi
macrophag
infiltr
brain
result
studi
suggest
macrophag
promot
neurogenesi
follow
herp
virusinduc
brain
damag
may
provid
avenu
therapeut
intervent
jessica
rotschaf
erin
roach
maxim
cj
cheeran
present
author
umnedu
depart
veterinari
popul
medicin
colleg
veterinari
medicin
univers
minnesota
herp
simplex
enceph
hse
character
chronic
inflamm
domin
presenc
tcell
previou
studi
laboratori
show
neural
stemprogenitor
cell
nsc
prolifer
significantli
impair
chronic
phase
hse
dpi
current
studi
evalu
role
tcell
modul
antiprolif
milieu
dpi
approxim
tcell
brain
produc
interferongamma
follow
viru
stimul
tcell
deplet
mice
brain
pi
use
neutral
antibodi
tcell
deplet
result
increas
nestin
nsc
compar
isotyp
antibodytr
control
tcell
number
phenotyp
chang
significantli
follow
deplet
increas
total
number
infiltr
macrophag
hi
well
downregul
mhcii
microglia
observ
interestingli
increas
number
infiltr
macrophag
macrophag
phenotyp
marker
seen
compar
appropri
control
analysi
macrophag
phenotyp
show
absenc
tcell
ratio
express
macrophag
shift
approxim
suggest
tcell
deplet
promot
macrophag
activ
phenotyp
moreov
gene
transcript
analysi
demonstr
signific
reduct
ifngamma
express
deplet
anim
compar
isotypetr
mice
previou
studi
laboratori
shown
polar
macrophag
enhanc
nsc
prolifer
howev
transplant
polar
macrophag
later
ventricl
chronic
infect
mice
show
signific
chang
neurogenesi
addit
cultur
nsc
treat
ifngamma
refractori
macrophag
induc
increas
prolifer
taken
togeth
data
suggest
tcell
impair
endogen
nsc
prolifer
subsequ
hse
ifngamma
depend
manner
studi
may
help
identifi
therapeut
intervent
enhanc
neurogenesi
viral
enceph
walter
royal
iii
joseph
bryant
ming
guo
harri
davi
christina
preming
sandra
navasrey
present
author
wroyal
somumarylandedu
univers
maryland
school
medicin
object
cigarett
smoke
link
increas
risk
diseas
progress
hiv
infect
includ
increas
risk
cognit
impair
preliminari
studi
examin
effect
cigarett
smoke
exposur
induct
gene
express
mediat
inflamm
oxid
stress
brain
transgen
rat
method
month
old
wildtyp
wt
transgen
tg
fisher
rat
expos
cigarett
smoke
cs
research
grade
cigarett
contain
regular
amount
nicotin
special
construct
smoke
chamber
day
per
week
week
frontal
cortex
subcort
white
matter
csexpos
nonexpos
anim
rat
group
examin
realtim
pcr
ifngamma
tnfalpha
ino
nadph
oxidas
isoform
dual
oxidas
thioredoxin
txn
superoxid
dismutas
sod
gene
express
result
infgamma
gene
express
higher
wt
tg
rat
increas
cs
exposur
tnfalpha
gene
express
increas
cs
wt
vs
cs
wt
rat
differ
express
either
tg
wt
rat
cs
exposur
absenc
cs
exposur
express
higher
tg
wt
rat
higher
tg
cs
rat
group
elev
express
cs
exposur
level
ino
txn
express
similar
group
howev
sod
decreas
cs
wt
rat
unchang
tg
rat
also
cs
increas
express
wt
rat
affect
express
tg
rat
conclus
increas
proinflammatori
decreas
oxid
stress
marker
gene
express
result
cs
exposur
tg
rat
cs
effect
oxid
stress
respons
tg
rat
may
reflect
alter
sensit
nicotin
walter
royal
mariana
tricia
christoph
kenneth
kanayo
ajay
scott
ming
anya
min
lindsay
alashl
joyc
william
present
author
wroyal
somumarylandedu
maryland
school
medicin
california
san
diego
school
medicin
colleg
human
virolog
nigeria
san
diego
school
medicin
object
neurocognit
impair
nci
hiv
infect
link
nervou
system
involv
virusinfect
activ
mononuclear
phagocyt
studi
associ
level
marker
monocytemacrophag
activ
level
circul
monocyt
presenc
nci
examin
individu
nigeria
method
seroposit
sp
women
men
seroneg
sn
men
women
subject
receiv
medic
assess
neuropsycholog
test
abil
domain
averag
global
deficit
score
gd
impair
indic
gd
deriv
demograph
adjust
test
score
percentag
circul
monocyt
hiv
rna
measur
perform
clinic
laboratori
level
plasma
solubl
solubl
marker
monocytemacrophag
activ
determin
elisa
measur
compar
sp
sn
gender
use
ttest
analysi
varianc
associ
test
result
examin
use
regress
analysi
analys
categor
data
employ
chisquar
test
result
sp
asymptomat
hiv
infect
gd
note
sn
sp
patient
among
impair
sp
measur
higher
hiv
rna
nonimpair
subject
higher
measur
gd
p
percent
monocyt
p
note
sp
sn
subject
gd
correl
level
p
hiv
rna
measur
higher
women
men
p
among
women
p
p
level
higher
sp
sn
among
men
p
percent
monocyt
p
higher
sp
sn
conclus
measur
circul
monocyt
monocyt
activ
use
detect
evid
diseas
activ
among
clinic
stabl
individu
particularli
women
hiv
infect
giusepp
traci
nanci
antonio
present
author
grusso
templeedu
institut
cancer
research
molecular
medicin
center
biotechnolog
colleg
scienc
technolog
templ
univers
philadelphia
pennsylvania
neurosci
center
neurovirolog
templ
univers
school
medicin
philadelphia
pennsylvania
physic
medicin
rehabilit
templ
univers
hospit
philadelphia
pennsylvania
despit
develop
combin
antiretrovir
therapi
hivassoci
neurocognit
disord
remain
preval
tradit
neuropsycholog
np
approach
commonli
use
paper
pencilbas
psychometr
test
impair
assess
although
approach
provid
highli
standard
control
deliveri
perform
challeng
extent
task
predict
everyday
function
alway
clear
task
simul
real
world
activ
manag
financ
rememb
appoint
assess
neurocognit
abil
use
task
simul
everyday
activ
may
confer
estim
patient
function
accur
one
within
laboratori
condit
virtual
realiti
vr
allow
user
interact
real
time
pseudo
immers
environ
behavior
interfac
present
close
real
life
test
environ
aim
studi
design
measur
detect
np
impair
hivinfect
subject
simul
environ
analyz
number
error
detect
environ
correl
np
dysfunct
tradit
test
end
develop
np
function
interact
vr
supermarket
facet
np
function
expect
correl
vr
test
episod
memori
execut
function
test
studi
support
development
grant
comprehens
neuroaid
center
cnac
nimh
grant
number
templ
univers
school
medicin
divya
shet
todd
steven
brian
pooja
zafar
present
author
poojajain
drexelmededu
microbiolog
immunolog
drexel
univers
colleg
medicin
microbiolog
immunolog
pennsylvania
state
univers
colleg
medicin
immunolog
section
neuroimmunolog
branch
nation
institut
health
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
viral
oncoprotein
tax
play
key
role
transform
human
tcell
leukemia
viru
type
infect
cell
lead
adult
tcell
leukemia
atl
key
antigen
recogn
htlvassoci
myelopathi
ham
asymptomat
carrier
well
atl
ham
patient
tax
epitop
exhibit
immunodomin
regard
immunotherapeut
potenti
epitop
evalu
transgen
mice
absenc
presenc
dendrit
cell
dc
given
recent
encourag
observ
made
phase
dcbase
vaccin
trial
atl
facilit
studi
hybrid
mous
strain
carri
gene
gener
tcell
immun
respons
gener
tax
epitop
deliv
absenc
presenc
freund
adjuv
andor
dc
overal
result
demonstr
natur
present
tax
epitop
could
initi
antigenspecif
tcell
respons
vivo
fail
upon
dc
deplet
addit
presenc
adjuv
potenti
tax
specif
respons
elev
serum
level
coincid
deplet
dc
wherea
decreas
tgfbeta
associ
adjuv
use
thu
tax
epitop
potenti
candid
dcbase
vaccin
newli
hybrid
mous
strain
could
use
investig
dc
involv
human
classirestrict
immun
respons
divya
jasmin
catherin
zafar
martin
pooja
present
author
divyasagar
drexeledu
institut
biotechnolog
virolog
research
depart
microbiolog
immunolog
drexel
univers
colleg
medicin
radiolog
john
hopkin
univers
healthi
individu
infiltr
dendrit
cell
dc
central
nervou
system
cn
tightli
control
highli
special
bloodbrain
barrier
bbb
howev
inflammatori
diseas
like
multipl
sclerosi
ms
dc
potenti
transmigr
across
bbb
cn
due
presenc
chemoattract
particularli
henc
studi
interact
circul
dc
bbb
repres
critic
step
cellular
traffick
neuroinflamm
nearinfrar
imag
dc
accumul
cn
correl
sever
inflamm
eae
experiment
autoimmun
encephalomyel
model
ms
ex
vivo
histolog
confirm
presenc
lesion
dc
emerg
perivascular
space
confoc
imag
reveal
exposur
lead
polymer
actin
dc
suggest
migratori
phenotyp
mechanist
studi
bbb
model
dc
exhibit
effici
transmigr
cell
presenc
addit
paracellular
versu
transcellular
pattern
migrat
dc
cell
seen
uniqu
enrich
lectin
receptor
dc
led
differenti
profil
specif
subset
dc
includ
myeloid
mdc
plasmacytoid
pdc
monocytederiv
mddc
subsequ
presenc
dc
subset
found
util
differ
lectin
receptor
order
adher
transmigr
across
bbb
subcelleular
level
crosstalk
actin
lectin
pathway
also
establish
prospect
select
regul
dc
entri
cn
open
new
possibl
diseas
pathogenesi
propag
ms
nmr
structurebas
mutagenesi
studi
jc
viru
agnoprotein
reveal
import
protein
stabil
dimeroligom
format
viral
dna
replic
sami
pascal
serg
mahmut
present
author
sariba
templeedu
univers
school
medicin
depart
neurosci
laboratori
molecular
neurovirolog
philadelphia
pa
usa
pari
descart
sorbonn
pari
citi
laboratoir
de
cristallographi
et
rmn
biologiqu
pari
franc
agnoprotein
small
multifunct
regulatori
protein
jc
viru
jcv
play
essenti
regulatori
role
viral
replic
cycl
absenc
express
jcv
unabl
sustain
product
life
cycl
recent
demonstr
agnoprotein
form
highli
stabl
dimer
oligom
vivo
vitro
leuilepherich
hydrophob
domain
protein
play
key
role
format
multimer
structur
previou
mutagenesi
analysi
region
result
phenotyp
show
defect
viral
life
cycl
addit
previou
attempt
determin
structur
agnoprotein
unsuccess
report
nmr
structur
synthet
agnoprotein
peptid
encompass
amino
acid
demonstr
amino
acid
span
form
amphipath
alphahelix
also
perform
nmr
structurebas
mutagenesi
studi
identifi
amino
acid
critic
agnoprotein
multimer
structur
function
alanin
substitut
three
leucin
residu
locat
within
alphahelix
region
result
mutant
exhibit
substanti
reduc
level
agnoprotein
express
viral
dna
replic
consist
vivo
find
vitro
studi
mutant
demonstr
consider
low
level
protein
express
bacteri
express
system
show
defect
monom
dimer
oligom
format
collect
find
suggest
residu
found
dimer
interfac
agnoprotein
play
critic
role
protein
stabil
dimeroligom
format
viral
dna
replic
thu
dimer
domain
agnoprotein
repres
potenti
target
site
develop
novel
therapeut
jcv
infect
affect
pml
patient
sami
sariba
mahmut
safak
present
author
msafak
templeedu
templ
univers
school
medicin
depart
neurosci
laboratori
molecular
neurovirolog
philadelphia
pa
usa
virus
evolv
highli
sophist
mechan
exploit
host
machineri
benefit
produc
infecti
virion
achiev
part
encod
util
multifunct
protein
multipl
step
viral
infect
cycl
includ
rna
export
type
viral
protein
distinct
function
domain
use
virus
process
jcv
agnoprotein
one
multifunct
protein
multipl
properti
exampl
local
mainli
perinuclear
area
infect
cell
consider
amount
also
found
nucleu
protein
consist
sever
function
domain
includ
bipartit
nuclear
local
signal
nl
leuilepherich
multimer
domain
exhibit
highli
basic
natur
contain
multipl
arg
ly
residu
found
n
cterminu
protein
addit
specif
interact
jcv
rna
harbor
put
ne
similar
rev
treatment
jcvinfect
cell
select
inhibitor
leptomycin
b
lead
accumul
agnoprotein
insid
nucleu
suggest
may
involv
regul
export
jcv
transcript
manner
provid
evid
possibl
proteinprotein
interact
studi
perform
agnoprotein
use
whole
cell
extract
svga
cell
infect
jcv
purifi
result
show
agnoprotein
strongli
interact
gst
alon
suggest
observ
interact
two
protein
specif
collect
result
studi
support
hypothesi
agnoprotein
may
play
regulatori
role
nucleocytoplasm
export
jcv
transcript
manner
futur
studi
aim
investig
molecular
mechan
regul
agnoprotein
export
jcv
transcript
ilker
sariy
rahsan
sariy
jennif
gordon
present
author
isariy
templeedu
depart
neurosci
center
neurovirolog
templ
univers
school
medicin
philadelphia
pa
major
human
popul
latent
infect
jc
viru
caus
fatal
demyelin
diseas
brain
progress
multifoc
leukoencephalopathi
immunocompromis
individu
mechan
viral
reactiv
molecular
switch
activ
product
replic
well
understood
previou
studi
identifi
puralpha
also
known
posit
neg
regul
jcv
gene
express
respect
studi
function
interplay
puralpha
regul
jcv
gene
express
transcript
splice
level
western
blot
analysi
brain
lysat
embryon
fibroblast
mice
lack
puralpha
show
dramat
increas
level
compar
wild
type
mice
point
neg
correl
cellular
express
protein
addit
overexpress
puralpha
glial
cell
line
caus
signific
reduct
level
next
test
effect
puralpha
jcv
transcript
luciferas
assay
expect
caus
strong
inhibit
puralpha
show
moder
increas
transcript
level
driven
jcvearli
promot
interestingli
observ
mediat
suppress
jcv
transcript
significantli
restor
express
puralpha
data
reveal
novel
interact
puralpha
regul
jcv
reactiv
work
made
possibl
grant
award
nih
ik
jg
ilker
sariy
onder
otlu
kasra
houshmand
kamel
khalili
present
author
isariy
templeedu
depart
neurosci
center
neurovirolog
templ
univers
school
medicin
philadelphia
pa
jc
viru
jcv
one
abund
polyomavirus
infect
major
human
popul
childhood
establish
persist
lifelong
infect
jcv
replic
glial
cell
brain
caus
fatal
demyelin
diseas
progress
multifoc
leukoencephalopathi
pml
pml
usual
seen
patient
underli
immunocompromis
condit
notabl
among
aid
patient
chronic
immunosuppress
regimen
jcv
genom
compos
three
function
region
includ
viral
earli
late
code
region
viral
noncod
regulatori
region
late
leader
sequenc
contain
open
read
frame
encod
small
regulatori
protein
call
agnoprotein
previou
studi
mutat
analysi
suggest
agnoprotein
requir
suffici
progress
infect
cycl
glial
cell
unknown
mechan
discov
agnoprotein
detect
cellfre
fraction
glial
cultur
infect
jcv
transfect
express
plasmid
transduc
adenoviru
express
system
moreov
treatment
cell
brefeldin
monensin
suppress
secret
agnoprotein
suggest
convent
secret
pathway
mainli
involv
agnoprotein
secret
demonstr
secret
agnoprotein
uptaken
glial
cell
studi
reveal
novel
phenomenon
agnoprotein
viral
life
cycl
potenti
develop
diagnost
therapeut
intervent
work
made
possibl
grant
award
nih
ik
kk
christina
nazira
elizabeth
myosoti
pamela
kurt
present
author
cjschier
vcuedu
pharmacolog
toxicolog
virginia
commonwealth
univers
central
del
carib
school
medicin
anatomi
virginia
commonwealth
univers
opiat
drug
use
posit
individu
report
exacerb
hiv
enceph
hive
hivassoci
neurodegen
disord
hand
recent
suggest
besid
muopioid
receptor
opiat
drug
also
activ
tolllik
receptor
likewis
receptor
plausibl
target
protein
transactiv
transcript
tat
therefor
aim
clarifi
role
morphin
tat
directli
use
hek
cell
line
express
human
cell
gene
cell
well
nfkappabinduc
report
quantifi
activ
found
exposur
nm
increas
report
activ
current
condit
time
point
exposur
morphin
morphin
enantiom
um
appear
activ
report
howev
higher
dose
still
need
test
addit
activ
tat
seem
specif
coapplic
antagonist
lpsr
significantli
decreas
tat
lpsek
agonist
induc
activ
similarli
signific
activ
tat
morphin
note
cell
final
use
elisa
note
exposur
tat
increas
product
cell
though
morphin
valid
model
confirm
presenc
absenc
muopioid
receptor
appropri
cell
line
use
qrtpcr
overal
current
result
suggest
overexpress
hek
cell
model
design
pure
test
activ
tat
morphin
activ
signal
pathway
support
nih
martha
schneider
christoph
ziegenhain
bianca
tigg
marku
helfer
ruth
brackwern
present
author
brack
helmholtzmuenchend
helmholtz
center
munich
institut
virolog
potenti
carrier
transcript
latent
provirus
immun
system
central
nervou
system
cn
includ
memori
tcell
astrocyt
possibl
also
neural
progenitor
cell
power
cell
cultur
model
exist
provir
latenc
tcell
reservoir
compar
model
lack
neural
cell
establish
cell
cultur
model
provir
transcript
latenc
neural
cell
subject
cell
human
neural
stem
cell
line
singleround
infect
variou
envdefect
genom
includ
report
virus
gfpencod
sequenc
infect
viral
express
monitor
quantit
pcr
analysi
provir
dna
viral
transcript
level
flow
cytometri
analysi
gfpexpress
longterm
cultur
led
establish
cell
popul
ceas
express
retain
provir
dna
express
reactiv
treatment
proinflammatori
cytokin
tnfalpha
saha
suberoylanilid
hydroxam
acid
potent
activ
latent
infect
tcell
induc
reactiv
express
maintain
numer
passag
differenti
cell
retain
singlecel
clone
sidebysid
assay
latent
infect
neural
tcell
jlat
reveal
reactiv
express
could
block
reservoir
cell
type
pretreat
variou
small
molecul
inhibit
activ
nfkappab
posit
transcript
elong
factor
ptefb
summari
report
establish
potent
cell
cultur
model
persist
latent
provirus
neural
cell
use
model
compar
modul
provir
latenc
brain
cell
tcell
result
rais
possibl
agent
influenc
provir
latenc
immun
system
may
also
affect
provir
latenc
cn
provid
proofofconcept
block
reactiv
provir
latenc
differ
reservoir
small
molecul
mohit
shruti
ann
edward
zafar
pooja
present
author
mohitsehg
drexeledu
institut
biotechnolog
virolog
research
depart
microbiolog
immunolog
drexel
univers
colleg
medicin
cell
vaccin
product
facil
univers
pennsylvania
oncolog
john
hopkin
school
medicin
transactiv
protein
human
tcell
leukemia
viru
type
tax
capabl
regul
viru
via
transcript
activ
viral
long
termin
repeat
ltr
host
transcript
machineri
howev
clear
understand
involv
host
transcript
factor
herein
describ
role
myocyt
enhanc
taxmedi
activ
ltr
infect
primari
cell
virusproduc
cell
line
confirm
chip
assay
recruit
ltr
primari
well
cell
associ
tax
furthermor
increas
express
observ
upon
infect
correl
tax
hat
complex
format
knockdown
shrna
inhibit
activ
overexpress
known
repressor
reduc
viral
mrna
protein
express
primari
cell
cell
line
confoc
microscopi
also
confirm
coloc
tax
viru
produc
cell
line
next
order
understand
regul
perform
compar
proteindna
array
analys
observ
global
upregul
mani
associ
transcript
factor
infect
cell
addit
studi
demonstr
express
key
signal
mediat
clearli
indic
signal
pathway
activ
infect
includ
nfkappab
mapk
tgfbeta
jakstat
signal
overal
studi
first
describ
involv
regul
novel
transcript
factor
cours
infect
pathogenesi
mohit
zafar
andrew
pooja
present
author
mohitsehg
drexeledu
institut
biotechnolog
virolog
research
depart
microbiolog
immunolog
drexel
univers
colleg
medicin
medicin
biomed
scienc
buffalo
univers
coinfect
repres
signific
burden
global
economi
public
health
hivinfect
patient
hivinfect
inject
drug
user
infect
hcv
wide
accept
hiv
acceler
cours
hcvrelat
chronic
liver
diseas
current
standard
treatment
treat
hcv
infect
coinfect
patient
administr
pegyl
interferon
antivir
drug
ribavirin
rbv
recent
breakthrough
directact
antivir
daa
telaprevir
boceprevir
hcv
genotyp
provid
hope
hcv
cure
howev
develop
viral
resist
daa
treatment
drugdrug
interact
among
proteas
inhibitor
two
key
concern
clinic
manag
infect
furthermor
telaprevir
boceprevir
yield
optim
result
upon
combin
ifn
andor
rbv
suggest
ifnrbv
still
backbon
antihcv
treatment
plasmacytoid
dendrit
cell
pdc
natur
produc
type
ifn
respons
mani
viral
infect
includ
howev
hcv
known
weak
induc
ifnalpha
pdc
known
scenario
chang
presenc
hiv
therefor
investig
qualiti
dc
respons
coinfect
patient
cours
ifnrbv
therapi
understand
molecular
basi
respons
analyz
differenti
express
mirna
target
mrna
sustain
virolog
respond
svr
nonrespond
nr
pre
posttreat
collect
result
studi
led
key
immun
molecular
correl
ifnrbv
treatment
coinfect
patient
satarupa
sen
kamel
shohreh
prasun
k
present
author
satarupasen
templeedu
biolog
cst
templ
univers
neurosci
center
neurovirolog
templ
univers
school
medicin
identif
cellular
protein
addit
alreadi
known
transcript
factor
nfkappab
cebp
interact
ltr
critic
understand
mechan
replic
monocytesmacrophag
studi
demonstr
upregul
pyruv
kinas
isoform
express
infect
pbmc
reactiv
chronic
infect
cell
furthermor
observ
infect
pbmc
reactiv
cell
result
increas
level
nuclear
henc
focus
understand
potenti
role
ltr
transactiv
studi
demonstr
express
tzmbl
cell
lead
transactiv
ltr
report
construct
use
variou
delet
construct
ltr
map
region
span
bp
bp
essenti
mediat
transactiv
region
contain
nfkappab
dna
bind
site
mutat
nfkappab
bind
site
attenu
mediat
transactiv
hivltr
chromatin
immuneprecipit
chip
analysi
pma
activ
tzmbl
cell
demonstr
interact
ltr
studi
suggest
transcript
coactiv
ltr
henc
open
anoth
possibl
target
curb
replic
transcript
level
work
support
nih
grant
sa
pkd
studi
also
util
servic
offer
core
facil
comprehens
neuroaid
center
cnac
nimh
grant
kk
satarupa
kamel
prasun
k
shohreh
present
author
satarupasen
templeedu
biolog
cst
templ
univers
neurosci
center
neurovirolog
templ
univers
school
medicin
virus
evolv
variou
strategi
protect
infect
cell
apoptosi
glycolysi
link
close
cell
fate
known
infect
macrophag
long
live
consid
viral
reservoir
provid
evid
protect
infect
macrophag
apoptosi
modul
host
glycolyt
pathway
glycolyt
enzym
hexokinas
hk
product
enzymat
activ
glucos
phosphat
known
play
nonmetabol
role
resist
support
apoptosi
respect
increas
associ
hk
voltag
depend
anion
channel
mitochondri
outer
membran
resist
apoptosi
maintain
mitochondri
membran
integr
hand
increas
pool
cytoplasm
forc
hk
dissoci
mitochondri
membran
induc
apoptosi
cytochrom
c
leakag
studi
analyz
regul
hk
convert
glucos
convert
fructos
phosphat
respons
activ
chronic
infect
cell
line
found
replic
cell
induc
hk
express
follow
transloc
hk
cytoplasm
mitochondria
cell
also
observ
viral
replic
increas
enzymat
activ
consequ
hk
associ
strongli
mitochondri
membran
associ
kept
tight
control
rapidli
turn
increas
activ
enzym
also
found
treatment
pentos
phosphat
pathway
blocker
dehydroepiandrosteron
dhea
also
inhibit
hk
vdac
interact
reduc
viral
replic
henc
work
suggest
hexokinas
new
therapeut
target
intervent
curtail
viral
persist
macrophag
work
support
nih
grant
sa
pkd
studi
also
util
servic
offer
core
facil
comprehens
neuroaid
center
cnac
nimh
grant
kk
sonia
shah
kevin
bloh
michael
nonnemach
vanessa
pirron
brian
wigdahl
present
author
gmailcom
depart
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
select
pressur
low
effici
revers
transcriptas
lead
genet
alter
within
human
immunodefici
viru
type
genom
result
quasispeci
differenti
regul
potenti
form
nich
within
specif
cell
type
tissu
previou
studi
identifi
singl
nucleotid
polymorph
snp
within
cebp
site
ctot
chang
posit
consensu
b
site
correl
dementia
addit
current
cohort
show
snp
within
sp
site
iii
ctot
chang
posit
consensu
b
site
occur
frequent
consensu
subtyp
b
sequenc
stabli
transfect
cell
line
develop
use
bone
marrow
progenitor
monocyt
cell
line
explor
promot
ltr
phenotyp
associ
genotyp
chang
integr
microenviron
lai
ltr
coupl
green
fluoresc
protein
gfp
polyclon
ltrgfp
stabl
cell
line
develop
examin
mechan
ltrdriven
gene
express
well
epigenet
modif
may
control
clone
deriv
popul
cell
clone
examin
respect
basal
transcript
cytokin
respons
tat
transactiv
result
suggest
nonexpress
clone
contain
ltr
within
cell
line
induc
express
addit
nonexpress
lai
lai
jurkat
clone
genotyp
could
induc
express
result
demonstr
genet
signatur
epigenet
modif
viral
host
dna
cellular
phenotyp
may
determin
overal
level
ltr
activ
work
support
nihnind
nida
nimh
nimh
seth
susan
igor
elys
howard
benjamin
b
dian
k
present
author
ssherman
emmescom
nntc
data
coordin
center
emm
corpor
rockvil
md
hiv
brain
bank
depart
neurolog
mount
sinai
medic
center
new
york
ny
neuroaid
tissu
network
univers
california
san
diego
la
jolla
ca
neurolog
aid
bank
depart
neurolog
univers
california
lo
angel
ca
pharmacolog
experiment
neurosci
univers
nebraska
medic
center
omaha
ne
neuroaid
research
center
depart
patholog
univers
texa
medic
branch
galveston
tx
data
coordin
center
emm
corpor
rockvil
md
background
nation
neuroaid
tissu
consortium
nntc
serv
research
commun
sinc
nihsponsor
multisit
repositori
distribut
antemortem
postmortem
tissu
clinic
serolog
data
hivinfect
individu
nntc
recent
evolv
tissu
bank
process
clinic
data
web
resourc
meet
chang
need
research
commun
serv
method
nntc
collect
distribut
cn
system
sampl
hiv
seroposit
seroneg
individu
tissu
provid
embed
fix
section
frozen
block
plasma
serum
pbmc
also
avail
tissu
andor
associ
data
avail
qualifi
investig
charg
beyond
ship
expens
new
web
resourc
avail
user
includ
public
use
data
set
documentationqueri
tool
download
utilityexperiment
result
previou
nntc
studiesbioinformat
resourc
univers
nebraska
tissu
bank
hold
fix
brain
specimen
hiv
seroposit
hiv
seroneg
hiv
seroposit
brain
antemortem
plasma
serum
csf
neurocognit
assess
prior
death
longitudin
cohort
enrol
seroposit
seroneg
case
hiv
seroposit
case
activ
deceas
autopsi
deceas
without
autopsi
inact
baselin
neurocognit
diagnosi
normal
mcmd
hiv
associ
dementia
nntc
impact
specimen
variou
tissu
type
distribut
scientif
contribut
result
nntc
resourc
signific
close
public
result
use
nntc
resourc
resourc
import
investig
secur
fund
research
applic
conclus
nntc
becom
invalu
resourc
expand
field
neuroaid
research
make
avail
uniqu
neurolog
focus
tissu
link
antemortem
clinic
data
websit
nntc
includ
user
inform
cohort
descript
wwwnntcorg
yuqiang
shi
subo
yuan
bei
li
benjamin
gelman
shaojun
tang
present
author
shtang
utmbedu
depart
neurosci
cell
biolog
univers
texa
medic
branch
galveston
tx
million
patient
develop
sever
chronic
pain
drastic
deterior
life
qualiti
pathogen
mechan
unclear
effect
therapi
avail
interest
elucid
host
mechan
cn
interact
hiv
toxin
contribut
devast
neurolog
complic
hiv
patient
undertak
interdisciplinari
approach
line
research
first
approach
focu
analyz
postmortem
nervou
tissu
patient
goal
identifi
clinic
relev
molecular
cellular
abnorm
painprocess
pathway
analys
reveal
critic
protein
may
caus
pain
syndrom
second
approach
interest
gener
rodent
model
chronic
pain
base
find
human
specimen
analysi
goal
establish
clinic
relev
anim
model
creat
mous
model
develop
extens
similar
patholog
seen
patient
chronic
pain
third
approach
focu
elucid
molecular
cellular
process
critic
pathogenesi
chronic
pain
use
mous
model
gener
character
current
determin
contribut
synapt
degener
glial
activ
wnt
signal
dysregul
pathogenesi
luzjeannett
denni
l
julio
present
author
drexeledu
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
neurolog
univers
pennsylvania
school
medicin
enter
cn
earli
system
infect
lead
varieti
neurocognit
motor
impair
refer
associ
neurocognit
disord
hand
macrophag
microglia
support
product
viral
infect
brain
viru
subsequ
adapt
cn
environ
goal
elucid
role
envelop
glycoprotein
env
infect
cn
obtain
virus
deriv
cerebrospin
fluid
csf
two
individu
dementia
sever
form
hand
isol
macrophag
tropic
ie
effici
infect
macrophag
wherea
bloodderiv
isol
highli
neurotox
amplifi
pcr
multipl
env
gene
isol
perform
extens
genotyp
phenotyp
character
interestingli
mixtur
genotyp
phenotyp
found
virus
obtain
mixtur
macrophagetrop
nonmacrophag
tropic
env
well
env
variou
degre
fusogen
abil
use
low
level
infect
sensit
entri
fusion
inhibitor
sensit
neutral
antibodi
direct
conserv
bind
site
importantli
env
context
isogen
recombin
virus
abl
mediat
infect
macrophag
lead
product
condit
medium
caus
neurotox
primari
pure
neuron
cultur
wherea
other
correl
genet
determin
report
phenotyp
investig
jiasheng
song
wonbin
young
present
author
upmcedu
molecular
imag
laboratori
depart
radiolog
univers
pittsburgh
school
medicin
infect
persist
spite
exposur
highli
activ
antiretrovir
therapi
haart
due
latent
stage
viru
latent
infect
cell
present
major
barrier
cure
infect
identif
viral
reservoir
essenti
monitor
therapeut
respons
haart
includ
latent
stage
biolumin
imag
bli
positron
emiss
tomographi
pet
magnet
reson
imag
mri
noninvas
imag
techniqu
employ
identifi
viral
reservoir
elimin
need
repeat
biopsi
vital
organ
brain
howev
latenc
stage
detect
viral
protein
target
imag
lab
develop
trojan
hors
type
strategi
engin
human
simian
felin
immunodefici
virus
hiv
siv
fiv
carri
report
gene
noninvas
imag
modal
includ
bli
pet
mri
engin
virus
remain
replic
compet
infect
target
cell
report
gene
express
report
engin
viru
either
without
promot
allow
detect
infect
cell
latenc
stage
long
termin
repeat
ltr
promot
inact
demonstr
imag
report
gene
incorpor
express
function
infect
cell
replic
kinet
engin
lentiviru
compar
wild
type
viru
current
work
toward
evalu
engin
virus
individu
speci
human
mice
hiv
macaqu
monkey
siv
felin
fiv
evalu
use
noninvas
imag
visual
spatial
tempor
natur
viral
reservoir
respons
haart
analyz
engin
virus
provid
abil
imag
viral
reservoir
provid
much
need
tool
monitor
evalu
therapeut
efficaci
virawudh
anya
sandra
megan
benchawanna
ben
andrea
david
eliez
ronald
scott
dilip
igor
cristian
present
author
cachim
ucsdedu
psychiatri
uc
san
diego
neurobehavior
research
program
uc
san
diego
medicin
uc
san
diego
colleg
osteopath
medicin
ohio
univers
neuroaid
tissu
network
uc
san
diego
burn
school
medicin
honolulu
hawaii
patholog
neurosci
uc
san
diego
neurosci
uc
san
diego
medicin
uc
san
diego
institut
research
age
uc
san
diego
benefit
highli
activ
antiretrovir
therapi
prevent
treat
hivassoci
neurocognit
disord
hand
especi
hivassoci
dementia
well
document
nonetheless
milder
form
hand
remain
preval
henc
suspect
associ
variou
comorbid
factor
includ
cumul
exposur
antiretrovir
arv
medic
propos
chronic
toxic
effect
arv
drug
cell
compon
blood
vessel
wall
contribut
brain
vascular
patholog
particularli
cerebr
small
vessel
diseas
csvd
includ
arteriosclerosi
arteriolosclerosi
even
earli
stage
decreas
cerebr
blood
flow
sever
enough
caus
infarct
white
matter
lesion
csvd
lead
disturb
cerebrovascular
autoregul
defici
function
hyperemia
use
multinomi
logist
regress
determin
associ
use
arv
drug
occurr
csvd
autopsi
hivinfect
case
california
neuroaid
tissu
network
use
univari
analysi
found
mild
csvd
vs
absent
associ
nucleosid
revers
transcriptas
inhibitor
nrti
proteas
inhibitor
pi
odd
ratio
respect
vascular
risk
factor
ie
older
age
year
diabet
mellitu
hypertens
hyperlipidemia
cigarett
smoke
lifetim
psychostimul
depend
hand
moderatesever
csvd
vs
absent
associ
older
age
diabet
respect
arvrel
predictor
find
suggest
use
nrti
pi
may
increas
risk
mild
csvd
consequ
neurocognit
impair
particular
interest
studi
molecular
mechan
arv
toxic
cell
compon
brain
vessel
wall
identifi
potenti
biomark
csvd
hivinfect
person
sergei
florin
john
steven
present
author
spitsin
emailchopedu
allergi
immunolog
children
hospit
philadelphia
research
institut
philadelphia
pa
allergi
immunolog
flow
cytometri
core
laboratori
children
hospit
philadelphia
research
institut
depart
pediatr
perelman
school
medicin
univers
pennsylvania
philadelphia
pa
allergi
immunolog
children
hospit
philadelphia
research
institut
depart
pediatr
perelman
school
medicin
univers
pennsylvania
philadelphia
pa
receptor
haptoglobinhemoglobin
complex
express
cell
monocytesmacrophag
origin
membranebound
molecul
cleav
proteas
releas
biolog
fluid
stabl
solubl
form
plasma
level
elev
hiv
infect
individu
howev
direct
involv
membranebound
solubl
hiv
pathogenesi
unknown
studi
demonstr
rel
high
concentr
sp
microm
trigger
intracellular
calcium
increas
monocyt
like
due
activ
truncat
isoform
neurokinin
receptor
sp
also
enhanc
express
monocyt
dose
timedepend
manner
albeit
lower
extent
cytokin
well
known
induc
altern
pathway
monocyt
differenti
spinduc
express
membranebound
accompani
increas
shed
human
monocytederiv
macrophag
mdm
effect
inhibit
antagonist
aprepit
decreas
express
membranebound
mdm
use
sirna
result
signific
decreas
hiv
infect
order
demonstr
level
express
membranebound
import
hiv
infect
use
cell
sort
separ
human
monocyt
express
high
low
level
product
hiv
infect
higher
cell
express
high
level
vs
cell
express
low
level
studi
indic
high
level
membranebound
facilit
hiv
infect
macrophag
work
support
nation
institut
health
grant
sdd
mariann
vanessa
wei
rui
brian
michael
present
author
michaelnonnemach
drexelmededu
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
biostatist
epidemiolog
center
clinic
epidemiolog
biostatist
univers
pennsylvania
school
medicin
opioid
abus
human
immunodefici
viru
type
infect
individu
lead
rapid
diseas
progress
increas
viral
replic
peripher
viral
load
increas
incid
sever
neurocognit
abnorm
compar
nondrug
abus
bloodbrain
barrier
bbb
obstacl
must
overcom
neuroinvas
subsequ
develop
hivassoci
neurocognit
disord
hand
previou
studi
address
role
muopioid
alter
bbb
permeabl
suggest
exposur
increas
cellular
transmigr
uncharacter
mechan
studi
human
brain
microvascular
endotheli
cell
hbmec
line
use
establish
vitro
transwel
model
bbb
investig
effect
chronic
h
morphin
treatment
barrier
structur
function
observ
cell
form
confluent
monolay
basal
rate
passag
kda
tracer
molecul
compar
primari
hbmec
also
shown
cell
express
mu
opioid
receptor
prolong
morphin
treatment
induc
chang
mrna
level
cellular
adhes
molecul
function
increas
pbmc
transmigr
firm
adhes
observ
follow
prolong
morphin
exposur
absenc
increas
overal
barrier
leaki
result
suggest
morphin
activ
cell
lead
cellular
environ
permiss
transmigr
studi
may
uncov
mechan
morphin
disrupt
peripherycn
homeostasi
lead
acceler
hand
work
support
nihnind
nida
nimh
nimh
gokul
swaminathan
renzo
peraleslinar
sonia
navasmartin
julio
martingarcia
present
author
drexeledu
drexel
univers
colleg
medicin
viral
particl
caus
agent
aid
contain
two
copi
ssrna
genom
tolllik
receptor
tlr
endosom
tlr
report
sens
rna
sequenc
endosom
primarili
sens
dsrna
common
viral
replic
intermedi
absent
retrovir
replic
howev
sinc
ssrna
contain
multipl
hairpinlik
secondari
structur
could
potenti
mimic
dsrna
entiti
hypothes
could
sens
respond
infect
differ
suscept
infect
virion
pseudotyp
murin
leukemia
viru
envelop
glycoprotein
vesicular
stomat
viru
glycoprotein
vsvg
observ
bone
marrowderiv
macrophag
isol
wildtyp
knockout
mice
howev
product
proinflammatori
cytokin
chemokin
includ
typei
ifn
significantli
reduc
bmdm
mice
similarli
presenc
inhibitor
bal
pseudotyp
infect
human
monocytederiv
macrophag
macrophag
result
significantli
reduc
product
proinflammatori
cytokin
chemokin
phosphoryl
transcript
factor
essenti
step
depend
upregul
typei
ifn
bal
infect
upregul
post
infect
howev
inhibit
significantli
reduc
induc
level
surprisingli
bal
infect
human
macrophag
result
signific
upregul
mrna
level
moder
increas
protein
level
final
infect
cell
stabli
express
murin
vsvg
pseudotyp
virion
result
signific
induct
tnfalpha
current
futur
experi
aim
investig
potenti
direct
interact
ssrna
overal
studi
provid
first
known
evid
sens
respond
infect
macrophag
sinc
crucial
innat
immun
sensor
brain
result
import
implic
neuropathogenesi
inflamm
comorbid
c
conov
talbot
jr
david
mohr
jasmeet
sethi
haip
hao
amanda
brown
present
author
jhmiedu
john
hopkin
univers
school
medicin
recent
studi
show
proinflammatori
cytokin
includ
osteopontin
opn
remain
elev
plasma
cerebrospin
fluid
csf
individu
suffer
hivassoci
neurocognit
disord
hand
beyond
abil
enhanc
hiv
replic
opn
promot
increas
number
activ
monocyt
cn
facilit
chemotaxi
cell
surviv
howev
molecular
mechan
opn
mediat
function
context
hand
remain
unexplor
use
nextgener
highthroughput
sequenc
transcriptom
analys
identifi
gene
pathway
differenti
regul
primari
human
macrophag
knock
sirna
kod
compar
wildtyp
macrophag
predict
disrupt
express
opn
receptor
integrin
itgav
signal
nfkappab
markedli
downregul
chemokin
downregul
fold
tnfrespons
gene
includ
tank
tifab
tifab
tolllik
receptor
differenti
express
kod
macrophag
key
gene
involv
cytokin
signal
includ
nfkbiz
nfkbid
either
modul
opn
kod
mac
promin
featur
kod
mac
differenti
regul
member
mitogenactiv
protein
kinas
cascad
interestingli
sever
member
host
restrict
factor
target
hiv
includ
trim
apobec
protein
downregul
kod
macrophag
unexpectedli
biomark
strongli
associ
hand
significantli
decreas
kod
mac
suggest
link
proinflammatori
gene
regul
opn
express
sever
host
gene
implic
hiv
life
cycl
also
differenti
regul
togeth
data
suggest
opn
potent
regul
proinflammatori
gene
express
impact
macrophag
activ
host
cell
resist
suscept
hiv
infect
replic
chen
sabrina
thoma
sarah
raphael
evelyn
jacalyn
michael
david
igor
present
author
ctan
bidmcharvardedu
virolog
vaccin
research
divis
infecti
diseas
depart
medicin
divis
neurovirolog
depart
neurolog
beth
israel
deaco
medic
center
harvard
medic
school
virolog
vaccin
research
depart
medicin
divis
neurovirolog
depart
neurolog
beth
israel
deaco
medic
center
harvard
medic
school
hopkin
medic
center
hematolog
oncolog
depart
medicin
beth
israel
deaco
medic
center
harvard
medic
school
infecti
diseas
depart
medicin
beth
israel
deaco
medic
center
harvard
medic
school
background
jcv
caus
progress
multifoc
leukoencephalopathi
pml
immunocompromis
patient
gener
popul
seroposit
jcv
jcvspecif
cellular
immun
respons
necessari
contain
viral
prolifer
mechan
jcv
reactiv
immun
transplant
immun
system
remain
unclear
method
prospect
enrol
patient
undergo
allogen
hsct
collect
blood
urin
sampl
month
hsct
detect
jcv
dna
pcr
blood
urin
sampl
perform
elisa
detect
jcv
igm
igg
well
elispot
ic
measur
tcell
respons
jcv
multivari
analysi
account
condit
regimen
cancer
diagnosi
concurr
viremia
age
transplant
type
result
pre
hsct
jcv
dna
detect
urin
pbmc
plasma
sampl
viruria
remain
stabl
hsct
viremia
detect
plasma
none
pbmc
sampl
month
hsct
preval
antijcv
igg
pre
hsct
remain
stabl
month
antijcv
igm
rare
detect
signific
increas
jcvspecif
cell
respons
month
hsct
mediat
tcell
jc
viruria
correl
directli
detect
antijcv
igg
cellular
immun
respons
jcv
measur
elispot
invers
correl
antijcv
igg
respons
age
patient
diagnosi
leukemia
significantli
reduc
cellular
immun
respons
jcv
conclus
jc
viruria
trigger
antibodi
respons
hsct
howev
increas
jcvspecif
cellular
immun
respons
month
hsct
lead
suppress
jc
viremia
decreas
jcv
humor
immun
respons
prospect
studi
hsct
patient
provid
model
interact
host
immun
respons
viral
activ
multipl
compart
time
katherin
taylor
tyson
wood
clayton
winkler
karin
peterson
present
author
katherinetaylor
nihgov
nih
rocki
mountain
laboratori
lpvd
neuroimmunolog
uniti
mosquitoborn
la
cross
viru
lacv
infect
lead
caus
infecti
enceph
children
adult
gener
resist
neuroinvas
diseas
agedepend
suscept
lacv
also
observ
mous
model
mice
younger
day
suscept
neurolog
diseas
mice
older
day
resist
current
studi
demonstr
resist
adult
anim
depend
type
ifn
respons
gener
rigi
like
receptor
rlr
signal
pathway
pathway
essenti
peripher
viru
control
prevent
spread
cn
particular
rigi
receptor
signal
myeloid
dendrit
cell
popul
implic
viru
control
young
mice
significantli
lower
number
myeloid
dendrit
cell
gener
weaker
type
ifn
respons
peripher
tissu
follow
either
lacv
infect
direct
stimul
ligand
compar
older
mice
inabl
young
mice
gener
strong
peripher
type
ifn
respons
myeloid
dendrit
cell
follow
stimul
may
explain
increas
suscept
viral
infect
spread
enceph
katherin
taylor
tyson
wood
karin
peterson
present
author
petersonka
niaidnihgov
laboratori
persist
viral
diseas
rocki
mountain
laboratori
niaid
nih
neuron
cell
death
hallmark
variou
neurolog
diseas
includ
viru
infect
innat
immun
respons
cn
contribut
neuron
damag
cytokin
neurotoxin
product
well
recruit
inflammatori
cell
howev
direct
role
innat
immun
respons
mediat
cell
death
viru
infect
neuron
known
current
studi
identifi
steril
alpha
heatarmadillo
motif
contain
neg
regul
tlr
signal
mediat
bunyavirusinduc
neuron
apoptosi
induc
neuron
follow
la
cross
viru
lacv
infect
inhibit
suppress
virusmedi
neuron
apoptosi
mechanist
studi
demonstr
upregul
due
stimul
mav
sarm
interact
mav
mitochondria
induc
oxid
damag
lead
neuron
apoptosi
data
provid
novel
mechan
immun
mediat
neuron
death
viru
infect
activ
patternrecognit
receptor
prr
lead
mav
activ
induct
oxid
stress
sinc
stimul
neuron
endosom
tlr
inhibit
neuron
growth
induc
apoptosi
also
analyz
role
sarm
tlrmediat
neuron
death
induc
agonist
stimul
cortic
neuron
tlrinduc
neuron
apoptosi
depend
data
indic
activ
patternrecognit
receptor
neuron
presenc
absenc
activ
viru
infect
lead
neuron
death
mechan
death
product
sarm
lead
mitochondri
damag
ravi
ann
ceereena
ubaida
david
brigitt
christin
david
present
author
jhmiedu
molecular
compar
pathobiolog
technolog
sciex
purpos
hivassoci
neurocognit
disord
hand
complic
hiv
hivinfect
individu
suffer
vari
degre
neurocognit
impair
hand
occur
treat
untreat
hiv
patient
make
larg
public
health
problem
etiolog
hand
gener
thought
least
partli
neuroinflammatori
infect
cell
peripheri
cn
caus
immun
activ
lead
synaptodendrit
damag
neuron
apoptosi
recent
sever
lab
includ
found
peripher
inflamm
correl
progress
neurocognit
diseas
rais
possibl
peripher
inflammatori
mediat
may
promot
neuroinflamm
cross
cn
sinc
protein
express
lipid
synthesi
small
molecul
metabol
may
involv
inflammatori
cascad
studi
determin
level
three
speci
spleen
method
studi
pigtail
macaqu
dual
inocul
neurovirul
molecular
clone
immunosuppress
viral
swarm
shown
pigtail
macaqu
develop
aid
enceph
within
day
macaqu
sacrif
day
postinfect
spleen
tissu
harvest
extract
protein
lipid
metabolit
speci
protein
lipid
metabolit
speci
profil
mass
spectrometri
result
lipidom
profil
msmsall
method
found
chang
triacylglycerid
metabolom
profil
highflow
lcm
align
target
msm
found
chang
nucleotid
guanosin
inosin
small
lipid
adip
acid
small
molecul
diethyl
oxalopropion
jewel
thoma
matthew
brier
beau
anc
present
author
ancesb
neurowustledu
depart
neurolog
washington
univers
st
loui
background
question
whether
hiv
individu
experi
agingrel
deficit
earlier
healthi
individu
simpli
experi
increas
ageassoci
deficit
across
agerang
unresolv
present
graph
theori
model
brain
function
connect
fc
add
import
evid
hiv
may
lead
advanc
brainag
phenotyp
method
bold
restingst
fc
scan
collect
hiv
hiv
particip
siemen
scanner
group
similar
demograph
though
hiv
group
higher
viral
load
lower
white
blood
cell
count
fc
timeseri
sampl
roi
subject
graph
construct
crosscorrel
matric
cluster
coeffici
measur
local
effici
path
length
measur
global
effici
modular
measur
subnetwork
structur
comput
across
rang
correl
threshold
subject
order
assess
stabil
group
differ
effect
hiv
linear
quadrat
effect
age
well
age
hiv
interact
graph
theori
topolog
assess
use
ancova
result
higher
cluster
coeffici
lower
path
length
observ
hiv
p
fdr
modular
decreas
suggest
graph
structur
chang
may
explain
chang
effici
measur
modular
began
declin
earlier
hiv
individu
hiv
individu
declin
quadrat
effect
age
p
immun
system
strength
modul
modular
chang
hiv
p
conclus
investig
graph
structur
particularli
modular
show
first
fmri
evid
agerel
chang
may
occur
earlier
hiv
individu
importantli
show
modular
decreas
explain
strength
immun
system
respons
stronger
immun
activ
led
greater
decreas
immun
activ
may
import
underli
caus
brain
deficit
hiv
age
result
suggest
hiv
age
may
impair
brain
function
immun
system
mechan
michal
toborek
ibolya
e
andra
present
author
mtoborek
medmiamiedu
depart
biochemistri
molecular
biolog
univers
miami
school
medicin
due
success
combin
antiretrovir
therapi
cart
chang
clinic
pictur
hiv
infect
acut
chronic
disord
sharp
increas
infect
patient
year
old
older
increas
age
hiv
infect
popul
constitut
new
challeng
hiv
epidem
affluent
countri
importantli
older
hiv
infect
patient
suscept
neurocognit
impair
associ
diseas
hiv
infect
brain
character
increas
deposit
amyloid
beta
abeta
perivascular
space
indic
import
brain
microvessel
amyloid
accumul
research
focus
mechan
interact
abeta
bloodbrain
barrier
level
exposur
hiv
result
accumul
abeta
brain
endotheli
cell
promin
nuclear
predisposit
demonstr
effect
depend
function
caveola
prevent
inhibit
ra
receptor
advanc
glycat
end
product
rage
additon
hivinduc
nuclear
entri
abeta
involv
activ
dynamindepend
tgfbetasmad
signal
use
transgen
mice
express
chimer
mousehuman
amyloid
precursor
protein
mutant
human
presenilin
next
demonstr
cerebrovascular
toxic
hiv
specif
protein
tat
enhanc
mice
amyloid
deposit
brain
inde
exposur
tat
increas
permeabl
across
cerebr
capillari
enhanc
disrupt
tight
junction
protein
elev
brain
express
transgen
mice
compar
agematch
litterm
control
chang
associ
increas
leukocyt
attach
transcapillari
migrat
support
lui
b
nino
veera
venkata
ratnam
bezawit
dionna
marlen
david
mihyun
david
daniel
joan
w
norman
j
present
author
llbtyr
gmailcom
neurolog
divis
neuroimmunolog
john
hopkin
univers
school
medicin
baltimor
md
usa
patholog
albert
einstein
colleg
medicin
bronx
ny
usa
molecular
compar
pathobiolog
john
hopkin
univers
school
medicin
baltimor
md
usa
pharmacolog
univers
oxford
oxford
uk
mechan
brain
inflamm
drive
system
immun
respons
current
unknown
studi
provid
evid
neuroimmun
axi
involv
microvesicl
releas
brain
enter
peripher
circul
tnfalpha
atp
evok
rapid
robust
efflux
microvesicl
astrocyt
stimul
releas
microvesicl
astrocyt
involv
stabil
ceramiderich
membran
cap
primarili
locat
filopodia
microvesicl
releas
block
inhibit
receptor
bind
inhibit
microvesicl
nm
size
contain
complex
lipid
protein
content
consist
exosom
use
vitro
bbbmodel
prepar
bmuec
gfapgfp
express
astrocyt
determin
microvesicl
carri
gfp
cargo
readili
cross
endotheli
cell
intact
tight
junction
electron
microscopi
demonstr
small
fraction
exosom
endocytos
endotheli
cell
caveola
major
appear
readili
cross
intact
particl
possibl
involv
local
phase
transit
membran
next
determin
releas
exosom
injur
brain
regul
leukocyt
traffick
intrastriat
inject
induc
rapid
focal
gener
ceramid
transmigr
neutrophil
lesion
site
within
genet
mutat
simultan
inject
antagonist
altenusin
block
induc
ceramid
block
neutrophil
influx
purifi
exosom
isol
plasma
follow
intrastriat
inject
exosom
isol
mice
receiv
intrastriat
inject
salin
reactiv
neutrophil
influx
infus
tail
vein
acceptor
mice
receiv
intrastriat
inject
altenusin
data
demonstr
microvesicl
releas
astrocyt
readili
cross
bbb
regul
peripher
immun
respons
cn
inflamm
vicki
jennif
anna
mari
stephani
xavier
cecili
lara
brent
eileen
ravi
present
author
ravimahalingam
ucdenveredu
microbiolog
tulan
univers
tulan
nation
primat
research
center
neurolog
univers
colorado
school
medicin
compar
patholog
tulan
univers
tulan
nation
primat
research
center
medicin
tulan
univers
tulan
nation
primat
research
center
allergi
clinic
immunolog
depart
allergi
asthma
clinic
immunolog
univers
colorado
school
medicin
clinic
patholog
immunolog
virolog
featur
simian
varicella
viru
svv
infect
primat
parallel
human
varicella
zoster
viru
vzv
infect
primari
svv
infect
primat
caus
varicella
viru
becom
latent
ganglion
neuron
reactiv
earlier
demonstr
experiment
reactiv
svv
xirradi
treatment
tacrolimu
prednison
latent
infect
monkey
herein
rhesu
macaqu
inocul
intrabronchi
pfu
svv
svvegfp
svv
express
green
fluoresc
protein
month
later
establish
latenc
monkey
transport
irradi
facil
expos
singl
dose
cgi
xirradi
treat
tacrolimu
ugkgday
prednison
mgkgday
durat
experi
one
monkey
immunosuppress
subject
stress
transport
zoster
rash
develop
week
immunosuppress
monkey
euthan
hr
later
multipl
tissu
skin
lung
ganglia
lymph
node
harvest
monkey
immunohistochemistri
reveal
svv
antigen
tissu
immunofluoresc
confoc
analysi
multipl
lymph
node
correspond
area
rash
show
coloc
svv
protein
macrophag
dendrit
cell
lymph
node
svvseroneg
monkey
detect
svv
protein
confirm
western
blot
lymph
node
one
monkey
qpcr
detect
svv
dna
lymph
node
anoth
monkey
find
suggest
svv
antigen
may
transport
drain
lymph
node
macrophag
dendrit
cell
present
activ
cell
direct
svv
richa
tyagi
wenxu
li
danelvi
parad
avindra
nath
present
author
tyagiricha
nihgov
section
infect
nervou
system
nation
institut
neurolog
diseas
stroke
nation
institut
health
amyotroph
later
sclerosi
al
fatal
neurodegen
diseas
character
progress
loss
motor
neuron
pathogenesi
unclear
although
sever
mechan
suggest
previous
studi
show
human
endogen
retroviru
type
k
hervk
activ
brain
al
patient
indic
hervk
may
involv
pathogenesi
al
herv
genom
sequenc
retrovir
origin
believ
integr
germlin
chromosom
million
year
ago
although
mostli
defect
inact
herv
may
activ
certain
physiolog
patholog
condit
drug
design
specif
target
herv
panel
fda
approv
hiv
antiretrovir
drug
hypothes
hiv
antiretrovir
drug
may
also
effect
inhibit
infect
replic
herv
may
use
treatment
hervk
activ
al
construct
plasmid
consensu
hervk
sequenc
produc
hervk
viru
test
effect
antiretrovir
drug
hervk
replic
first
determin
effect
nucleosid
nonnucleotid
revers
transcriptas
inhibitor
hervk
product
enhanc
revers
transcript
assay
pert
found
abacavir
zidovudin
could
significantli
inhibit
hervk
revers
transcriptas
activ
similar
effect
dosag
determin
effect
abacavir
integras
inhibitor
raltegravir
hervk
viral
replic
pseudotyp
hervk
vsvg
use
pseudotyp
hervk
viru
infect
hela
cell
replic
hervk
measur
quantit
real
time
polymeras
chain
reaction
qrtpcr
found
abacavir
raltegravir
block
replic
hervk
low
concentr
summari
identifi
sever
fda
approv
antiretrovir
drug
effect
inhibit
hervk
viru
antiretrovir
may
open
new
prospect
treatment
hervk
activ
al
neuropsychiatr
diseas
elena
caterina
giusepp
ilker
k
kamel
antonina
present
author
doleivir
unissit
biomed
scienc
univers
sassari
neurosci
templ
univers
philadelphia
neurosci
templ
univers
philadelphia
reactiv
jcv
polyomaviru
fulli
explain
mechan
caus
progress
multifoc
leukoencephalopathi
patient
sever
immunosuppress
treat
immunosuppress
antibodi
diseas
upregul
endogen
retrovirus
report
hervw
potenti
neuropathogen
gliotox
superantigen
fusogen
immunodisregolatori
etc
wonder
jcvhervw
interact
could
contribut
neurodegener
end
human
primari
fetal
astrocyt
svg
cell
line
either
infect
strain
transfect
express
plasmid
carri
earli
late
jcv
gene
monitor
express
env
construct
carri
promot
data
show
jcv
infect
upregul
msrvlike
syncytin
env
transcript
transient
transfect
experi
show
jcvearli
late
protein
stimul
transcript
express
env
gene
glycosyl
form
data
obtain
rtreal
time
pcr
western
blot
analysi
hervw
promot
activ
presenc
jcv
protein
gene
report
experi
construct
carri
fulllength
promot
promot
delet
mutant
cotransfect
jcv
earli
late
plasmid
carri
data
indic
fulllength
promot
upregul
jcv
earli
late
protein
delet
upstream
cellular
regulatori
region
indic
stimulatori
effect
lie
ltr
viral
moieti
due
ident
ltr
msrv
like
upregul
jcv
antigen
msrv
requir
mainli
promot
viral
moieti
given
neuropathogen
properti
hervwenv
protein
wonder
whether
upregul
jcv
astrocyt
could
contribut
neurodegener
novel
interact
among
jcv
hervw
may
open
new
avenu
understand
neurodegen
diseas
victor
valcour
edgar
busovaca
lauren
wendelken
pardi
esmaeili
katherin
p
rankin
iryna
lobach
howard
rosen
present
author
vvalcour
memoryucsfedu
memori
age
center
neurolog
depart
univers
california
san
francisco
brain
white
matter
hyperintens
wmh
magnet
reson
imag
mri
known
occur
hiv
typic
late
diseas
link
dementia
wmh
also
occur
cerebrovascular
diseas
cvd
absenc
hiv
sinc
cvd
risk
increas
age
patient
live
hiv
age
underli
mechan
clinic
import
wmh
becom
less
clear
use
custom
wmh
quantif
pipelin
measur
lesion
volum
number
lesion
count
lobar
distribut
wmh
hiv
compar
age
gender
match
healthi
hivneg
control
hiv
subject
age
year
median
rang
median
rang
count
durat
hiv
year
eightyeight
percent
suppress
plasma
hiv
rna
copi
wmh
volum
tightli
link
wmh
count
spearman
hiv
hivneg
respect
p
highest
wmh
volum
adjust
intracrani
volum
icv
seen
hiv
subject
wilcoxon
test
median
hiv
subject
higher
wmh
volum
correl
poorer
perform
execut
function
test
spearman
wmh
volum
correl
count
nadir
count
durat
hiv
plasma
hiv
rna
hiv
group
subject
smoke
hypertens
higher
burden
wmh
volum
wilcoxon
test
median
respect
smoke
hiv
statu
interact
effect
wmh
volum
adjust
age
similarli
hypertens
hiv
statu
tend
interact
effect
conclud
wmh
older
hiv
subject
close
relat
cvd
rather
hiv
risk
paramet
hiv
appear
modul
effect
lesion
link
cognit
perform
lifestyl
factor
remain
import
target
improv
cognit
morbid
mike
dionna
w
kathryn
joan
w
present
author
mikeveenstra
phdeinsteinyuedu
patholog
albert
einstein
colleg
medicin
medicin
epidemiolog
popul
health
albert
einstein
colleg
medicin
patholog
microbiolog
immunolog
albert
einstein
colleg
medicin
bronx
ny
hiv
enter
cn
infect
monocyt
within
two
week
peripher
infect
within
cn
cell
mediat
inflammatori
environ
lead
hiv
associ
neurocognit
disord
infect
individu
despit
success
antiretrovir
therapi
increas
amount
present
cn
individu
neurocognit
disord
increas
transmigr
hivinfect
monocyt
across
bloodbrainbarri
bbb
effect
transmigr
cell
larg
unknown
engag
hiv
coreceptor
find
also
interact
contribut
differ
understand
mediat
process
character
direct
transmigr
monocyt
across
bbb
studi
process
vitro
bbb
model
examin
matur
monocyt
enrich
popul
cultur
demonstr
cultur
monocyt
transmigr
preferenti
across
bbb
effect
moreov
express
cultur
monocyt
similar
monocyt
hivposit
individu
valid
cultur
model
monocyt
hivposit
individu
express
compar
amount
express
specif
increas
monocyt
popul
monocyt
transmigr
across
bbb
low
concentr
also
potent
cell
chemoattract
yet
cell
requir
higher
concentr
bbb
transmigr
surfac
monocyt
decreas
transmigr
greatli
increas
cell
suggest
may
specif
mediat
monocyt
transmigr
across
bbb
propos
signific
respons
monocyt
transmigr
across
bbb
like
mediat
least
part
implic
hiv
neuropathogenesi
therapeut
stephani
juan
juan
c
eliseo
eugenin
present
author
stphvelasquez
gmailcom
health
research
institut
depart
microbiolog
molecular
genet
rutger
univers
de
neurologia
facultad
de
medicina
pontificia
universidad
catolica
de
chile
de
fisiologia
pontificia
universidad
catolica
de
chile
last
year
role
pannexin
hemichannel
play
immun
cell
receiv
extens
attent
previou
work
show
hiv
infect
induc
biphas
open
channel
earli
open
min
late
open
h
hiv
exposur
data
indic
open
hemichannel
essenti
viral
entri
replic
howev
function
physiolog
condit
unknown
thu
propos
activ
specif
chemokin
receptor
result
physiolog
open
hemichannel
lymphocyt
determin
treatment
lymphocyt
key
chemokin
lymphocyt
migrat
hiv
infect
induc
transient
open
compar
hiv
hemichannel
block
block
lymphocyt
migrat
induc
suggest
open
essenti
lymphocyt
migrat
mechan
involv
local
releas
atp
alter
migrat
occur
hiv
infect
cell
also
pn
cn
diseas
multipl
sclerosi
ms
use
ko
mous
model
eae
anim
model
ms
demonstr
hemichannel
essenti
migrat
immun
cell
cn
pn
conclus
find
demonstr
hemichannel
play
essenti
role
hiv
infect
leukocyt
migrat
cn
open
potenti
new
therapeut
target
block
pathogenesi
neuroaid
ms
jussi
oskari
jeffrey
emili
naomi
yoshimi
steve
present
author
virtanenjo
nindsnihgov
nimhclin
proteom
viral
infect
associ
autoimmun
diseas
multipl
sclerosi
ms
exact
mechan
viral
infect
could
induc
autoimmun
poorli
character
although
molecular
mimicri
suggest
mechan
convinc
viral
autoantigen
target
identifi
ms
anoth
possibl
viral
infect
could
induc
andor
modifi
cellular
protein
recogn
immun
system
human
herpesviru
antigen
nucleic
acid
found
ms
brain
lesion
suggest
might
particip
lesion
develop
identifi
possibl
intrathec
humor
immun
respons
target
human
infect
cell
use
immunoprecipit
base
mass
spectrometri
analysi
identifi
possibl
cellular
target
present
infect
cell
furthermor
identifi
ms
brain
endogen
igg
protein
target
use
similar
approach
cerebrospin
fluid
csf
igg
pull
uniqu
protein
infect
cell
came
serum
noninfect
cell
three
protein
identifi
ms
brain
lesion
associ
endogen
igg
target
well
process
valid
result
immunoassay
result
suggest
infect
induc
cellular
protein
recogn
ms
csf
igg
thu
might
provid
target
autoimmun
ms
jussi
oskari
virtanen
yoshimi
enoseakahata
raya
massoud
steven
jacobson
present
author
virtanenjo
nindsnihgov
nihnindsneuroimmunolog
human
tlymphotrop
retroviru
caus
agent
central
nervou
system
diseas
associ
myelopathytrop
spastic
paraparesi
hamtsp
like
patient
multipl
sclerosi
ms
relat
diseas
central
nervou
system
hamtsp
patient
increas
igg
index
oligoclon
band
ocb
marker
intrathec
antibodi
product
studi
investig
specif
cerebrospin
fluid
csf
serum
antibodi
antigen
luciferas
immunoprecipit
system
lip
assay
specif
oligoclon
band
antigen
hamtsp
patient
gag
env
tax
antibodi
csf
one
ocb
specif
least
one
antigen
studi
gag
envspecif
ocb
found
often
taxspecif
ocb
ham
data
show
hamtsp
antibodi
produc
intrathec
ocb
specif
antigen
detect
intrathec
antibodi
product
lip
antigen
specif
ocb
isoelectr
focus
immunoblot
might
provid
tool
differenti
hamtsp
patient
seroposit
ms
case
might
suggest
involv
humor
immun
respons
pathogenesi
hamtsp
christian
bogdan
fgh
sarah
michael
ronald
stephen
pojen
mylyn
elizabeth
joseph
e
xin
claudia
f
igor
j
present
author
chriswuthrich
hmsharvardedu
neurovirolog
depart
neurolog
center
virolog
vaccin
research
depart
medicin
beth
israel
deaco
medic
center
harvard
medic
school
anatomi
cell
biolog
cameco
ms
neurosci
research
center
univers
saskatchewan
saint
joseph
medic
center
hyci
howard
hill
neurosci
institut
movement
disord
center
south
buena
vista
street
burbank
ca
geffen
school
medicin
univers
california
lo
angel
le
cont
ave
lo
angel
ca
depart
medicin
northridg
hospit
medic
center
rosco
blvd
northridg
ca
tzu
chi
medic
center
south
garfield
avenu
alhambra
ca
patholog
laboratori
medicin
mayo
clinic
first
street
sw
rochest
minnesota
neurolog
mayo
clinic
first
street
sw
rochest
minnesota
background
natalizumab
monoclon
antibodi
direct
integrin
date
associ
case
progress
multifoc
leukoencephalopathi
pml
worldwid
patient
receiv
treatment
multipl
sclerosi
ms
due
limit
number
histolog
studi
interplay
ms
pml
lesion
investig
object
report
clinic
radiolog
histolog
find
ms
patient
develop
pml
month
natalizumab
monotherapi
follow
withdraw
natalizumab
receiv
plasma
exchang
mefloquin
mirtazapin
pass
away
soon
thereaft
post
mortem
studi
restrict
examin
brain
spinal
cord
result
extens
pml
lesion
character
presenc
jcv
dna
found
cerebr
white
matter
neocortex
sharpli
demarc
area
activ
pml
lesion
contain
promin
inflammatori
infiltr
compos
approxim
equal
number
cell
consist
immun
reconstitut
inflammatori
syndrom
iri
convers
ms
lesion
identifi
hypocellular
longstand
inact
plaqu
character
myelin
loss
rel
axon
preserv
gliosi
importantli
devoid
jcvdna
activ
inflamm
conclus
case
demonstr
coexist
chronic
inact
ms
pml
lesion
harbor
activ
jcv
infectionchron
inact
ms
lesion
separ
distinct
nearbi
pml
lesion
furthermor
iri
greatli
affect
shape
appear
pml
lesion
involv
ms
lesion
whether
pml
may
alter
natur
activ
ms
lesion
remain
determin
john
walsh
stacey
reink
ferdinand
maingat
william
branton
david
broadhurst
christoph
power
present
author
chrispow
ualbertaca
depart
medicin
univers
alberta
human
immunodefici
viru
type
infect
caus
activ
innat
immun
pathway
brain
often
ensu
neurovirul
evid
neuron
injuri
death
accompani
neurobehavior
disord
specif
innat
immun
gene
drive
earli
inflammatori
respons
remain
uncertain
brain
cell
activ
inflammasom
myeloid
cell
subsequ
cleavag
releas
interleukin
il
repres
import
pathogen
compon
underli
multipl
inflammatori
disord
investig
inflammasom
express
function
human
brain
infect
inflammasomeassoci
gene
examin
show
induc
brain
hivinfect
person
larg
detect
activ
brain
myeloid
cell
cultur
human
microglia
constitut
express
inflammasomeassoci
gene
includ
asc
unlik
human
astrocyt
neuron
induc
human
microglia
hr
postinfect
appear
cleav
form
peak
releas
prevent
caspas
inhibitor
yvadfmk
exposur
microglia
solubl
mediat
induct
subsequ
releas
microglia
hivdepend
releas
human
myeloid
cell
line
also
inhibit
defici
high
extracellular
k
vivo
infect
felin
immunodefici
viru
fiv
caus
induct
multipl
inflammasomeassoci
gene
microglia
accompani
neuron
loss
neurobehavior
impair
multivari
analys
fivinfect
uninfect
anim
disclos
repres
key
molecular
determin
develop
neurovirul
thu
inflammasom
activ
earli
integr
aspect
hivaid
neuropathogenesi
might
repres
potenti
target
therapeut
intervent
susan
l
dillon
joshua
yize
ling
ruth
robert
present
author
weisssr
upennedu
microbiolog
perelman
school
medicin
univers
pennsylvania
cancer
biolog
lerner
research
institut
cleveland
clinic
murin
coronaviru
mhv
accessori
protein
phosphodiesteras
inhibit
activ
interferon
ifn
induc
oligoadenyl
synthetas
oa
rnase
l
pathway
facilit
viral
replic
macrophag
lineag
cell
induc
hepat
howev
effici
mhv
replic
brain
subsequ
enceph
independ
enzymat
activ
compar
liver
peripher
organ
cn
express
lower
basal
level
ifnstimul
gene
includ
sever
oass
requir
rnase
l
activ
thu
hypothes
express
oa
cn
suffici
activ
rnase
l
mhv
infect
inde
mhv
mutant
express
inact
protein
replic
similar
extent
wild
type
wt
viru
cn
compar
replic
wt
bone
marrow
deriv
macrophag
primari
microglia
neuron
astrocyt
oligodendrocyt
contrast
restrict
replic
macrophag
microglia
wt
replic
similar
kinet
primari
cell
addit
induc
rnase
l
activ
assess
ribosom
rna
rrna
cleavag
myeloidderiv
cell
fail
cell
type
parenchym
cell
pretreat
ifn
restrict
wt
similar
extent
indic
inhibit
due
rnase
l
activ
howev
astrocyt
neuron
compet
rnase
l
activ
cleav
rrna
transfect
poli
c
thu
rnase
l
activ
depend
viru
kinet
infect
ifn
induct
furthermor
express
rel
high
level
oa
gene
necessari
suffici
induct
effect
rnase
l
antivir
respons
activ
rnase
l
mute
cn
perhap
prevent
potenti
destruct
effect
unrestrict
activ
nonrenew
cell
dionna
w
kathryn
susan
joan
w
present
author
dionnawilliam
phdeinsteinyuedu
patholog
albert
einstein
colleg
medicin
medicin
epidemiolog
popul
health
albert
einstein
colleg
medicin
neurolog
neurosci
patholog
mount
sinai
school
medicin
patholog
microbiolog
immunolog
albert
einstein
colleg
medicin
hiv
enter
cn
earli
primari
infect
result
hand
hiv
associ
neurocognit
disord
hiv
infect
individu
despit
success
combin
antiretrovir
therapi
cart
monocyt
critic
cell
involv
hand
bring
viru
cn
upon
transmigr
across
blood
brain
barrier
bbb
subset
circul
matur
monocyt
express
surfac
highli
suscept
hiv
infect
accumul
brain
hand
mechan
matur
monocyt
transmigr
across
bbb
fulli
understood
previous
demonstr
use
vitro
cultur
system
diapedesi
monocyt
across
bbb
facilit
junction
protein
alcam
jama
character
monocyt
subset
hiv
infect
individu
manhattan
hiv
brain
bank
women
interag
hiv
studi
cohort
found
monocyt
popul
present
significantli
greater
number
irrespect
cart
statu
viral
load
count
gender
compar
individu
without
hiv
determin
monocyt
peopl
preferenti
transmigr
across
vitro
model
human
bbb
respons
potent
monocyt
chemoattract
elev
cn
hiv
infect
peopl
hand
monocyt
isol
hiv
seroposit
individu
higher
surfac
express
alcam
jama
rel
hiv
seroneg
peopl
block
antibodi
alcam
jama
inhibit
transmigr
monocyt
baselin
level
suggest
import
facilit
monocyt
transmigr
across
bbb
target
increas
junction
protein
present
monocyt
deriv
hiv
infect
peopl
preferenti
infiltr
cn
repres
novel
therapeut
strategi
may
reduc
ongo
chronic
neuroinflamm
occur
hiv
neuropathogenesi
kimberli
william
dierdr
killebrew
gillian
clari
youmei
xie
rick
meeker
present
author
williak
emailuncedu
univers
north
carolina
chapel
hill
hiv
activ
macrophag
microglia
cell
central
nervou
system
cn
trigger
secret
unknown
neurotoxin
thought
caus
neuron
damag
macrophag
phenotyp
control
extens
extracellular
signal
influenc
brain
deriv
signal
macrophag
phenotyp
poorli
understood
recent
shown
human
macrophag
monocyt
express
trka
neurotrophin
receptor
respond
natur
ligand
nerv
growth
factor
ngf
flow
cytometri
show
decreas
receptor
trka
human
monocyt
stimul
hiv
virion
prongf
hiv
ngf
hiv
increas
receptor
stimul
macrophag
hiv
also
caus
prolong
calcium
accumul
block
pretreat
ngf
prongf
pretreat
howev
result
spike
calcium
activ
macrophag
block
neutral
antibodi
hiv
coreceptor
suggest
interact
neurotrophin
chemokin
receptor
ngf
prongf
also
oppos
effect
macrophag
neurotoxin
secret
assess
calcium
dysregul
rat
cortic
neuron
hiv
virion
result
increas
neurotox
activ
macrophag
condit
medium
pretreat
ngf
partial
suppress
prongf
exacerb
neurotox
rearrang
actin
cytoskeleton
macrophag
polar
podosom
locat
also
seen
neurotrophin
hiv
stimul
prongf
stimul
result
increas
polar
podosom
compar
ngf
neuron
signal
pro
matur
form
neurotrophin
result
oppos
action
pro
matur
form
ngf
may
also
exert
oppos
regul
monocytemacrophag
phenotyp
base
data
conclud
matur
ngf
promot
less
destruct
macrophag
phenotyp
prongf
may
increas
neurotox
pharmacolog
control
interact
may
provid
new
therapeut
avenu
treatment
hivassoci
cognit
disord
nih
grant
jean
william
michael
vanessa
benjama
adam
shendra
brandon
wen
brian
rui
david
sharon
jeffrey
brian
present
author
jeanwilliam
drexelmededu
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
consult
ltd
biostatist
epidemiolog
center
clinic
epidemiolog
biostatist
univers
school
medicin
infecti
diseas
hiv
medicin
depart
medicin
drexel
univers
colleg
medicin
current
clinic
studi
focus
identif
ltr
snp
deriv
peripher
blood
pb
patient
enrol
drexelm
hivaid
genet
analysi
cohort
philadelphia
identifi
individu
prone
develop
advanc
diseas
andor
neurolog
dysfunct
patient
demograph
clinic
paramet
includ
drug
use
tcell
count
viral
load
perform
everi
visit
drug
abus
common
within
cohort
cocain
use
favor
cohort
categor
nonus
pn
preferenti
cocain
pc
multidrug
user
mdu
snp
identifi
associ
tcell
count
viral
load
snp
also
identifi
uniqu
drug
abus
categori
use
silico
sensit
analysi
abl
determin
signific
differ
transcript
factor
footprint
site
variat
atog
posit
significantli
differ
pn
pc
pn
mdu
subcohort
addit
atog
alter
posit
within
cebp
site
ii
found
signific
psychomotor
construct
neuropsycholog
impair
patient
previou
studi
shown
posit
increas
affin
cebp
beta
increas
basal
ltr
activ
decreas
preval
pbderiv
ltr
patient
increas
diseas
progress
increas
preval
brainderiv
ltr
result
suggest
cocain
may
appli
select
pressur
respect
genet
architectur
ltr
within
critic
bind
site
work
support
nihnind
nida
nimh
nimh
clayton
winkler
tyson
wood
karin
e
peterson
present
author
claytonwinkl
nihgov
laboratori
persist
viral
diseas
rocki
mountain
lab
niaid
nih
la
cross
viru
lacv
primari
caus
pediatr
arboviru
enceph
unit
state
result
sever
neurolog
symptom
even
death
lacv
enceph
character
perivascular
infiltr
leukocyt
central
nervou
system
cn
neuron
death
howev
mechan
lead
leukocyt
infiltr
role
cell
lacv
pathogenesi
remain
unclear
intraven
inject
evan
blue
dye
demonstr
increas
vascular
leakag
cn
day
post
infect
dpi
prior
onset
neurolog
diseas
brain
endotheli
cell
time
point
show
decreas
express
primari
compon
endotheli
tight
junction
well
increas
express
involv
leukocyt
recruit
find
suggest
cn
blood
vessel
lacv
infect
anim
permiss
cellular
infiltr
prior
neurolog
sign
examin
cn
infiltr
determin
activ
monocytesmacrophag
cell
present
number
peak
neurolog
diseas
onset
inflammatori
monocytesmacrophag
far
predomin
infiltr
popul
found
close
associ
area
neuron
infect
suggest
may
relev
neurolog
diseas
concordantli
deplet
cell
present
low
number
alter
kinet
onset
diseas
suggest
infiltr
critic
neurolog
diseas
develop
interestingli
mice
suscept
lacv
cn
infect
wildtyp
control
suggest
b
cell
antibodi
respons
protect
role
diseas
pathogenesi
howev
b
cell
infiltr
observ
suggest
role
lacvinduc
neurolog
diseas
distant
cn
collect
role
infiltr
monocytesmacrophag
still
investig
conclud
adapt
immun
cell
infiltr
cn
appear
influenc
develop
lacvinduc
neurolog
diseas
valeri
joyc
dianedi
toro
yolanda
marang
richard
melissa
marin
calribel
loyda
bruce
present
author
upredu
puerto
rico
medic
scienc
campu
puerto
rico
hopkin
univers
hawaii
background
hivassoci
neurocognit
disord
hand
persist
spite
antiretrovir
therapi
recent
data
demonstr
high
dna
circul
activ
monocyt
associ
hand
activ
monocyt
dna
migrat
brain
may
repres
csf
viral
reservoir
studi
shown
correl
oxid
stress
hand
therefor
propos
determin
relationship
dna
csf
cell
oxid
stress
hand
method
retrospect
review
perform
prospect
collect
clinic
data
sampl
cohort
hivseroposit
hispan
women
stratifi
cognit
impair
normal
asymptomat
mild
impair
dna
measur
csf
cell
use
real
time
pcr
csf
oxid
stress
marker
detect
dotblot
analysi
protein
carbonyl
pc
oxi
dotblot
cognit
perform
determin
establish
criteria
parametr
nonparametr
statist
use
result
posit
associ
observ
higher
dna
copycel
csf
cell
use
cart
control
cart
use
neg
correl
higher
dna
blood
cell
wors
perform
trail
make
b
tmb
verbal
memori
test
neg
correl
also
observ
csf
cell
higher
dna
copycel
lower
csf
level
pc
conclus
increas
dna
correl
wors
cognit
perform
increas
dna
csf
cell
correl
lower
csf
oxid
stress
level
find
may
suggest
persist
csf
viral
reservoir
contain
latent
viru
grant
support
partial
hassen
wollebo
kamel
khalili
mahmut
safak
martyn
white
present
author
templeedu
depart
neurosci
center
neurovirolog
templ
univers
school
medicin
philadelphia
human
polyomaviru
jc
jcv
etiolog
agent
rare
devast
neurolog
diseas
progress
multifoc
leukoencephalopathi
global
preval
infect
jcv
high
jcv
believ
persist
latent
state
primari
infect
even
though
jcv
common
popul
pml
extrem
rare
suggest
viru
tightli
regul
cellmedi
immun
previous
laboratori
other
shown
jcv
promot
transcript
activ
regul
multipl
transcript
factor
provid
evid
jc
viru
promot
activ
goe
anoth
level
regul
epigenet
event
involv
protein
acetyl
found
histon
deacetylas
inhibitor
profoundli
stimul
transcript
earli
late
jc
viru
promot
transient
transfect
experi
stabl
earli
late
report
cell
line
suggest
acetyl
statu
histon
may
import
mechan
control
latenc
reactiv
statu
jcv
anjana
lorrain
michael
denni
ronald
present
author
ayadav
mailmedupennedu
medicin
univers
pennsylvania
school
medicin
neurolog
univers
pennsylvania
school
medicin
microbiolog
univers
pennsylvania
school
medicin
associ
neurocognit
disord
hand
result
indirect
effect
mediat
activ
blood
monocyt
traffic
brain
activ
andor
infect
brain
macrophag
releas
inflammatori
chemokin
cytokin
includ
neurotox
mediat
glutam
hand
remain
major
problem
even
among
patient
antiretrovir
therapi
art
effect
viral
suppress
link
persist
immun
activ
inflamm
statin
hmgcoa
reductas
inhibitor
pleiotrop
immunomodulatori
properti
mediat
effect
intracellular
signal
transduct
pathway
first
investig
immunomodulatori
effect
lipophil
statin
simvastatin
atorvastatin
human
monocytemacrophag
activ
vitro
statin
treatment
reduc
monocyt
popul
follow
lp
stimul
strongli
suppress
product
activ
pbmc
statin
treatment
also
strongli
inhibit
monocyt
chemotaxi
demonstr
statin
inhibit
product
neurotoxin
glutam
infect
macrophag
also
direct
neuroprotect
effect
rat
neuron
expos
macrophagehiv
supernat
carri
small
open
label
vivo
pilot
studi
five
hiv
art
subject
treat
atorvastatin
week
follow
washout
period
small
number
subject
atorvastatin
treatment
associ
trend
toward
decreas
total
monocyt
reduc
mean
fluoresc
intens
monocyt
declin
plasma
hscrp
treatment
period
observ
suggest
potenti
statin
candid
adjuv
treatment
prevent
hand
modul
monocytemacrophag
function
antiinflammatori
effect
warrant
larger
random
clinic
trial
longer
treatment
period
lu
tomohisa
shilpa
present
author
luyang
unmcedu
pharmacolog
experiment
neurosci
univers
nebraska
medic
center
toxicolog
school
pharmaci
pharmaceut
scienc
hoshi
univers
tokyo
although
art
effect
suppress
viral
suppress
express
viral
protein
tat
remain
unaffect
turn
could
lead
chronic
activ
glia
result
neuroinflamm
er
stress
recent
implic
play
import
role
impair
cn
homeostasi
hiv
patient
respons
er
stress
cell
activ
set
tightli
control
regulatori
program
unfold
protein
respons
upr
restor
normal
function
er
howev
er
stress
sustain
adapt
upr
fail
elimin
unfoldedmisfold
protein
balanc
shift
apoptosi
mechan
clear
stress
protein
hypothes
tat
mediat
activationapoptosi
astrocyt
involv
er
stress
respons
preliminari
data
demonstr
hiv
tat
induc
er
stress
astrocyt
activ
three
upr
pathwaysperk
accompani
disrupt
calcium
homeostasi
gener
reactiv
oxid
stress
ro
induct
apoptosi
particular
interest
chaperon
receptor
critic
er
stress
intriguingli
overexpress
astrocyt
significantli
decreas
tatmedi
ro
gener
inhibit
express
proapoptot
chop
protein
reciproc
knock
result
decreas
express
antiapoptot
increas
cellular
apoptosi
could
envis
critic
modul
glial
cell
surviv
may
import
target
therapeut
intervent
hand
yonggang
zhang
fan
yang
rafal
kaminski
fang
li
kamel
khalili
wenhui
hu
present
author
zygot
templeedu
neurosci
center
neurovirolog
templ
univers
school
medicin
nibp
nik
protein
novel
protein
enhanc
cytokineinduc
nfkb
activ
requir
neuron
differenti
tnfalpha
well
known
stimul
nfkb
activ
contribut
cytokineinduc
reactiv
hypothes
nibp
may
regul
infect
reactiv
via
nfkb
signal
test
perform
long
termin
repeat
ltr
driven
fireflyluciferas
report
assay
use
mous
brain
neural
stemprogenitor
cell
human
fibroblast
nibp
delet
surpris
nibp
overexpress
mous
neural
stemprogenitor
cell
significantli
inhibit
constitut
tnfalphainduc
ltr
promot
activ
inhibit
independ
nfkb
signal
nfkb
sitedelet
ltr
mutant
inhibit
tnfalphainduc
ltr
activ
prevent
nibpinduc
inhibit
valid
cell
speci
includ
human
fibroblast
breast
cancer
cell
well
rabbit
colon
smooth
muscl
cell
interestingli
ltrluciferas
activ
increas
nibp
delet
fibroblast
cell
patient
mental
retard
overexpress
nibp
fibroblast
rescu
inhibit
nibp
known
interact
bovin
viral
diarrhea
viru
nonstructur
protein
hijack
nibpmedi
nfkb
activ
coimmunoprecipit
assay
cell
cotransfect
flagtag
nibp
cfptag
tat
yfptag
vpr
vector
show
nibp
nibp
interact
tat
nibp
interact
vpr
data
suggest
nibp
may
act
novel
restrict
factor
suppress
transcriptionreactiv
interact
viral
protein
interact
may
hijack
nibpmedi
nfkb
activ
sinc
nibp
highli
express
nonpermiss
neuron
permiss
microgliamacrophag
cell
nibp
gene
therapi
may
serv
novel
approach
treat
neuroaid
wen
vanessa
michael
shendra
nirzari
benjama
william
peter
yvonn
christian
david
brian
rui
jeffrey
brian
present
author
laindh
microbiolog
immunolog
center
molecular
virolog
translat
neurosci
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
microbiolog
immunolog
center
immunolog
vaccin
scienc
institut
molecular
medicin
infecti
diseas
drexel
univers
colleg
medicin
patholog
drexel
univers
colleg
medicin
neurolog
drexel
univers
colleg
medicin
consult
ltd
biostatist
epidemiolog
center
clinic
epidemiolog
biostatist
univers
pennsylvania
school
medicin
infecti
diseas
hiv
medicin
depart
medicin
drexel
univers
colleg
medicin
introduct
haart
result
significantli
lower
mortal
rate
culmin
hiv
epidem
increasingli
affect
older
adult
emphas
import
understand
risk
factor
associ
age
infect
addit
immun
failur
commonli
occur
age
hiv
infect
current
studi
focu
impact
age
ltr
signatur
correl
clinic
paramet
includ
tcell
count
viral
load
vl
prospect
longitudin
studi
conduct
patient
current
enrol
drexelm
hivaid
genet
analysi
cohort
philadelphia
pa
histori
illicit
drug
alcohol
medic
use
tcell
count
viral
load
along
patient
histori
includ
age
collect
approxim
everi
month
use
linear
mix
model
longitudin
data
determin
viral
snp
significantli
correl
increas
age
addit
age
modifi
snp
effect
respect
tcell
count
vl
differ
degre
infect
age
also
known
immunomodulatori
effect
cytokin
profil
adult
age
individu
analyz
understand
impact
age
infect
cytokin
modul
diseas
sever
interestingli
among
cytokin
investig
cytokin
profil
appear
differ
two
popul
addit
appear
number
snp
correl
age
effect
cytokin
level
conclus
age
context
infect
appear
impact
viral
gene
express
immun
activ
work
support
nihnind
nida
nimh
nimh
jun
zhu
adrian
gomez
narasimha
midd
present
author
zhuj
sccpscedu
depart
drug
discoveri
biomed
scienc
south
carolina
colleg
pharmaci
univers
south
carolina
columbia
sc
central
dopamin
da
neurotransmiss
play
crucial
role
develop
neurocognit
dysfunct
patient
associ
neurocognit
disord
hand
demonstr
tat
protein
vitro
inhibit
da
transport
dat
alloster
modul
cocain
bind
site
dat
rat
striatal
synaptosom
cell
express
human
dat
understand
vivo
express
viral
protein
influenc
dat
function
kinet
analysi
da
uptak
prefront
cortex
pfc
striatum
bind
striatum
determin
transgen
fisher
rat
compar
fisher
rat
maxim
veloc
vmax
datmedi
da
uptak
prefront
striatal
synaptosom
rat
increas
respect
wherea
km
valu
da
uptak
reduc
striatum
pfc
rat
addit
rat
exhibit
decreas
maxim
bind
site
bmax
increas
da
uptak
turnov
rate
vmaxbmax
striatum
compar
fisher
rat
explor
potenti
mechan
underli
alter
dat
function
rat
ongo
studi
determin
whether
increas
da
uptak
region
due
redistribut
membran
dat
chang
datassoci
protein
membran
microdomain
collect
result
suggest
neuroadapt
chang
occur
rat
might
help
compens
viral
proteininduc
inhibit
dat
function
support
grant
nih
jun
zhu
christin
lucio
janic
celina
amilcar
present
author
mczink
jhmiedu
hopkin
univers
school
medicin
genet
feder
univers
rio
de
janeiro
rio
de
janeiro
rj
brazil
develop
sivpigtail
macaqu
model
result
rapid
develop
cn
diseas
aid
provid
robust
model
test
antiretrovir
neuroprotect
therapeut
strategi
also
demonstr
obtain
suppress
plasma
vrna
detect
level
use
combin
three
differ
class
antiretrovir
drug
cn
penetr
nonpenetr
last
year
number
hivinfect
patient
experienc
least
function
cure
berlin
patient
mississippi
child
french
cohort
ceas
antiretrovir
therapi
without
viral
reactiv
develop
diseas
initi
search
way
duplic
natur
experi
recent
number
compound
abl
activ
hiv
dna
suggest
coadjuv
cart
therapi
propos
antiretrovir
drug
would
prevent
viral
spread
host
lymphocyt
would
kill
reactiv
infect
cell
express
viral
protein
investig
hexano
deriv
ingenol
kyoiib
phorbol
ester
isol
euphorbia
tiruc
kyoiib
treatment
rest
cell
isol
viru
suppress
sivinfect
macaqu
led
signific
increas
reactiv
latent
cell
viral
rna
transcript
pilot
trial
sivinfect
macaqu
kyoiib
administ
escal
dose
oral
bid
one
week
altern
offtreat
week
activ
marker
blood
leukocyt
plasma
viral
load
increas
treatment
decreas
washout
period
contrast
phorbol
ester
kyoiib
less
toxic
oral
administ
anim
appar
side
effect
plan
treat
viru
suppress
sivinfect
macaqu
kyoiib
determin
abil
compound
reactiv
siv
vivo
reduc
number
siv
latent
infect
rest
cell
monocyt
macrophag
proofofconcept
function
hiv
cure
meredith
zoch
sarah
price
jeann
sisk
lucio
gama
janic
clement
present
author
jhmiedu
depart
molecular
compar
pathobiolog
john
hopkin
univers
school
medicin
baltimor
md
major
barrier
erad
hiv
persist
viru
latent
reservoir
cell
wide
studi
rest
cell
consid
major
latent
reservoir
hiv
siv
infect
hiv
siv
replic
activ
cell
small
percentag
cell
becom
rest
memori
cell
infect
harbor
latent
viru
monocyt
macrophag
microglia
brain
shown
support
hiv
siv
infect
hiv
siv
infect
individu
combin
antiretrovir
therapi
viral
dna
found
brain
ongo
chang
brain
suggest
viru
persist
latent
recent
focu
erad
hiv
identif
latent
viral
reservoir
becom
crucial
howev
littl
understood
mechan
hiv
siv
latenc
myeloid
cell
cn
astrocyt
abund
cell
brain
also
infect
hiv
siv
infect
product
order
character
viral
latenc
macrophag
microglia
astrocyt
develop
vitro
primari
cell
latenc
model
order
recapitul
environ
cn
cytokin
use
determin
role
establish
viral
latenc
macrophag
microglia
astrocyt
shipe
kurt
pamela
present
author
szou
vcuedu
anatomi
neurobiolog
virginia
commonwealth
univers
pharmacolog
toxicolog
virginia
commonwealth
univers
myelin
pallor
frequent
report
hiv
patient
occur
cn
prior
evid
diseas
process
oligodendrocyt
ol
myelin
cell
cn
highli
vulner
excitotox
due
fact
nmda
receptor
nmdar
express
ol
weakli
block
ampa
receptor
ampar
ol
lack
hypothes
tat
transactiv
transcript
activ
nmdar
ampar
turn
lead
influx
ol
injuri
repeat
measur
experi
establish
nm
toxic
immatur
ol
matur
ol
hand
matur
ol
expos
nm
tat
exhibit
reduc
myelinlik
membran
area
indic
potenti
injuri
cell
morpholog
function
investig
effect
mediat
via
use
quantifi
within
individu
cell
matur
mbp
immatur
ol
mbp
expos
nm
tat
show
dosedepend
gradual
increas
nm
vs
nm
control
high
level
maintain
h
experiment
period
tatinduc
increas
complet
abolish
medium
suggest
extracellular
primari
sourc
nmdar
antagonist
reduc
tatinduc
increas
immatur
matur
ol
surprisingli
ampakar
antagonist
cnqx
also
attenu
tatinduc
influx
ol
suggest
nmdar
ampakar
ol
activ
tat
importantli
cnqx
block
tatinduc
immatur
ol
death
revers
tatinduc
matur
ol
membran
area
chang
result
add
evid
suggest
ol
target
hiv
also
suggest
viabil
phenotyp
chang
immatur
matur
ol
respect
may
involv
differ
glutamaterg
mechan
author
index
aron
aronow
aarthi
narayanan
ada
francia
adam
wojno
adarsh
kumar
aditya
bade
adrian
gomez
adriana
bora
adriano
ferrucci
ahmet
ozdemir
ajay
bharti
ako
vert
alashl
abimiku
alessandra
mei
alessia
bachi
alex
dicken
alexand
choe
alexand
gill
alexandra
carid
alfredo
garzinodemo
alina
popescu
hategan
allen
reitz
allyssia
boelk
amanda
brown
amanda
j
morgan
amanda
robert
amber
paul
amilcar
tanuri
ana
sanchez
anasta
popratiloff
andrea
bucci
andrea
cuconati
andrea
partridg
andrea
raymond
andrew
miller
andrew
g
maclean
andrew
levin
andrew
miller
andrew
talal
anjana
yadav
ann
ragin
ann
wyborni
anna
bellizzi
anna
blackmon
anna
heintzman
anna
teresa
palamara
ann
blackwel
ann
lamontagn
antonina
dolei
antonio
giordano
anya
umlauf
apurva
kulkarni
archana
gupta
arthur
feldman
asha
kallianpur
ashley
azar
ashok
verma
avindra
nath
ayman
bodair
ayuna
v
dagdanova
barbara
krynska
barbara
slusher
barri
waterhous
beau
anc
bei
li
ben
gouaux
benchawanna
soontornniyomkij
benedikt
kaufer
benjama
aiamkitsumrit
benjamin
lepen
benjamin
b
gelman
bezawit
megra
bezawit
megra
bianca
tigg
biju
issac
bill
switzer
bindesh
shrestha
bing
sun
biswajit
da
bogdan
fgh
popescu
bradley
nash
brandon
blakey
brandon
bullock
breanna
caruso
brenna
duffi
brent
palmer
brian
augelli
brian
daniel
brian
draper
brian
frantz
brian
moldov
brian
wigdahl
bridgett
jeann
billioux
brigitt
simon
bruce
brew
bruce
shiramizu
c
conov
talbot
jr
caitlin
duffi
calribel
gonzalez
camilla
carloni
camilo
roja
cari
dowl
cari
fritzfrench
carlo
amorin
daep
carol
petito
carolina
ionet
carolin
anderson
caterina
serra
caterina
turco
catherin
foss
cecilia
shikuma
cecili
midkiff
ceereena
ubaida
mohien
celina
abreu
charl
eberhart
charl
f
mactutu
charl
grose
charl
reynold
chelsea
bleckwehl
chen
sabrina
tan
chen
zeng
chigo
eze
chri
gutoskey
christian
sell
christian
wuethrich
christina
kollia
christina
preming
christina
schier
christoph
ziegenhain
christoph
akolo
christoph
coe
christoph
power
christoph
power
claribel
gonzalez
claudia
avalo
claudia
f
lucchinetti
claudia
hernandez
claudia
hilera
claudio
torr
clayton
winkler
colleen
kovacs
cori
teuscher
cristian
achim
cynthia
munro
cyru
de
rozier
dan
barouch
dan
duiculescu
danelvi
parad
daniel
c
anthoni
daniel
reich
davey
smith
david
alsop
david
alvarez
david
avigan
david
broadhurst
david
colquhoun
david
downi
david
graham
david
hackney
david
holman
david
j
nolan
david
libon
david
mohr
david
moor
david
r
graham
david
roh
debasi
nayak
debbi
brown
debjani
guha
deepika
dinesh
deni
chatelain
denni
kolson
dian
griffin
dian
k
brandt
dianedi
toro
niev
dianna
cheneypet
diann
c
daniel
diann
langford
diego
franciotta
diego
ojeda
dierdr
killebrew
dilip
jest
dionna
w
william
divya
sagar
gilden
donatella
maria
rodio
dora
schnur
dorian
mcgavern
dorothi
kisielewski
edgar
busovaca
edward
harhaj
edward
j
grace
edward
johnson
edward
makarov
eileen
deharo
eileen
martin
elena
anzivino
elena
colombo
elena
uleri
eliez
masliah
eliseo
eugenin
elizabeth
blankenhorn
elizabeth
crow
elizabeth
jaworski
elizabeth
norton
elizabeth
podhaiz
ellen
tedaldi
elys
singer
emilio
dimitriadi
emili
leibovitch
emma
wall
eric
cohen
eric
miller
erica
l
gray
eridania
vald
erin
roach
erin
shirk
eugen
major
evamaria
ratai
evelyn
borad
evelyn
bord
evgenia
gerasimovskaya
fabio
romerio
fan
yang
fang
li
fatah
kashanchi
fengbin
song
ferdinand
maingat
fiorella
rossi
florin
tuluc
francesca
de
simon
francesca
elia
franci
novembr
francoi
villing
frank
bearoff
fred
c
kreb
gabriel
lehmick
gavin
sampey
gayl
baldwin
gillian
clari
giordano
madeddu
giovanna
brunetto
girish
hemashettar
giusepp
mame
giusepp
russo
glen
baker
gloria
von
geldern
gokul
swaminathan
govind
nair
grace
lu
gratiela
tardei
gregori
antel
gwenn
garden
haip
hao
hamid
akbarali
han
rempel
hao
chen
harri
davi
hassen
wolllebo
heidi
kay
holli
dykstra
howard
gendelman
howard
rosen
howard
fox
hugh
perri
ibolya
e
andra
igor
grant
igor
koralnik
igor
traktinskiy
ilker
sariy
iren
catalan
iren
cortes
iren
guendel
iren
dustin
irwin
chaiken
iryna
lobach
italo
mocchetti
jacalyn
rosenblatt
jaclyn
knibb
jacob
raber
jacob
sloan
jacquelin
bowlin
jacquelin
coley
jame
artho
jame
connor
jame
lokensgard
jame
becker
jami
dorsey
jane
kovalevich
jane
libbey
janic
clement
jasmeet
sethi
jasmin
herz
jasmin
vassileva
jasmin
sharazi
javier
sierra
jay
rappaport
jayasri
da
sarma
jean
manson
jean
william
jeann
sisk
jed
shumski
jeffrey
jacobson
jeffrey
kowalak
jennif
gordon
jennif
h
campbel
jennif
manfredo
jennif
mcguir
jennif
p
bharucha
jeremi
hill
jeremi
j
martinson
jessica
krueger
jessica
ott
jessica
rotschaf
jesu
fernandez
jewel
thoma
jiasheng
song
jiri
forejt
joan
berman
joan
ohayon
joan
w
berman
john
fazakerley
john
meshki
john
schreiber
john
walsh
jonathan
carter
jonathan
geiger
jonathan
karn
jonathan
oakley
jorg
quarleri
joseph
bryant
joseph
cheung
joseph
e
parisi
joseph
hardardt
joseph
mankowski
joseph
steiner
joshua
lisinicchia
joshua
thornbrough
joy
ngwainmbi
joyc
balinang
joyc
johnson
joyc
velez
juan
orellana
juan
c
saez
juhi
motiani
julio
martingarcia
jun
zhu
jussi
oskari
virtanen
jussi
virtanen
justin
mcarthur
kalamo
farley
kamel
khalili
kanayo
okwuasaba
kareem
zaghloul
karim
garcia
karin
peterson
kasra
houshmand
katherin
p
rankin
katherin
taylor
kathleen
kelli
kathryn
anasto
kathryn
medder
kati
kercher
kaushiki
biswa
kaylan
fenton
kelli
metcalf
pate
kelsi
fri
kenneth
johnson
kenneth
shindler
kenneth
william
kenta
matsuda
kevin
bloh
kevin
egan
kimberli
william
kori
johnson
kri
hogan
krista
siefri
kristen
n
fantetti
kristof
jen
kurt
hauser
kyle
lord
kylen
kehnhal
l
dillon
birdwel
landh
moran
lara
doylemey
larisa
poluektova
laura
mccourt
laur
case
lauren
odonnel
lauren
wendelken
lawrenc
c
kenyon
lawrenc
kingsley
lee
campbel
lena
alharthi
leonard
shultz
liang
hui
lillian
cruzorengo
lilli
lopez
lili
franci
linda
chang
lindsay
eyzaguirr
lindsay
festa
lindsey
gerngross
ling
zhao
lisa
henderson
lisa
mangu
lishomwa
c
ndhlovu
lita
murphi
lola
hudson
long
ngo
lorrain
kolson
loyda
melendez
lu
yang
lucett
cysiqu
lucia
nencioni
luciana
poddigh
lucio
gama
lui
b
tovaryromo
luke
ollila
luminita
ene
luzjeannett
sierra
lynn
pulliam
christin
zink
madhavan
nair
mahendra
kumar
mahmut
safak
mailan
ho
mallori
witt
manohar
mutnal
manuela
morreal
marang
huerta
marcu
kaul
margaret
j
wortman
maria
nagel
maria
nica
mariana
cherner
mariana
cherner
mariana
figuera
losada
mariann
strazza
marin
plaud
marion
stein
mark
lafferti
mark
lewi
mark
p
mattson
marku
helfer
marlen
kanmong
martha
schneider
martin
pomper
martyn
white
mari
barb
mari
wellish
matt
thoma
matteo
gastaldi
matthew
anderson
matthew
brier
matthew
cusick
matthew
rimbey
matthew
taylor
maureen
mccarthi
maureen
richard
mauricio
caroben
maxim
cheeran
maya
desai
megan
cochran
melani
hoefer
melani
seaton
melissa
agsaldagarcia
melissa
agsalda
melissa
wasilewski
meredith
zoch
michael
bett
michael
boska
michael
ferenczi
michael
khouri
michael
marvi
michael
nonnemach
michael
park
michael
weaver
michael
wong
michal
toborek
michelin
mccarthi
michel
mielk
michel
potter
mihyun
bae
mike
veenstra
min
zhan
ming
guo
ming
li
miriam
mato
moham
saifuddin
mohit
sehgal
moniqu
anderson
moniqu
maubert
mudit
tyagi
mylyn
tham
myosoti
rodriguez
myounghwa
lee
myraida
moral
myriam
gorosp
myung
chung
nagagop
venna
nana
merabova
nanci
minniti
nanci
reichenbach
naomi
lee
narasimha
midd
naresha
saligrama
natalia
sejbuk
natali
chen
nazira
elhag
nazli
shafagati
neal
shah
ned
sacktor
nelli
khmeleva
nichola
baird
nicol
renner
nicol
haverland
nikolau
osterried
nino
tabatadz
nirzari
parikh
norman
haughey
nyater
ngouth
ola
seln
olga
latinov
olimpia
meucci
onder
otlu
otoniel
martinezmaza
pallavi
chitturi
pamela
knapp
pankaj
seth
paolo
fortina
pardi
esmaeili
pascal
coric
pasqual
ferrant
patric
lundberg
patricia
vanc
patrick
autissi
patrick
lam
patrick
tarwat
paul
castellano
paul
pozniak
paul
shapshak
pawel
ciborowski
pedro
piccardo
peter
abbink
peter
dicki
peter
j
gaskil
peter
katsiki
peter
langfeld
philip
boyer
philip
kinkel
philipp
afonso
philipp
afonso
pooja
jain
pornpun
vivithanaporn
prachi
sharma
prasanta
dash
prasun
datta
pratima
agarw
priya
ganesan
r
gilberto
rachel
van
duyn
radhika
adiga
rafal
kaminski
raghothama
chaerkadi
rahsan
sariy
raissa
menendezdelmestr
randal
cohr
raphael
viscidi
rasha
el
baz
raul
gonzalez
ravi
da
ravi
mahalingam
ravi
tharakan
raya
massoud
raymond
ownbi
rebeca
geffin
reena
deutsch
renaud
mahieux
renno
fragkoudi
renzo
peraleslinar
ricardo
martinez
richa
tyagi
richard
moxley
iv
richard
skolaski
rick
meeker
ricki
maung
rinki
saha
robert
adam
robert
fujinami
robert
mathey
robert
poppiti
robert
silverman
roberto
bergamaschi
roberto
manetti
roberto
perez
robyn
klein
rodrigo
hasbun
roja
roxana
rolf
pfannl
ronald
collman
ronald
elli
ronald
ziman
rosa
hechavarria
rosa
janet
rodriguezbenitez
rosemari
booz
rossella
russo
roxana
radoi
roy
william
rui
feng
ruth
brackwern
ruth
elliott
ruth
ruprecht
ruturaj
masvekar
ryan
fassnacht
ryan
donnel
sagarika
banerje
samantha
molsberri
sami
sariba
sandra
chung
sandra
navasrey
sandra
reynold
sankar
addya
santhi
gorantla
sara
cioccolo
sarah
beck
sarah
gheuen
sarah
inati
sarah
j
bertrand
sarah
price
satarupa
sen
satind
dahiya
satish
deshman
scott
letendr
scott
schachtel
sebastian
perez
serena
delbu
serg
bouaziz
sergei
spitsin
sergey
iordanskiy
servio
ramirez
seth
sherman
shabana
shabbeermey
shaili
malik
shaojun
tang
shaona
acharje
sharon
lewi
shawn
keogan
shendra
passic
shet
masih
shilpa
buch
shipe
zou
shohreh
amini
shruti
agnihotri
shruti
singh
shuxian
hu
siddappa
byrareddi
silvia
carluccio
simona
pontecorvo
simona
ruta
simon
dallari
sivabalan
manivannan
slava
rom
sonia
navasmartin
sonia
shah
spyridon
chalkia
srimoy
banerje
sriniva
narasipura
stacey
reink
stephani
velasquez
stephani
batson
stephani
cross
stephani
jame
stephani
miln
stephani
min
stephen
jen
stephen
pojen
denq
steve
horvath
steve
jacobson
steven
b
harrod
steven
dougla
steven
jacobson
steven
wolinski
subo
yuan
sudheesh
pilakkakanthikeel
sudhir
penugonda
surendra
ambegaokar
susan
morgello
susan
v
westmoreland
susan
weiss
suzann
gartner
suzann
queen
svetlana
senina
swati
thorat
sylvia
fit
tatro
erick
tatyana
russo
tetyana
buzhdygan
thoma
broge
thoma
goodwin
thoma
marcott
thoma
waldmann
thuong
tran
tijana
knezev
timothi
w
claridg
timothi
nacarelli
tina
calderon
todd
reinhart
todd
schell
tom
freeman
tomohisa
mori
toni
robert
tori
johnson
tori
johnson
traci
fischersmith
tricia
burdo
tyler
clement
tyson
wood
umberto
girolami
unsong
oh
upal
roy
valentina
pecchenini
valeria
pietropaolo
valeri
wojna
vanessa
hirsch
vanessa
pirron
veera
venkata
ratnam
bandaru
velpandi
ayyavoo
venkata
subba
rao
atluri
vicki
trainadorg
victor
valcour
victoria
baxter
victoria
lutgen
victoria
pelak
vidya
sagar
vikram
durairaj
vipulkumar
patel
virawudh
soontornniyomkij
walter
royal
iii
walter
royal
wei
lin
wen
zhong
wendelin
wagner
wenhui
hu
wenxu
li
toperoff
william
blattner
william
h
theodor
william
tyor
william
yen
winston
liu
wonbin
young
wuyuan
lu
xavier
alvarez
xiaoen
wang
xin
dang
xuesong
chen
yamil
gerena
yize
li
yoelvi
garciamesa
yolanda
rodriguez
yonggang
zhang
yoshimi
enoseakahata
youmei
xie
yuetsu
tanaka
yuji
liu
yuqiang
shi
yuri
persidski
yutong
liu
yvonn
mueller
zafar
khan
